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Abstract 
Background 
Limited evidence is available to advise people with Type 1 diabetes about self-
management strategies for maintaining acceptable glycaemic control when 
exercising. It is recognized that hypoglycaemia is a potential risk and this is a major 
barrier towards exercise participation for these people. Related research exploring 
this topic has mostly been performed in laboratory environments.  
Aim  
Following a specifically designed self-management algorithm, the impact of the 
algorithm and environment (real-life versus laboratory) was investigated regarding 
the attainment of acceptable glucose concentrations during and after 40 minutes 
exercise at 70% VO2 max.  
Methods 
Nine individuals with Type 1 diabetes (five male, four female) completed the pilot 
study over a 2 week period. All used a basal bolus analogue insulin regimen and 
exercised regularly. On Days 1 and 3 of each week they undertook 40 minutes of 
moderate intensity exercise (day 1 and 8 in the laboratory, and day 3 and 10 in real-
life environments). All were instructed to follow the self-management algorithm. Data 
were collected for glucose concentrations at 10 time-points during and after exercise.  
Results 
Statistical analysis used a 3-way repeated measures ANOVA for time-points, 
environment and day, which demonstrated a highly significant main effect on time-
points [F(9, 72) = 4.088, p = < 0.005, partial eta squared = 0.338. During exercise 
the mean blood glucose difference was significantly lower from baseline to: 20 
minutes during, 2.21mmol/l (SE±0.354) (p=0.011), and 40 minutes at end 3.41mmol/l 
(SE±0.511) (p=0.007). However, the different environments did not have a significant 
main effect on the mean glucose concentration of participants [F(1, 8) = 1.489, p = 
0.257]. For the study period, 8 out of 9 participants experienced at least one 
hypoglycaemic episode. For hypoglycaemic episodes, the main differences between 
environments occurred: during exercise (laboratory n=5, real-life n=1), and during 8-
12 hours post-exercise (laboratory n=3, real-life n=8).  
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Conclusion  
There were differences in glycaemic patterns between environments when using a 
descriptive analysis. Despite post-exercise insulin reduction, nocturnal 
hypoglycaemia occurred in the real-life environment, and algorithm adjustments 
regarding carbohydrate consumption at bedtime were required for prevention. 
Therefore, a self-management recommendation for evening exercisers would be to 
perform blood glucose monitoring 8-12 hours after post-exercise insulin and 
consumption of carbohydrate. A larger study with the sample size to demonstrate 
significance, using the adjusted algorithm would clarify the reliability and efficacy of 
the algorithm in real-life. 
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Chapter One 
Background 
 
1.1 Introduction 
 
This chapter provides information to underpin the rationale of this study and includes 
an overview about Type 1 diabetes and patient self-management, healthcare, and 
the importance of achieving optimal glycaemic control. The short and long-term 
problems regarding blood glucose management are described, giving an insight into 
the challenges individuals encounter in their daily lives. Finally, self-management 
when performing physical activity will be discussed, concluding with the importance 
of the results of this research. 
 
 
“Diabetes is a condition primarily defined by the level of hyperglycaemia giving rise 
to risk of microvascular damage (retinopathy, nephropathy and neuropathy). It is 
associated with reduced life-expectancy, significant morbidity due to specific 
diabetes related microvascular complications, increased risk of macrovascular 
complications (ischaemic heart disease, stroke and peripheral vascular disease), 
and diminished quality of life.” (World Health Organization (WHO) 2006, p. 5).  
 
Diabetes Mellitus can been described as a modern day health endemic. The 
estimated number of people with diabetes worldwide is 347 million (Danaei et al 
2011cited by WHO 2013). With the prevalence of both Type 1 and Type 2 increasing 
globally, this has been shown to result in economic and social burdens for the 
person with diabetes and health systems, regarding both daily and long-term care 
(Dunning and Ward 2008). There are two main types of diabetes: Type 1 caused by 
pancreatic beta cell destruction resulting in absolute insulin deficiency, and Type 2 
which accounts for around 85% of those people with diabetes and is characterised 
by a relative insulin deficiency and resistance to insulin (Williams and Pickup 2004). 
Both types have different disease pathologies and thus require different treatments 
and approaches to healthcare.  
 
The current study presented in this thesis is directed to improve a common aspect of 
daily patient self-management regarding strategies for participation in physical 
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activity. From the author‟s clinical experience and the characteristics of Type 2 
diabetes, problems with erratic blood glucose and difficulties with tablet medication, 
insulin and dietary management when participating in exercise, do not appear to be 
such arduous challenges when compared with those with Type 1 diabetes. Thus for 
the purpose of this study, the target population was people with Type 1 diabetes. 
 
1.2 Type 1 diabetes management and care 
The most recent figures from the annual Scottish Diabetes Survey (2011), shows 
that Type 1 diabetes affects 28,272 people in Scotland. This demonstrates that 
diabetes is a fairly common chronic condition for many of the general public.  Type 1 
diabetes is an autoimmune disease which causes a destruction of the insulin–
producing beta cells found in the pancreas, and results in an abolition of insulin 
production (Watkins 2003). Insulin replacement is vital for survival otherwise death 
will occur, and the usual current treatment is insulin injection therapy (Dunning and 
Ward 2008).  
 
Presently, the most common method of insulin therapy attempts to mimic the natural 
beta cell activity in relation to glucose ingestion and energy requirements. This 
therapy is called a basal bolus regimen and involves administering a once or twice 
daily injection of a 24 hour acting insulin to provide background insulin (basal), and 
giving calculated fast-acting analogue insulin injections before meals or snacks 
containing carbohydrate (CHO) food (bolus). Exercise levels and CHO quantities 
influence the insulin dose calculation, and to attain optimal glycaemic control, a 
balance between the CHO amount, subsequent exercise and fast-acting insulin dose 
is essential otherwise hypoglycaemia or hyperglycaemia occurs.  
 
Treatment and care of diabetes focuses on education and patient empowerment to 
promote self-management, and within the Diabetes Health Care Professional (HCP) 
team, one of the main roles of the Diabetes Specialist Nurse (DSN) is to facilitate this 
to the best of the individuals‟ abilities. The author has practiced as a DSN for 14 
years, with specialist interest in caring for patients with Type 1 diabetes. Within daily 
living, there are multiple factors which impinge upon an individual‟s glucose 
homeostasis. These are associated with diet, exercise, stress and lifestyle issues 
(Perry and Gallen 2009).  Promoting self-management to achieve optimal glycaemic 
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control around lifestyle is one of the difficult challenges of the role of the DSN. 
Limited evidence-based guidelines makes offering advice and guidance difficult.  The 
guidelines available i.e. National Institute for Clinical Excellence (NICE) (2009) and 
Scottish Intercollegiate Guidelines Network (SIGN) (2010), offer general 
recommendations in lifestyle management in an attempt to achieve standardized 
best practice in the UK. However, advice is vague and for individuals to live their 
chosen lifestyle they must strive to adjust their treatment to maintain optimal 
glycaemic control and prevent the following complications.  
 
1.3 Acute and long-term complications of Type 1 diabetes 
People with Type 1 diabetes have an on-going and lifelong risk of developing 
physical problems due to abnormal glucose metabolism. These potential problems 
can be divided into acute and long-term complications (Watkins 2003). 
 
Acute complications 
Acute complications of Type 1 diabetes relate to hypoglycaemia and 
hyperglycaemia. Both can cause a varying range of unpleasant symptoms 
depending on the blood glucose concentration, and may require external assistance 
depending on the severity of the episode. They can be life-threatening and may 
require immediate attention to prevent medical intervention, and also cause 
psychological distress and have a major impact on an individual‟s life when 
attempting to avoid occurrence by treatment and lifestyle modification. 
 
 Hypoglycaemia 
Hypoglycaemia is a term used for any blood glucose concentration under 4.0mmol/l 
(SIGN 2010), and is a common day-to-day phenomenon when living with Type 1 
diabetes. Clinical symptoms include light headedness, tremor, confusion, 
unsteadiness, drowsiness and sometimes unconsciousness. The onset of 
hypoglycaemia is rapid and the speed of deterioration is dependent on active insulin 
and activity levels. Its rapid onset makes hypoglycaemia one of the most feared 
complications of diabetes (Frier 2008), and its prevention is one of the main aims of 
diabetes management. Hypoglycaemia is usually caused by either the administration 
of a greater insulin dose than required, increased exercise or inadequate CHO 
consumption (Dunning and Ward 2008).  The treatment will depend on the actual 
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blood glucose concentration and patient state, and will range between the person 
consuming dextrose, drinking glucose-containing fluids, massaging glucose gel into 
the buccal cavity and finally the administration of intramuscular Glucagon or 
intravenous glucose. Hypoglycaemia is an acute emergency that may have serious 
consequences.  For example, the Driver and Vehicle Licensing Agency (DVLA) 
published a driving regulations update and report (DVLA 2011), which stated that the 
penalty for a person with insulin-treated diabetes sustaining two severe 
hypoglycaemic episodes within a 12 month period, would result in a loss of their 
license to drive. 
 
 Hyperglycaemia 
Whereas hypoglycaemia is classed as a low blood glucose concentration, 
hyperglycaemia is generally termed as a blood glucose concentration over 9mmol/l 
(Montague et al 2005). Clinical symptoms include lethargy, polydipsia, polyuria, 
nocturia, blurred vision and weight loss. If blood glucose concentrations reach 
17mmol/l or above, a person is at potential risk of developing diabetic ketoacidosis 
(DKA), which is a medical emergency (Riddell and Perkins 2006) and can cause 
death if untreated. However, people with Type 1 diabetes may lapse into 
hyperglycaemic ranges on a regular basis and suffer from symptoms, but not 
encounter an emergency clinical state. Hyperglycaemia may be caused by either the 
administration of a reduced insulin dose, decreased exercise or increased CHO 
consumption (Dunning and Ward 2008). In comparison to hypoglycaemia, 
hyperglycaemia has a slower rate of progression to an emergency state, although 
mild hyperglycaemic symptoms can be unpleasant and debilitating for the individual. 
For hyperglycaemia in a non-ketotic state, the treatment is the administration of 
insulin, the dose being dependent on a range of individual issues i.e. blood glucose, 
current active insulin, preceding physical activity and CHO, and the underlying 
cause. 
 
Long-term complications  
As described above, hypoglycaemia and hyperglycaemia are a day-to-day 
phenomenon of living with diabetes. Other potential consequences are long-term 
complications, which are usually caused by sustained poor glucose and 
hyperglycaemic concentrations over years (Diabetes Control and Complications Trial 
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Research Group 1993). An indicator of this situation, which is monitored ideally 
every 3 – 6 months, is a laboratory blood test called an HbA1c, which gives the 
average blood glucose concentration over the previous 14-16 weeks (SIGN 2010), 
and clarifies overall glycaemic control and highlights patients with poor glycaemic 
control.  
 
For Type 1 diabetes the main micro and macro-vascular long-term complications 
include: retinopathy, nephropathy, neuropathy, cardiovascular problems and sexual 
dysfunction (Shaw and Cummings 2006). Depending on the stage of the 
complication, these symptoms can have a major impact on the quality of life and 
psychological well-being. The prevention or the delay of progression of long-term 
complications has not been incorporated into the research aim of this study. 
However, it is acknowledged that improvement of glycaemic control and increasing 
exercise behaviour for people with Type 1 diabetes, will affect many physiological 
factors. These factors could potentially minimise the risk of development, or 
progression of long-term problems, especially cardiovascular complications of 
diabetes. However, on the other hand, incorporating regular exercise into an 
individuals‟ daily life may precipitate daily self-management problems due to the 
effect on glycaemic control. 
 
1.4 Type 1 diabetes and exercise  
The impact of exercise on glycaemic control will now be discussed. The term 
physical activity or exercise has many interpretations, and for the purpose of this 
study, the defined term stated by the Scottish Intercollegiate Guidelines Network 
(SIGN) for diabetes (2010 p.17) was applied: 
 
 “Exercise is a subset of physical activity which is performed with the goal of 
enhancing or maintaining an aspect of fitness (e.g. aerobic, strength, flexibility, 
balance). It is often supervised (e.g. in a class), systematic and regular (e.g. jogging, 
swimming, attending exercise classes)”.   
 
The term VO2 max is the maximal capacity of an individuals‟ body to utilize oxygen 
during exercise i.e. volume, oxygen, maximum (Wilmore and Costill 2004).  In order 
to distinguish exercise intensity, a percentage value for VO2 max is the current 
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measurement used (Nagi 2008).  For the general population aged 18 – 64 years old, 
Department of Health (2009) recommended moderate intense exercise or exercise 
at 60 - 70% VO2 max, taken for 30 minutes duration for 5 days per week. This 
alludes to 60-70% of an individuals‟ maximum exercise capacity. To allow for 
individual adaptation and flexibility, this recommendation was amended to 2.5 hours 
per week rather than 5 days, for people with diabetes by SIGN (2010) and the World 
Health Organisation (WHO) (2010). By undertaking these recommendations, for a 
person with Type 1 diabetes, exercise can improve their quality of life and 
psychological well-being (Guelfi et al 2005), and also reduce cardiovascular risk 
factors that impact on mortality (Brazeau et al 2008). 
 
In view of this, exercise recommendations should be incorporated into diabetes 
patient education to support, encourage and empower patients to achieve the 2.5 
hour weekly target. To achieve these goals, patient motivation is crucial, in order to 
gain knowledge and experience to effectively manipulate insulin doses and 
carbohydrate intake (Kilbride et al 2011a). As current advice is not evidence-based, 
and self-management is generally achieved through trial and error over time (Gallen 
2004, Guelfi et al 2005), difficulties frequently arise during education when advising 
people with Type 1 diabetes on self-management when participating in exercise. 
Patients are often uncertain about diabetes management around exercise, and when 
using ad hoc self-management strategies they can experience acute complications 
(Kilbride et al 2011a) which cause confusion, upset, frustration and sometimes can 
be a reason for stopping all participation in exercise. These experiences and 
emotions were previously highlighted throughout a focus group analysis regarding 
patient perspectives relating to diabetes and exercise management (Kilbride et al 
2011a).   
The main implications for individuals are the potential risk of acute complications that 
can be a result of mismanagement. 
 
Hypoglycaemia and exercise 
Hypoglycaemia associated with exercise is the main deterrent for participation due to 
fear and anxiety (Brazeau et al 2008). Prior to exercise, hypoglycaemia delays the 
start of an exercise session as a person needs to consume CHO and wait until the 
blood glucose has risen to an acceptable level before exercise. During exercise they 
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may encounter a further hypoglycaemic episode due to depleted liver glycogen 
stores (Ertl and Davis 2004, Gravelling and Frier 2010). Hypoglycaemia during 
exercise results in diminished performance due to changed glycaemic levels, and the 
cessation of the exercise session. Post-exercise hypoglycaemia is also a risk 
especially for afternoon and evening physical activity which can result in nocturnal 
hypoglycaemia; a common fear for patients (Brazeau et al 2008, Lumb and Gallen 
2009). 
 
From clinical experience, the usual advice given by the author to prevent 
hypoglycaemia occurring from exercise was to recommend insulin dose reduction 
prior to the exercise. However, from experience with working with patients, and the 
focus group analysis describing challenges in Type 1 self-management regarding 
exercise (Kilbride et al 2011a), this tended to be the least preferred preventative 
measure for patients due to the uncertainty surrounding their physiology, insulin time 
actions and the required size of the dose reduction. The alternative action to prevent 
hypoglycaemia developing was increased CHO consumption. This intervention also 
presented problems as it was sometimes difficult to define the type and amount of 
CHO required and if, for example, weight management was one of the reasons for 
performing physical activity in the first place, increasing the CHO intake and also the 
associated calorific intake, was not desirable for some individuals.  
 
Hyperglycaemia and exercise 
For all patients, hypoglycaemia prevention is the ultimate goal during exercise, and a 
common strategy used by people with Type 1 diabetes is to purposely cause 
hyperglycaemia. When discussing exercise management with patients, many 
consume extra CHO and aim for a higher blood glucose before exercise. This tactic 
was also reported by Wallymahmed et al (2007) in a study regarding the relationship 
between glycaemic control, physical activity and hypoglycaemia avoidance in people 
with Type 1 diabetes. By achieving hyperglycaemia, when the blood glucose falls 
during exercise it will not decrease sufficiently to cause hypoglycaemia. Whilst this 
intervention is commonly used and can assist in the prevention of hypoglycaemia 
(Kilbride et al 2011a), some patients experienced hyperglycaemic symptoms thus 
affecting performance, with possible ketone formation, and over time, may run the 
risk of increased long-term complications.  
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1.5 Conclusion 
Both insulin dose adjustment and dietary modification are management strategies 
used to overcome the acute complications whilst exercising, and must be used to 
ensure safety for an individual (Lumb and Gallen 2009). However, more evidence 
based guidance is required to ensure that this can be achieved effectively. 
Information about exercise self-management strategies are scarcely found in clinical 
practice in the form of national guidelines, local policies, and patient information 
leaflets or websites, which clarifies the lack of evidence. Also whilst research is rare, 
another important factor is that all studies have been performed only in a laboratory 
environment and not evaluated in real life situations (Grimm et al 2004, Peter et al 
2005, West et al 2010). The real-life environment means performing habitual 
exercise in a participants‟ usual location. 
 
This lack of evidence makes the implementation of recommendations of 2.5 hours of 
exercise per week (SIGN 2010) a challenge, which instigated this current study. For 
the above recommendations, the exercise intensity of 70% VO2 max is required, 
which is equivalent to jogging, cycling, aerobics classes and brisk walking, and are 
all popular methods of exercise.  As a DSN, when discussing exercise patterns with 
patients, it became apparent that physical activity after work and before consuming 
the evening meal was popular for many people. With this in mind, a self-
management algorithm for 70% VO2 max exercise, taken 3 hours after a fast-acting 
analogue injection taken at lunchtime, and before the evening meal would help many 
people, and from clinical experience, patients specify that approximately 30-40 
minutes is their usual time duration. 
 
Evidence generated to inform patients and HCPs of self-management strategies 
during and after moderate intensity exercise is much needed for a large number of 
people. If this specific area of research is ignored, then people with Type 1 diabetes 
will be challenged with physical and psychological barriers and problems when 
participating in exercise, and they will continue to use ad hoc strategies that have 
safety implications with potential complications, and may precipitate long-term 
debilitating health problems.   
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Chapter 2 
Literature Review 
 
2.1 Introduction 
The previous chapter provided a general diabetes overview and introduced the 
complexities for people with Type 1 diabetes when performing exercise. This chapter 
is necessary to underpin the current study and focused on three areas:  
 
 The challenges that people with Type 1 diabetes experience when exercising.  
 Management strategies regarding insulin dose adjustment and dietary 
changes, and the effects on glycaemic control of people with Type 1 diabetes 
(not athletes) during and after exercise at moderate intensity.  
 Research performed in the real-life environment, and the replication of 
laboratory-based self-management research strategies compared with the 
real-life environment. 
 
2.2      Design 
A systematic review was conducted which followed the general principles used by 
Kennedy (2008), which was also described in the SIGN recommendations for 
literature critiques (SIGN) (2001). The approach and format undertaken are detailed 
in table 2.1.  
 
Table 2.1  
Systematic review approach 
1. Identification of aims and objectives  
2. Determine key words to highlight potentially relevant studies 
3. Identify appropriate literature following the search strategy 
4. Implementation of inclusion and exclusion criteria to select studies 
5. Assess and critique the selected literature  
6. Present the analysis of relevant studies  
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2.3 Search Strategy 
A systematic literature search was performed using CINAHL (Cumulative Index of 
Nursing and Allied Health Literature), MEDLINE, Cochrane Controlled Trails Register 
and SPORTdiscus databases. The key Medical Subject Headings (MeSH) search 
terms selected were: “Type 1 diabetes”, “physical activity”, “moderate intensity 
exercise”, “sport” and “running”, as they were the key terms used within the 
published literature. Other related search terms of “glycaemic control”, “insulin 
adjustment” and “self-management” were used initially, but due to lack of published 
evidence, it was decided that the term „Type 1 diabetes‟  applied as an alternative. 
Using “Type 1” as the main key-term, the number of hits in searches increased and 
gave assurance that all related abstracts were found. The search strategy included 
MeSH and terms were truncated with (*) to allow for multiple spellings and endings. 
From the selected publications any additional related literature found in the reference 
lists were also assessed.  
 
2.4 Inclusion and exclusion criteria 
All abstracts retrieved through the search were reviewed using the inclusion and 
exclusion criterion as described below. 
 
Inclusion  
Results were limited to: a) adults or individuals over 18 years, b) use of analogue 
basal bolus regimens, c) moderate intensity exercise or running for a short period of 
time (< 2 hours), d) publications using English language e) research published in the 
past 10 years. This timeframe was decided because basal bolus regimens have 
been common practice for the past 15 years but analogue insulin has only been 
available on prescription for the past 10 years (Roach 2008). Prior to this period, 
older fast-acting insulin types were administered but it may be difficult to extrapolate 
data from studies using these insulins compared with modern insulin types which 
have different pharmacokinetics.  
 
Exclusion 
The exclusion criterion were: a) studies which included other types of diabetes rather 
than Type 1, because they have a different pathophysiology, treatment and 
glycaemic responses to exercise, b) Studies including different types of sport i.e. 
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endurance, intermittent, and high intensity, because the physiological response on 
the body was different, requiring different insulin and CHO adjustments., c) Literature 
relating to athletes and professional sportspersons, because the intensity and 
supreme fitness levels of these subjects would not be replicated by the more general 
population, d) Articles which only described cellular activity, because insulin 
replacement therapy in relation to patient experiences, were not discussed, e) 
Exercise programmes and their effects on long-term behaviour and glycaemic 
control, because the present study was concerned only with the acute response to 
exercise, f) Studies of older insulin types and regimens, because of the difficulty to 
extrapolate data and use in conjunction with current therapies. 
 
2.5 Results 
The search strategy for the four databases is shown in Appendix 1a. The search 
results are shown in Table 2.2. From the search, 31 publications were included in the 
review, and from these, 21 key studies were analysed and described individually in 
the literature review. The remaining 10 studies contained some relevant information 
and were included as narrative inclusions.  
 
The literature review was performed in 2010 prior to performing the current study, 
but it has been acknowledged that since the initial review, some related recent 
research has been published which is described in the discussion chapter. 
 
Table 2.2: Search results 
Potentially relevant papers identified by literature search: 203 
↓ 
Papers excluded after evaluation of abstract: 134 
↓ 
Papers retrieved for detailed examination: 69 
↓ 
Additional 7 papers included after review of reference list of included papers: 76 
↓ 
Papers excluded after review of full paper: 45 
↓ 
Papers assessed for methodological quality and included in review: 31 
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Search terms Initial hits   
Type 1 diabetes 29,694   
Physical activity 8,085   
Moderate intensity 
exercise 
2,027   
Sport 646,959   
Running 103,421   
Combined search 
terms 
Potential Reviewed and included Excluded 
Type 1 and physical 
activity  
C= 46 
S=0 
M=0 
Total=46 
American Diabetes Association(2002) 
Brazeau et al (2008) 
Butler (2006) 
Kilbride et al (2011a) 
Peter et al (2005) 
Nagi and Gallen (2010)  
Wallymahmed et al (2007) 
31 
Type 1 and moderate 
intensity exercise  
C=9 
S=3 
M=6 
Total=18 
Brazeau et al (2008) 
Nagi and Gallen (2010) 
Wallymahmed et al (2007) 
West et al (2010) 
10 
Type 1 and sport C=13 
S=75 
M=6 
Total=94 
Lumb and Gallen (2009) 
Perry and Gallen (2009) 
Gallen (2005)  
Kavookjian et al (2007) 
Kilbride et al (2011b) 
Jimenez et al (2007) 
68 
Type 1 and running  C=27 
S=7 
M=11 
Total=45 
Brazeau et al (2008) 
Ertl and Davis (2004) 
Francescato et al (2004) 
Gallen (2005)  
Graveling and Frier (2010) 
Grimm et al(2004) 
Hermandez et al (1999) 
Lumb and Gallen( 2009) 
Peter et al (2005) 
Pierce (1999) 
Rabasa-Lhoret et al (2001) 
West et al (2010) 
25 
Reference list searches  DAFNE (2002) 
Riddell and Perkins (2006) 
Guelfi et al (2005) 
Fery et al (1987) 
Robertson et al (2008)  
Biankin et al (2003)  
Sandoval and Davis (2006) 
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Abbreviations: 
1. Initial hits: C=CINAHL, S=SPORTDiscus, M=MEDLINE 
 
The literature search results identified that little was written in the area of diabetes 
and moderate intensity exercise, especially outside the laboratory environment. The 
following review focused around the three areas; 1) challenges for people with Type 
1 diabetes, 2) self-management strategies, 3) and the study environment, with the 
purpose of examining each key publication with discussions regarding the relevance 
in this study. A table displaying the key publications with a summary of the main 
points is shown in Appendix 1b. 
 
2.6 The challenges people with Type 1 diabetes experience when 
exercising. 
In order to undertake a study examining the impact of exercise on people with Type 
1 diabetes, and the effect of specific self-management strategies, it was necessary 
to first determine that problems in this area existed. It was important to ensure that 
research undertaken and the evidence generated was worthwhile, valuable, and 
beneficial for both patients and HCPs. From clinical experience, the author was 
aware of the difficulties faced by patients when exercising. However, these 
difficulties were an issue for a minority of individuals encountered, and by chance 
may have experienced similar problems.  Evidence from the literature was necessary 
to ensure the certain presumptions were relevant and correct.  
 
Brazeau et al in 2008 published a quantitative study with the aim to determine 
barriers for people with Type 1 diabetes participating in physical activity, which 
addressed the opinions of the author. The examination of 103 people with Type 1 
diabetes (mean age 43.5 ± sd 11.6 years) who had varying exercise behaviours, 
when attending routine clinic appointments, completed a diabetes-specific barriers 
measure (BAPAD1 scale).  The results demonstrated that the highest barrier scores 
were associated with fear of hypoglycaemia, work schedule, loss of glycaemic 
control and low fitness levels respectively. Also demonstrated was that exercising 
with another person, resulted in significantly fewer barriers (p<0.001), and by 
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exercising with a companion familiar with hypoglycaemia, acted as a supportive 
measure and served also to boost confidence. Participants having an evening CHO 
snack after exercise as a preventative strategy, also significantly reduced fears of 
hypoglycaemia (p<0.007), thus providing glucose to replenish glycogen stores, and 
preventing hypoglycaemia (Ertl and Davis 2004). Another finding was that 
participants with knowledge of peak actions and pharmacokinetics of insulin also had 
reduced fears of hypoglycaemia (p=0.021).  
 
The strength of this study was the large sample of Type 1 participants with different 
exercise behaviours, which provided a representation of real-life barriers and 
problems during the performance of exercise. The major limitation of the study was 
the lack of demographic data regarding treatment and exercise behaviour 
characteristics of the participants, which without these raised questions concerning 
the results presented. Another factor was the number of participants actively 
involved in regular exercise was not stated. This is important as regular exercisers 
and exercise-naïve patients may have different perspectives in relation to barriers 
and although this has not been described in other studies, it is a consideration 
derived from clinical experience. Another limitation was the fact the type of insulin 
participants used was not described. From clinical experience, if some were using a 
twice daily regimen compared to a basal bolus regimen this could increase 
hypoglycaemia and self-management problems due to the inflexibility of the insulin 
time-action and dose-adjusting practicalities. Another issue not clarified was that 
participants were questioned about their CHO snacks consumed at bedtime for 
nocturnal hypoglycaemia prevention, but the findings were not presented regarding 
types or amounts consumed and the effects experienced on individuals‟ glycaemic 
control, which would have been useful for this current study.  
 
However, this study did provide information for practical aspects of the current study, 
relating to the algorithm design and participant information guidelines. The key 
messages taken were:  
 
1). Knowledge of insulin pharmacokinetics improved anxiety levels in people with 
Type 1 diabetes.  
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2). Hypoglycaemia risk does cause anxiety, hence, accurate data collection for 
hypoglycaemic episodes were emphasised to the participants as preventative 
strategies are one of the main aspects of performing research in this area.  
3). Incorporate CHO snack at bedtime to reduce hypoglycaemia anxiety. 
 
Another study related to challenges faced by people with diabetes was published by 
Kilbride et al (2011a) who used a qualitative approach, with similar aims as Brazeau 
et al (2008), to explore the experiences of people with Type 1 diabetes when 
exercising. A focus group was used and the demographics for the four participants 
were: age 48.5 (± sd 2.5) years, and HbA1c 7.35 (± sd 0.5)%, and all had >2 years 
duration of Type 1 diabetes. This study presented detailed results regarding insulin 
and exercise behaviours compared with the generalisation by Brazeau et al (2008), 
and stated that all participants used a basal bolus insulin regimen and counted CHO, 
and that they participated in exercise for 30 minutes at least 3 times a week,  both of 
which were applicable to the current study inclusion criteria.  
 
The issues explored were self-management, hypoglycaemia and coping strategies 
and the results showed from the content analysis of the transcripts that there were 
three emerging themes: i) trial and error; all participants stated how they “juggled” 
and experimented with their diet and insulin doses. ii) trade-off; despite participants 
experiencing difficulties with self-management and hypoglycaemia, they were all 
motivated and considered that the benefits of exercise out-weighed the associated 
problems. iii) Locus of control; all participants were motivated and took control over 
implementing and adjusting their self-management strategies. The results 
demonstrated that participation in any form of exercise provoked inconsistency, 
unpredictability and variability in glucose control, and highlighted the substantial 
amount of time and effort required by patients to self-manage effectively. There was 
no single strategy that could be used for all types of exercise for both during and 
after, and different management was required for each exercise situation. Again, as 
highlighted by Brazeau et al (2008), participants identified a specific limitation which 
was their knowledge regarding physiology and insulin pharmacokinetics. 
 
The study gave an in-depth description which demonstrated the difficulties and 
motivation required by patients to succeed in performing exercise whilst maintaining 
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acceptable glycaemic control. However the main limitation was the sample size of 
four participants which was small, compared to the large sample size in the Brazeau 
et al study (2008). Another potential disadvantage was that the participants were 
regular exercisers who had overcome hypoglycaemia fears by motivation and 
determination, and in order to understand their individual requirements for adjusting 
insulin and CHO, they may have forgotten about previous difficulties encountered. 
This study provoked uncertainty regarding whether a standardized approach for self-
management was possible to achieve acceptable glycaemic control.   Inconsistency 
and variability in glycaemic control, however, may exist because of lack of 
pharmacokinetic and physiology knowledge of the participants.  It did confirm that 
people with Type 1 diabetes do have fears, concerns and difficulties relating to 
exercise. It also emphasised the gap between available current research and 
evidence, and applying findings to every-day self-management and patient 
education. 
 
These studies demonstrated that anxieties and lack of information regarding self-
management strategies existed, with the major focus centering around the 
prevention of hypoglycaemia (Brazeau et al 2008, Kilbride et al 2011a). Kilbride et al 
(2011a) described glucose variability, whereas Brazeau et al (2008) highlighted the 
loss of glycaemic control, which both suggest difficulties in achieving acceptable 
glycaemic control. This reinforces and clarifies the authors initial presumptions and 
supports the necessity for the current study to develop information regarding how to 
exercise safely, and from the patient perspective, how to take away the arduous task 
of trial and error in self-management approaches. In order to develop a self-
management tool, practical strategies regarding exercise and diabetes were also 
examined. 
 
 
2.7 Self-management strategies   
The existing problems regarding exercise and Type 1 diabetes previously 
highlighted, lead to the next area to explore in the literature, which are self-
management strategies designed to overcome these difficulties. There is general 
consensus amongst authors that different types of sport, intensity and duration 
require altered approaches to treatment adjustment because of the different effects 
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on glucose levels (Guelfi et al 2005, Kilbride et al 2011a, Kilbride et al 2011b, Perry 
and Gallen 2009, Robertson et al 2008). However, as discussed previously in 
section 1.2, current national guidelines for HCPs are vague, general and non-specific 
(NICE 2009, SIGN 2010). In order to support these national guidelines, review 
publications were found in the literature search which highlighted evidence of 
experiential opinions and recommendations from physicians with specialist 
knowledge in the area of diabetes and physical activity. The relevant publications are 
described below, however only the key relevant messages to the current study are 
stated as the reviews all offer a general overview of diabetes and exercise. 
 
In order to understand the rationale behind self-management strategies, an 
understanding of specific physiology and metabolism factors in Type 1 diabetes was 
necessary. A literature review regarding self-management problems to overcome the 
physiological response to exercise in Type 1 diabetes was published by Riddell and 
Perkins (2006). The review adopted an educational stance to inform HCPs about the 
physiological effects of exercise on a person with Type 1 diabetes. Related research 
was incorporated into the article, although specific details and analysis of individual 
studies were not included. The relevant aspects included in the review were that 
large excursions in blood glucose concentrations were a challenge in self-
management, with one of the reasons being that the absorption of subcutaneously 
injected insulin may increase with exercise. Also, self-injected circulating insulin does 
not decrease during exercise, whereas in a non-diabetic individual, insulin production 
would decrease. Another factor is that in a non-diabetic individual the release of 
glucagon would counter-act hypoglycaemia caused by exercise, however, in Type 1 
diabetes this mechanism is impaired. Hence, all of these factors contribute to the risk 
of hypoglycaemia. Another challenge is that hyperglycaemia can be exaggerated in 
Type 1 diabetes due to increased hepatic glucose production, which happens to 
provide glucose for energy during exercise. This is also difficult for an individual to 
predict and prevent with self-management strategies. 
 
Similar to the Riddell and Perkins (2006) review, Ertl and Davis (2004) published a 
review that was specifically aimed at hypoglycaemia and physiology which analysed 
relevant studies. The key message was moderate intensity exercise caused 
hypoglycaemia unless adjustments were made to exogenous insulin and glucose 
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intake. To counteract this, it was recommended that insulin be reduced before and 
after exercise (although timing issues were not stated), to account for increased 
insulin sensitivity with Glut 4 receptors and increased skeletal muscle glucose 
uptake. These two physiology reviews highlighted comparable issues regarding 
hypoglycaemia (Ertl and Davis 2004, Riddell and Perkins 2006) to underpin the 
rationale for insulin and CHO adjustment for the current algorithm design. 
 
In 2004, Gallen published a narrative description that combined the physiological 
challenges described above, with management strategies to normalise blood 
glucose and prevent hypoglycaemia. Forty references were cited within the review 
which provided a wide range of narrative descriptions of key findings from original 
studies, although the individual studies were not critically analysed. Experiential 
descriptions and recommendations were given by the author which were not 
supported with evidence and were vague. However, a practical point for the current 
study was after exercise 60-120 grams (g) of CHO should be taken with insulin to 
replenish glycogen stores, which were emphasised by authors elsewhere describing 
physiology (Ertl and Davis 2004, Peirce 1999, Riddell and Perkins 2006). The 
drawback of the recommendation by Gallen (2004), was that it was not evidence 
based or related to any particular intensity or duration of exercise. 
 
In a review by Perry and Gallen (2009), again the physiology of Type 1 diabetes and 
exercise with evidence based management strategies were described. A narrative 
description of key findings from original studies was provided but these individual 
studies were not critically analysed. Again, only experiential descriptions and 
recommendations were given by the authors. However, there were relevant 
messages from this review which demonstrated that multiple variables control 
glucose homeostasis, but advice for individuals differed as described by Riddell and 
Perkins (2006). In relation to self-management, the reduction of post-exercise bolus 
insulin dose prevented nocturnal hypoglycaemia, however, the amount of reduction 
was not stated.  It was also suggested that a pre-exercise blood glucose target be 
between 7.0 -12.0 mmol/l, however, this also was not evidence based. The lack of 
research performed in real-life environments was highlighted and it was 
acknowledged that evidence is required to support the practical considerations 
suggested by the authors. 
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Once gathering these practical considerations and self-management strategies as 
described, the information must be disseminated amongst HCPs. The American 
Diabetes Association (ADA) (2002) provided an update for HCPs regarding the role 
of physical activity in diabetes management. Six publications from 1990-1995 were 
reviewed to give clinical recommendations for HCPs when advising patients on 
exercise management. The results gave a narrative description of physiological 
issues and management strategies for Type 1 and Type 2 diabetes. Information was 
given regarding pre-exercise physical assessment, and preparation regarding warm-
up and cool-down periods. The Information was very vague but implied that any 
exercise can be performed by people with Type 1 diabetes and hypoglycaemia can 
be avoided by manipulation of CHO and insulin, but did not highlight the difficulties in 
which to achieve this. The key messages for the current study were to avoid exercise 
if blood glucose > 13.9mmol with ketosis, or blood glucose > 17mmol without ketosis. 
In relation to hypoglycaemia prevention, it emphasised the importance to eat CHO if 
blood glucose <5.5mmol before exercise. However, these strategies were again not 
evidence based. 
 
Following a similar structure, Jimenez et al (2007) published similar 
recommendations as those by the ADA (2002), but aimed for certified athletic 
trainers regarding Type 1 diabetes management on behalf of the American National 
Athletic Trainers Association. This was a practical over-view with a narrative 
description of Type 1 diabetes and exercise management, aimed at trainers with no 
diabetes knowledge and was based on 91 cited publications. The only relevant key 
message from this review was that it did highlight the complex intricacies of Type 1 
management that a HCP working in diabetes may assume that lay persons 
understand. The array of variables that HCPs were required to consider when 
advising a patient were also described by Perry and Gallen (2009), and Riddell and 
Perkins (2006). 
 
With regard to HCPs, a narrative description by Lumb & Gallen (2009), reviewed 
management strategies for exercise and Type 1 diabetes, based upon patient 
scenarios, and cited 28 references but were not critically analysed. The results 
provided experiential descriptions and recommendations for different intensities and 
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types of exercise but they were not supported by evidence. However, this review did 
highlight issues which were included in the current algorithm design. Lumb and 
Gallen (2009) stated if severe hypoglycaemia occurred in the previous 24 hours, 
exercise should be performed with caution, if at all, a point also highlighted by 
Gravelling and Frier (2010). Lumb and Gallen (2009) also discussed the peak 
hypoglycaemia risk-time after moderate intensity exercise occurring 60-90 minutes 
post-exercise, and during the night, which was also suggested by Robetson et al 
(2008), but was not evidence based. An important factor stated in the review, was an 
insulin dose reduction of 30% was advised after exercise for hypoglycaemia 
prevention, although again there was no evidence basis. Lumb and Gallen (2009) 
stipulated that management strategies be tailored to individuals, which were 
highlighted by several authors and probably stemmed from glucose variability 
(Jimenez et al 2007, Perry and Gallen 2009, and Riddell and Perkins. 
 
A further review by Nagi and Gallen (2010), on behalf of the British Clinical 
Diabetologists Committee, presented a position statement to assist diabetes HCPs 
to familiarise themselves with issues regarding exercise management. A narrative 
description of key findings from 41 publications without critical analysis, were 
discussed alongside experiential opinions and descriptions from this well-recognised 
expert group. The key messages in relation to long-term complications that came 
from this review revealed no evidence to suggest that moderate intensity exercise 
had a detrimental effect on non-proliferative retinopathy. Also physical activity (apart 
from high intensity, strenuous exercise) should not be restricted in people with 
nephropathy. Treadmill use should not be undertaken by people with significant 
neuropathy for safety reasons. These recommendations were of interest, although 
were not applicable for the current study as selected participants were complication-
free. Advantages and disadvantages for specific dose-adjusting were described, but 
insulin-adjusting for use after exercise was not mentioned. However, it was 
highlighted to reduce basal insulin in order to prevent nocturnal hypoglycaemia, 
which was also suggested by Lumb and Gallen (2009), but stated this may also 
cause morning hyperglycaemia, a fact relevant in the current study. 
 
Finally, Kavookjian et al (2007) conducted a systematic review to assess and 
summarise evidence and gaps in the literature regarding interventions for exercise 
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among people with diabetes. The aim was to establish evidence regarding exercise 
in all types of diabetes for learning, behavioural, clinical and humanistic outcomes. 
The results focused mainly on Type 2 diabetes with a limited Type 1 review. 
However, some relevant conclusions were found, the first being that self-
management and glycaemic control intervention studies were all conducted in 
artificial environments i.e. laboratory, with no translation into the patients‟ daily life. In 
addition, blood glucose monitoring was described as essential to evaluate self-
management strategies regarding CHO and insulin in relation to the exercise 
intensity and time of day. Although no analysis of diet or insulin dose-adjusting 
intervention studies were provided, which was acknowledged by the authors. 
 
The above publications which reviewed current exercise and diabetes literature and 
provided HCPs with knowledge for use within clinical practice, also gave a general 
overview regarding the effects of exercise and possible self-management strategies 
to overcome them. The problem with these findings was they did not give specific 
evidence based practical guidance, but only experiential opinions for patient care 
and education.  However, despite several claims by authors (Gallen 2004, 
Kavookjian et al 2007, Lumb and Gallen 2009, Perry and Gallen 2000) that there 
was a lack of evidence to support self-management for exercise participation, this 
literature search did identify some publications to underpin the design of the current 
self-management algorithm.  
 
2.8   Self-management algorithm design: Before exercise 
After examination of the review publications, the next section of the literature search 
was to identify specific evidence-based insulin dose-adjustment and dietary 
management strategies, and the subsequent effects on glycaemic control for both 
during and after moderate intensity exercise. The section has been divided into 
before and after exercise. 
 
The issues applicable to self-management before performing afternoon exercise 
include: 1). Pre-exercise insulin reduction, 2). Target blood glucose concentration 
and 3). CHO consumption.  
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2.8.1 Pre- exercise fast-acting analogue reduction 
The reduction of insulin before performing exercise is an important factor to consider 
as national guidelines and review publications advise on pre-exercise insulin 
reduction (ADA 2002, Lumb and Gallen 2009, Nagi and Gallen 2010, NICE 2009, 
Perry & Gallen 2009, SIGN 2010). In relation to the current study, evidence was 
needed to support this recommendation when performing exercise 3 hours after 
administering a meal-time insulin injection. This time followed the peak action of the 
preceding fast-acting analogue dose, and subsequent hypoglycaemia risk time 
(Rabasa-Lhoret et al 2001, Robertson et al 2008, West et al 2011), which confirmed 
that the time of the highest risk of hypoglycaemia after fast-acting analogue 
administration, was 40-90 minutes following injection. 
 
The only studies found relating to pre-exercise insulin dose-adjustment associated 
with moderate intensity exercise, investigated the effect of adjustments of insulin and 
CHO before breakfast, and within 1 to 3 hours of commencing exercise (Rabasa-
Lhoret et al 2001, West et al 2011). In these studies, the strategies and data 
collected were aimed at preventing hypoglycaemia during or immediately following 
exercise, without focusing specifically on post-exercise hypoglycaemia; an important 
issue for patient safety and anxieties (Brazeau et al 2008, Graveling and Frier 2010). 
No research was found for any other time of the day, or for adjusting 3 hours after 
fast-acting analogue insulin. Despite the different timings of exercise, the two studies 
by Rabasa-Lhoret et al (2001) and West et al (2011), were reviewed as the exercise 
intensity and duration were similar to the current study and thus may provide 
clarification regarding the effects of exercise on glycaemic control, especially post-
exercise. Both studies also offered a rationale for possible insulin adjustment in this 
current study as both were designed at preventing hypoglycaemia. 
 
West et al (2010) performed a quasi experiment to examine pre-exercise insulin 
reductions before running at 75% VO2 max and the consequent 24 hour effect on 
glycaemic control. Seven participants attended four study visits and were 
randomised to conditions which administered the full breakfast fast-acting analogue 
dose or a reduction of 25, 50 or 75% immediately before breakfast. All participants 
undertook all conditions. After 2 hours, participants completed 40 minutes running at 
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75% VO2 max on a treadmill. Blood glucose was tested every 15-30 minutes during 
and immediately after exercise, and every 2 hours until bedtime, and then on 
awakening. The results showed the pre-exercise blood glucose ranged between 11 - 
15mmol in all four conditions. The full-dose condition experienced three 
hypoglycaemic episodes within 180 minutes of exercise, although each of the other 
conditions only had one single hypoglycaemia episode (not significant). All 
conditions demonstrated decreases in blood glucose (p<0.01). During exercise and 
21 hours post-exercise, all conditions demonstrated hypoglycaemia, but the 75% 
reduction condition experienced fewer episodes (p<0.05), and achieved more 
acceptable 24 hour post-exercise blood glucose concentrations.  
 
This study followed a strict protocol regarding timings of insulin administration and 
exercise, which followed a robust exercise protocol to achieve 75% VO2 max. Data 
were collected at specific times to ensure precise and appropriate data collection. 
The results showed that if performing moderate intensity exercise within 2 hours of a 
fast-acting analogue dose, the dose should be reduced by 75%. 
 
However, several limitations were revealed on analysis. The first discrepancy was 
that hypoglycaemia was stated as blood glucose <3.5mmol, but the accepted 
hypoglycaemia range for someone with diabetes in the UK is 4.0mmol/l or below 
(Diabetes UK 2012, NICE 2009, SIGN 2010). Hence, some hypoglycaemic episodes 
may have been missed. Also the results were presented as mean glucose values 
which may conceal hypoglycaemic episodes and so there was a possibility that more 
participants were hypoglycaemic or between 3.5-4.0mmol/l. Data were not presented 
to clarify this. With regard to the 75% reduction group, the mean blood glucose 
concentrations at the end of exercise were 11.0mmol/l, 1‾ ¹, (s˟ 0.7), and the 
participants were given correction doses at this time, thus possibly contributing to 
post-exercise hypoglycaemia. Data for up to 21 hours post-exercise regarding 
glucose and dose adjustments (adjustments decided by participants), including blood 
glucose concentrations during the night were not described. These data were taken 
from the real-life environment, and the authors described the difficulties concerned 
with analysing data when participants self-managed and used different strategies 
with CHO amounts, insulin dose, monitoring and injection times. These were not 
correlated nor described in conjunction with blood glucose concentrations or 
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hypoglycaemia episodes, which makes data analysis and extrapolating appropriate 
evidence impossible. Another limitation was that the required sample size to gain 
80% power was determined with the use of 33 participants, based on data from 
Rabasa-Lhoret et al (2001). The West et al (2010) study recruited seven participants, 
which would have influenced the lack of statistical significance.  Again, as described 
by Brazeau et al (2008) and Kilbride et al (2011b) the intra-individual variability of 
blood glucose across participants was highlighted by the authors as a limitation, and 
would affect the mean glucose figures.   
 
Despite these limitations, there were issues to be considered for the current study: 
1. The glucose-lowering effect of the fast-acting analogue insulin began 
approximately 10 minutes after injection, with peak-action at 60 minutes and duration 
up to 5 hours. The peak-action is an important factor to consider as it did not occur 
during this study exercise session time, however, the duration was up to 5 hours 
which would coincide with participants exercise times in the current study. 
2. The range of the starting blood glucose concentration was 11 - 15.0mmol/l     (1‾¹), 
which is hyperglycaemic. Despite the high starting glucose concentrations and 
insulin reduction 2 hours prior to the start of exercise, participants still experienced a 
glucose drop during exercise. For the full dose condition, this drop was 6.1mmol/l 
(s˟ 0.4). 
3. A discussion point was the reported variability of blood glucose concentrations in a 
controlled laboratory environment. This is an important factor to consider when 
analysing and discussing data in the current study.  
 
Another similar study by Rabasa-Lhoret et al (2001) performed a randomised, cross-
over laboratory based study to evaluate pre-meal insulin dose reductions for 
exercise at different intensities and durations to minimize hypoglycaemia. Eight 
males with Type 1 diabetes participated, and all used a basal bolus regimen using 
pre-meal fast-acting analogue insulin, and Ultralente for the basal insulin. The pre-
meal fast-acting analogue insulin was adjusted 90 minutes before exercise. The 
participants took either the full insulin dose or a reduction dose of 25 or 50%. 
Exercise was then performed at: 25% VO2 max for 60 minutes, 50% VO2 max for 30 
and 60 minutes, and 75% VO2 max for 30 minutes. The blood glucose was 
monitored for 18 hours post-exercise.  
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The results demonstrated firstly that increased physical activity for any intensity from 
25, 50 and 75% VO2 max, without reduced insulin doses or additional CHO, caused 
hypoglycaemia. Again, hypoglycaemia was defined as a blood glucose < 3.5mmol/l 
which is the same as West et al (2010). Sixty exercise sessions were performed 
which resulted in 24 minor hypoglycaemic episodes. Two episodes occurred in the 
90 minute rest period before exercise, and four episodes during exercise. The 
remaining 18 episodes occurred within the 18 hour post-exercise period. From these, 
more than two-thirds of hypoglycaemic episodes happened in the patient group who 
took the full pre-meal dose.  In relation to hypoglycaemia, during exercise at 75% 
VO2 max the mean decrease in glucose was 2.7mmol/l (± 0.38) with the 75% 
reduction compared with 3.0mmol/l (± 0.71) with the full dose group. Despite this, the 
starting blood glucose was higher at 9.8mmol/l (±1.1) in the 75% reduction group, 
and the overall glucose profile during exercise was higher (p=0.05). The study 
demonstrated that a 75% reduction was required to maintain acceptable post-
exercise glucose. 
 
This study was of a complicated design, which succeeded in conducting 60 
individual exercise sessions. It followed a robust protocol to ensure that appropriate 
dose-adjusting and exercise intensity were performed. The results demonstrated that 
pre-meal insulin reduction were required prior to exercise within 90 minutes of fast-
acting analogue injections and were similar to the results of West et al (2010). 
 
There were several limitations when extrapolating data for evidence in the current 
study. In comparison with West et al (2010), the sample size was small, although this 
was not discussed by the authors and the power calculation was not specified. Other 
limitations included issues that the data were not presented regarding the time that 
hypoglycaemia occurred within the 21 hour study period, especially the 18 episodes 
that occurred post-exercise which is crucial to ascertain the probable cause. Also, 
despite participants being examined for 18 hours post-exercise, blood glucose 
results were only described for the following one hour post-exercise period, which 
was similar to West el al (2010). After exercise, the participants used their usual 
insulin doses rather than reduced dosages but the authors failed to describe blood 
glucose concentrations and any insulin adjustments. 
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The relevant key messages for the current study were limited due to the lack of post-
exercise data:  
1. In the discussion Rabasa-Lhoret et al (2001), does recommend that exercise 
performed after lunch may require reductions in insulin prior to the following meal to 
prevent delayed hypoglycaemia at night. This recommendation was based on the 
post-exercise hypoglycaemia episodes despite limited published data, and this is 
relevant in the current study. 
2. The results demonstrated that improved glucose profiles were maintained by 
starting with higher pre-exercise glucose concentrations, however, the actual levels 
were not stated. 
In these two studies, exercise was performed in the early morning and the 
adjustment of fast-acting analogue insulin dose and CHO was made at breakfast 
time. This time of day ensures that participants have fasted overnight which 
eliminates the effects of any delayed CHO absorption or previously injected active 
insulin. In Type 1 diabetes, insulin resistance can occur in the early morning which 
sometimes requires increased insulin doses compared to the rest of the day (Pang 
and Narandran 2008). Thus, it is of interest, that for 30-45 minutes of exercise at 
75% VO2 max, a 75% reduction of the insulin dose was still required to prevent 
hypoglycaemia during and after exercise (Rabasa-Lhoret et al 2001, West et al 
2010). As stated by Riddell and Perkins (2006), hypoglycaemia would occur because 
of an overdose of insulin before exercise, and with increased insulin absorption 
during exercise, its action and sensitivity can therefore last for several hours post-
exercise. This has been demonstrated by West et al (2010) as the full dose group 
that exercised after 2 hours had a blood glucose drop of 6.1 after 45 minutes 
exercise, compared with the full dose group that exercised after 90 minutes, had a 
3.0mmol/l decrease after 30 minutes of exercise shown by Rabasa-Lhoret et al 
(2001). The differences between the glucose decrease were probably due to the 
different exercise durations and demonstrated by the different insulin actions, which 
was reflected in the duration of fast-acting analogue action at 5 hours, which is 
applicable to the current study.  
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Although data were collected, Rabasa-Lhoret et al (2001) and West et al (2010) did 
not publish findings for the 18-21 hour post-exercise blood glucose concentrations 
and hypoglycaemic episodes. This may have been due to difficulties with data 
collection as the participants self-managed and did not follow dose-adjusting 
guidelines outside the laboratory environment. Because of ad hoc strategies and 
glucose variability (Kilbride et al 2011a, Jimenez et al 2007, and Riddell and Perkins 
2006) this may have made data extrapolation difficult. However, both studies 
described post-exercise hypoglycaemia, although only Rabasa-Lhoret et al (2001) 
stated the exact figure of 18 episodes. Post-exercise hypoglycaemia was applicable 
to the current study and clarified the need for post-exercise insulin reduction.  In both 
studies the variations of individual self-management were not described, thus 
making data analysis of strategies and blood glucose concentrations difficult to 
correlate and probably contributed to the reason for the lack of published data and 
discussion. This was an important factor to consider in the current study design from 
a patient perspective and also for HCPs when advising patients regarding safety and 
well-being. 
 
2.8.2 Blood glucose targets.  
Another area to consider when educating people with Type 1 diabetes regarding 
exercise management was to provide information about target blood glucose 
concentrations for patient guidance, which also would help to determine the success 
of their self-management. From clinical experience, pre-exercise blood glucose 
targets were an issue debated between HCPs and patients. As previously discussed, 
West et al (2010) and Rabasa-Lhoret et al (2001) showed that the starting mean 
blood glucose concentrations of participants were 11-15mmol/l and 9.8mmol/l 
respectively. A target blood glucose concentration was not stated and therefore 
assumed that participants controlled their own individual starting blood glucose 
concentration.  
 
With regard to this, in general, current literature has recommended that exercise 
should not be performed if an individual is hyperglycaemic. The literature review 
published by Lumb and Gallen (2009), suggested that from clinical guidelines, 
exercise should be avoided with blood glucose concentrations over 14mmol/l 
38 
 
because of reduced circulating insulin. The rationale for this advice was determined 
because of a further increase in mobilisation of glucose from liver and fat stores 
when exercising, hence, further hyperglycaemia can occur if the individual has 
limited amounts of injected insulin acting to transport glucose into the cells (Riddell 
and Perkins 2006). A higher pre-exercise blood glucose may increase the risk of 
ketoacidosis in this situation (ADA 2002, Fery et al 1987, Lumb and Gallen 2009). 
American guidelines state that exercise should be avoided if blood glucose is over 
13.9mmol/l with ketosis, or 17mmol/l without ketones (American Diabetes 
Association 2002). However, these publications are based on experiential opinions 
and clinical knowledge rather than research.  
 
These publications also do not incorporate patient behaviour and preference, which 
on discussion with patients is to aim for higher concentrations, which were 
demonstrated in the West et al (2010) and Rabasa-Lhoret et al (2001) studies. A 
study regarding these issues was performed by Wallymahmed et al (2007) which 
confirmed that people with Type 1 diabetes (not athletes) avoided hypoglycaemia by 
aiming for higher blood glucose before and during exercise. This study assessed the 
relationship between glycaemic control, self-reported physical activity, aerobic 
capacity and hypoglycaemia avoidance in people with Type 1 diabetes. Fifty patients 
attending a routine diabetes clinic appointment participated. The mean age 36 ±9.2 
years (range 18-52), duration 18 ±8.8 years, HbA1c 9.1±1.3%. Aerobic fitness was 
assessed by a sub-maximal step-test, and physical activity, hypoglycaemia and 
hypoglycaemia avoidance was measured by a non-validated questionnaire.  
 
The results showed that 60% reported participating in regular vigorous exercise 
(RVE) and had significantly worse HbA1c; 9.5 ±1.35, compared with those not 
regularly exercising or not vigorously active (NVA); 8.5±1.2% (p<0.002). The 
implications for higher HbA1c levels, are that frequent regular exercisers who strive 
to achieve higher blood glucose concentrations for longer periods of time during 
exercise, are in danger of producing damaging effects for long-term complications 
due to prolonged poor glycaemic control. The RVE group reported they aimed for 
higher starting blood glucose (although targets were not stated), before exercise, 
levels compared to the NVA group (8 individuals vs 0 individuals p<0.03). In the RVE 
group 83% reported taking precautions to avoid hypoglycaemia. From these, 77% 
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increased the consumed amount of CHO, 7.7% reduced their insulin intake, 12.8% 
increased the consumed amount of CHO plus insulin reduction. The suggestions 
from these above data may be that patients were unable to understand how to adjust 
insulin effectively.  
 
A strength of this study (Wallymahmed et al 2007), was the large sample size which 
provided a description of exercise and diabetes behaviour and management within a 
normal population with Type 1 diabetes, and confirmed that people with Type 1 
diabetes aimed for higher blood glucose concentrations during exercise to prevent 
hypoglycaemia.  
 
There were several limitations with regard to utilizing data for the current study. First 
there was no report of the level of target blood glucose, which would have been 
useful when deciding on the pre-exercise blood glucose target in the current 
algorithm.  The study used a non-validated questionnaire, and the questionnaire was 
not published. Also it was difficult to extrapolate data and information for the current 
study algorithm because specific areas i.e. dose adjustments, food amounts, glucose 
concentrations during exercise, hypoglycaemic events related to exercise, were not 
described in sufficient detail. Another limitation was that hypoglycaemia was not 
defined. This is essential as patients often classify hypoglycaemia with different 
glucose concentrations as seen in the current recommendations (Diabetes UK 2012, 
NICE 2009, SIGN 2010), and studies; Grimm et al 2004, Rabasa-Lhoret et al 2001 
and West et al 2010.  
 
However, relevant key messages were found and used in the current study:  
1. Patients consumed more CHO before and during exercise in order to achieve 
higher blood glucose concentrations, despite advice being given by HCPs in the 
clinic on insulin dose reduction. The interpretation once again suggested that 
patients do not understand or have not been given adequate advice by HCPs to 
adjust their insulin doses. This is comparable to findings from Brazeau et al (2008) 
and Kilbride et al (2011a). 
2. The HbA1c was higher in participants who exercised regularly, which might 
suggest that participants purposely aimed for higher glucose concentrations. 
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From this section of the literature review, it was shown that although optimal blood 
glucose targets at exercise were not incorporated into any reviewed study aims 
(Grimm et al 2004, Rabasa-Lhoret et al 2001, West et al 2010), the publications 
suggested that blood glucose concentrations recommended prior to the 
commencement of exercise should be higher. Gallen (2004) recommended a 
glucose concentration between 7-10 mmol/l, before exercise which was slightly 
different from that of 7-12mmol/l which was published 4 years later (Lumb and 
Gallen 2009).   However, a study analysing an algorithm for 50% VO2 max exercise 
(Kilbride et al 2011b), aimed for the pre-exercise blood glucose target at 10mmol/l.  
The resulting blood glucose concentration remained high but stable during exercise, 
which suggested that the target of 10mmol/l could be lowered. This glucose pattern 
was also demonstrated by Rabasa-Lhoret et al (2001). As discussed previously, 
Wallymahmed et al (2007) showed that patients who exercised regularly, purposely 
had blood glucose concentrations higher during exercise in order to avoid 
hypoglycaemia. This strategy has also been highlighted during patient discussions in 
clinical practice and also with participants in the focus group described by Kilbride et 
al (2011a). 
 
There are clearly discrepancies in the published literature with large variations of 
acceptable blood glucose among authors (Gallen 2005, Kilbride et al 2011b, Lumb 
and Gallen 2009, Wallymahmed et al 2007). However, patient preference of glucose 
appears to be higher than recommended in current guidelines (Diabetes UK 2012, 
NICE 2009, SIGN 2010). A balance should be sought to consider hypoglycemia 
prevention, patient comfort and long-term effects of hyperglycaemia.  
 
2.8.3 Pre-exercise CHO consumption   
The next area of the literature review to explore is CHO consumption which is a 
common strategy used by patients to prevent hypoglycaemia and initiate 
hyperglycaemia (Wallymahmed et al 2007), However, limited evidence is available 
regarding CHO amounts and types to be consumed prior to and during exercise, 
although CHO consumption in general is recommended in guidelines to prevent 
hypoglycaemia (Diabetes UK 2012, Francescato et al 2004, NICE 2009, SIGN 
2010). 
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One study was found in the literature review which addressed this issue. Grimm et al 
(2004) compared different amounts of consumed CHO with insulin dose adjustment 
for people with Type 1 diabetes who exercised at different intensities and for different 
durations. Sixty-seven people with Type 1 diabetes participated, all had acceptable 
glycaemic control (HbA1c <7.5%, sd not reported) and used a basal bolus regimen 
with fast-acting analogues and Neutral Protamine Hagedorn (NPH) insulin which is 
an older intermediate-acting insulin. They were placed into 4 different treatment 
groups depending on their usual exercise self-management strategies. These were: 
1). consuming 10-20g of CHO hourly for the duration of the exercise. 2). consuming 
10-20 g of CHO hourly for the exercise duration plus reducing the daily insulin dose 
by >10%. 3). no extra CHO but reduced daily insulin dose by >10%. 4). no extra 
CHO or insulin dose reduction. Each participant performed an exercise programme 
of three different intensities and durations. For the purpose of this review the groups 
using the intensity of 60-75% VO2 max and 20-60 minutes duration were analysed.  
 
The results demonstrated that exercise sessions for 20-60 minutes at 60-70% VO2 
max, required 20-60g of CHO to prevent hypoglycaemia. From the results the 
recommendations in general for intense and moderate exercise duration require a 
20-30% reduction of total daily insulin dose (not stating analogue or NPH).  In the 
study from 265 exercise sessions, there were 6 hypoglycaemic episodes which all 
occurred at least four hours after exercise, and was much less than that 
demonstrated by Rabasa-Lhoret et al (2001) and West et al (2010).   
 
This study had a large sample size, and was the only study found that specifically 
evaluated CHO amounts prior to exercise. The mean age of participants was not 
stated, although the inclusion criterion was 18-35 years old, which is a young age 
group compared to all other studies in the exercise and diabetes field. The limitations 
found were again related to hypoglycaemia levels, with hypoglycaemia stated as a 
blood glucose concentration of <2.8mmol. This is a dangerously low value, 
compared with UK guidelines of <4.0mmol (Diabetes UK 2012, NICE 2009, SIGN 
2010). The insulin types used in the study were fast-acting analogues or NPH. NPH 
is an earlier type of intermediate-acting insulin which peaks between 4-8 hours after 
injection, which would affect post-exercise glycaemia in this study. The amount and 
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type of insulin dose adjustment were not specified and was reported only as a 10% 
reduction of the total daily dose which could be either fast-acting analogue or NPH. 
From the data, hypoglycaemia occurred post-exercise, but participant dose 
adjustment strategies after exercise were not described. Also the type of CHO that 
was consumed prior to exercise was not described. This is a major limitation as the 
glycaemic index of CHO can cause large fluctuations on absorption and the effect on 
the rise of blood glucose.  
 
However, despite the limitations, the important key message taken from this study 
was that hypoglycaemia occurred at least four hours after the finish of exercise 
despite insulin reduction and CHO consumption prior to exercise. The study showed 
that 20-60g CHO was necessary for 75% VO2 max to prevent hypoglycaemia. These 
findings were used in the current algorithm design. 
 
Relating to Grimm et al (2004), although not an original study but an experiential 
report, Biankin et al (2003) suggested that physiological elements which affected 
glycaemic control, included CHO digestion and intestinal absorption or the glycaemic 
index (GI) of CHO foods. This report also stated that exercise at > 75% VO2 max can 
delay absorption, but 50-70% VO2 max should not affect the rate absorption. No 
other literature in this area was found, however these dietary and physiological 
issues were relevant to the current study due to consumed CHO prior to exercise 
when the blood glucose concentration was low.  An applicable recommendation from 
the Dose Adjusting For Normal Eating (DAFNE) Group (2002), stated that 10g of 
CHO raised the blood glucose concentrations by 2.5 mmol/l, which is information 
given to patients within NHS education sessions throughout the UK and also 
acknowledged by Diabetes UK (2012). This recommendation was appropriate for 
inclusion to the current study. 
 
The above literature therefore indicates that there are multiple factors to consider 
when deciding CHO consumption before exercise i.e. type of CHO, the GI index and 
the amount, and needs to be balanced with the amount of active fast-acting 
analogue insulin, and the intensity and duration of the exercise. This is a complex 
area, for which there are many gaps and weaknesses in the limited evidence 
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available for inclusion in this current study, and highlights the need that further 
research is required. 
 
2.9 Self-management design:  After exercise  
Following on from pre-exercise self-management, post-exercise issues will now be 
discussed.  The literature search found no studies on the effects of insulin and/or 
CHO adjustment after exercise, to maintain acceptable glycaemic control, and thus 
avoid the complication of hypoglycaemia.  
 
Rabasa-Lhoret et al (2001) and West et al (2011) reported post-exercise 
hypoglycaemia, and from a patient perspective, Frier (2008) experientially described 
the patient‟s fear and concerns of hypoglycaemia, especially overnight after evening 
exercise. As suggested by Rabasa-Lhoret et al (2001), delayed hypoglycaemia is a 
potential problem, particularly for those who exercise in the afternoon, which is 
relevant to this current study. From this, hypoglycaemia can occur overnight and it is 
often more severe when people are asleep, and therefore more difficult to detect. In 
the review discussed by Ertl and Davis (2004), a detailed account described how 
hypoglycaemia can occur up to 12 hours post-exercise. This is a result of the 
replacement of utilized glycogen stores within the liver and muscles, which were 
used to provide energy during exercise.  The review also highlighted the increased 
risk of nocturnal hypoglycaemia in some patients after evening exercise. However, 
evidence-based preventative strategies are limited and this gap has been 
acknowledged by previous authors who provide recommendations on post-exercise 
self-management based on clinical experience rather than research based evidence 
(Ertl and Davis 2004, Perry and Gallen 2009). For a HCP, it is therefore important to 
discuss risks with patients during education sessions and provide information 
regarding prevention.  
 
The important factors to consider in post-exercise management include: 1). Post-
exercise insulin reduction, 2). CHO intake, and 3). Target blood glucose at bedtime. 
These will now be discussed to underpin the self-management algorithm. 
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2.9.1 Post-exercise fast-acting analogue reduction 
The risk of delayed or nocturnal hypoglycaemia is increased after exercise, and from 
a physiological stance, Ertl and Davis (2004) described increased insulin sensitivity 
post-exercise due to the increase in Glut 4 receptors. These receptors are 
responsible for muscle uptake of glucose in conjunction with replenishing glucose 
stores which supports the necessity of insulin reduction.  Similarly, Sandoval and 
Davis (2006) described the dysfunctional autonomic regulation of metabolism after 
exercise and delayed hypoglycaemia, but did not recommend insulin adjusting 
strategies for prevention. 
 
From the literature review, all recommendations for post-exercise insulin adjusting 
were based on experiential opinions. Perry and Gallen (2009), described evidence-
based percentage adjustments for pre-exercise bolus doses, but only suggested 
post-insulin reductions with no guidance to the amount.  Lumb and Gallen (2009) 
recommended a 30% decrease of post-exercise insulin dose which was not 
evidence-based. Peirce (1999) suggested a 30-50% post-exercise insulin-dose 
reduction, depending on exercise intensity and duration but again this was not 
evidence-based and vague. Rabasa-Lhoret et al (2001) also suggested a 50-75% 
pre-exercise insulin-dose reduction, but specific reductions for post-exercise meal 
doses were not recorded. The consensus of opinions from these authors all 
recommend dose reductions, however, amounts were variable and not evidence-
based. This is a major gap in the literature as no published research was found 
regarding post-exercise insulin dose adjusting to assist hypoglycaemia prevention. 
 
2.9.2 Long-acting analogue reduction 
Another self-management strategy used by HCPs to prevent nocturnal 
hypoglycaemia was basal insulin adjusting. Insulin Glargine (Lantus) is a basal 
insulin replacement designed to mimic natural insulin secretion to suppress 
glycogenolysis and to facilitate bolus insulin action. After injection, Lantus takes one 
hour to start a glucose lowering effect, and remains stable for an approximate 24 
hour period (Peter et al 2005). Within clinical practice, HCPs advise patients to 
reduce their Lantus dose after exercise to prevent delayed or nocturnal 
hypoglycaemia. However, because of the effect on the subsequent 24 hour blood 
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glucose profile, there is an increased risk of hyperglycaemia during the following day, 
and therefore it is not ideal.  
 
In relation to basal insulin adjustment, the only related publication found was by 
Peter et al (2005), which studied the effects of the absorption of Lantus on blood 
glucose after exercise in Type 1 diabetes. Using a randomised cross-over design, 
thirteen participants with Type 1 diabetes, using a basal bolus regimen were given 
their usual Lantus dose administered into the thigh, on the evening before visit 1 and 
visit 2. On both visits, the usual fast-acting analogue insulin dose was given 
immediately before breakfast. They were then randomly assigned to perform a 30 
minute bout of exercise one hour after one of the visits at 65% VO2 max. For data 
collection, blood glucose concentrations were monitored for the following 210 
minutes.  
 
The results demonstrated that the fasting blood glucose concentrations were similar 
on both days; exercise day, 8.4mmol/l and non-exercise day, 8.2mmol/l. Then during 
the 210 minute post-exercise period there were no differences in glucose levels 
(p=0.345). However, during exercise, the glucose concentrations were significantly 
lower (p=0.001) which is likely due to the full fast-acting analogue dose being given 
and not reduced. Also there were no statistical differences in plasma Lantus insulin 
levels during (p = 0.506) or after (p =0.116) exercise on both days.  
 
This study provided strong evidence for an important area in diabetes management. 
The positive outcome of the study demonstrated that plasma Lantus levels remained 
stable during and after the 210 minutes post-exercise period. However, again 
sample size was not discussed, and two further important limitations were noted that 
would affect clinical practice and the extrapolation of data. The first was that blood 
glucose concentrations were recorded at 15 minute intervals from baseline to 3 
hours and 30 minutes post-exercise. But the authors failed to study blood glucose 
concentrations for the following 24 hours when hypoglycaemia was a potential risk 
because of the Lantus time-action. Secondly, there was no adjustment made to the 
fast-acting analogue insulin dose pre-exercise which was the likely cause of the 
blood glucose decrease during exercise.  
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Despite this, the relevant key messages taken from this study were:  
1. The Lantus dose was not a contributing factor to hypoglycaemia during, or in the 
initial period after exercise. The plasma Lantus levels during 30 minute sessions of 
65% VO2 max exercise were not different between exercise and non-exercise visits. 
The Lantus absorption from injection sites after exercise was a previous concern of 
the author prior to performing this literature review, due to the potential increased 
hypoglycaemia risk which is currently discussed by HCPs with patients.  
2. The suggestion from this study was that the usual Lantus dose can be safely 
administered, although it must be highlighted that the nocturnal glucose response 
after exercise was not studied.  
 
2.9.3 Pre-bed blood glucose target and CHO amounts 
To prevent nocturnal hypoglycaemia, CHO consumption before bedtime is another 
common self-management strategy used by patients and advised by HCPs. In view 
of this, Brazeau et al (2008), stated that participants who consumed a CHO snack 
before bedtime to prevent nocturnal hypoglycaemia were significantly less fearful of 
hypoglycaemia (p=0.007). Increased CHO consumption before bedtime was 
reported as a possible intervention which may reduce overnight hypoglycaemia and 
thus balance increased insulin sensitivity and glucose uptake during the restoration 
of muscle and liver glycogen after exercise (Ertl and Davis 2004, Riddell and Perkins 
2006). However, despite the importance of these preventative hypoglycaemia factors 
for both psychological and safety reasons, no research regarding CHO snacks at 
bedtime after participating in exercise was found.  
 
2.10 Algorithm design 
All of the above issues regarding strategies before and after exercise are essential to 
incorporate into patient education. From this literature review, no publications have 
been found that provide a strategy that incorporates recommendations for patients to 
follow before and after performing moderate intensity exercise. All research has 
focused on one specific area i.e. before exercise insulin adjusting. An algorithm with 
written guidance to support verbal education which incorporates before and after 
exercise self-management strategies would be unique. 
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The author of this current study designed a similar formatted algorithm for exercise 
at 50% VO2 max, which is the equivalent to fast walking and was incorporated into a 
recent study by Kilbride et al (2011b). The study aim was to develop and evaluate an 
algorithm for diabetes self-management before, during and after exercise at 50% 
VO2 max in a laboratory environment for people with Type 1 diabetes exercising 
within 2 hours of fast-acting analogue insulin and food. Fourteen people with Type 1 
diabetes participated in the study over 2 weeks, with mean demographics: age 38 
yrs, BMI 25 kg/m² and HbA1c 7.5% ± 0.7%. All used a basal bolus analogue insulin 
regimen, CHO counted, and exercised regularly. On Days 1 and 3 of each week they 
undertook 40 minutes of moderate exercise at 50% VO2 max. During week 1 
participants self-managed their insulin and CHO, and in week 2 followed the self-
management algorithm stipulating a 30% fast-acting analogue insulin reduction pre- 
and post-exercise, and recommended CHO amounts based on the current glucose 
concentration. Continuous blood glucose monitoring was performed. The starting 
blood glucose target was 10mmol/l.  
 
These study results were discussed in relation to the usage of the algorithm as a 
self-management tool and not the effect on glycaemia as the exercise type was 
different to the current study. The relevant issues for the current study were that the 
measured glucose reproducibility and variability during and after exercise was poor. 
On a positive note, on discussion with the study participants, they found the 
algorithm was a useful and easy tool to understand and follow. 
 
With regard to the current study, a potential problem was the variability of glucose 
concentrations within subjects despite controlling the environment, exercise intensity 
and insulin dose adjustment which was demonstrated, and the authors 
acknowledged that this type of research does generate difficulties with analysis when 
using standard statistical techniques (Kilbride et al 2011b), and was also highlighted 
by West et al (2010). However, although this study used a different type of exercise 
and time of the day, an advantage of this study was that this method of informing 
patients of self-management strategies, by use of an algorithm was effective, and 
would be an ideal teaching resource.  
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There were sections of the 50% VO2 max algorithm that were appropriate for a 70% 
VO2 max algorithm:  
1. To achieve stable blood glucose concentrations, the starting blood glucose aim 
would be between 7-8 mmol/l. This is in contrast to previous research described in 
section 2.8.2, and considers patient comfort by avoiding hyperglycaemia. 
2. From reviewing the data and results, for post-exercise the algorithm remained 
unchanged indicating a 30% reduction in the following meal analogue dose for 50% 
VO2. This is evidence-based and gives the only information found from the literature 
search regarding post-exercise adjusting. 
3. If the exercise was undertaken during the evening, 10 – 30g of extra CHO would 
be recommended before bedtime, which was not suggested in other research.  
4. Long-acting analogue doses would not be adjusted, based on data from Peter et 
al (2005).  
5. From experience when using the 50% VO2 max algorithm with patients and 
reviewing its usage, some amendments to the design were necessary to make the 
algorithm easier to use with regard to insulin dose and CHO adjusting information, 
an example being to insert bullet points with specific guidelines.  
 
2.11 Study environment 
Following on from the algorithm development, it was important to ensure the 
information was safe for patients to use in their own exercise environment as all of 
the literature discussed so far in this review has been performed in a laboratory 
environment. Hence, the final section of this literature review was to identify any 
related research performed in a real-life environment, where the replication of 
laboratory-based self-management research findings were applied into the real-life 
environment, and then to demonstrate any differences regarding the impact on 
glycaemic control between environments. 
 
After selecting the relevant publications, it became evident that all studies regarding 
the evaluation of self-management strategies and the maintenance of glycaemic 
control surrounding exercise, were based in a laboratory environment using either a 
treadmill or bicycle, and not applied to real-life situations. However, it has been 
acknowledged that this apparatus can also be used in real-life (Grimm et al 2004, 
Peter et al 2005, Rabasa-Lhoretet et al 2001, West et al 2010). It was apparent that 
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the major difficulty when conducting this type of research was blood glucose and 
behavioural variability with exercise, hence the need for a controlled laboratory 
environment as described by Jimenez et al (2007).  
 
Depending on the individuals‟ real-life environment, possible factors that influence 
the exercise intensity i.e. seasonal weather conditions or road or grass surfaces can 
increase or decrease the intensity (Potteiger 2010), and have a profound effect on 
glycaemia data collected. Another situation would be when exercising in a gym in a 
real-life environment, when the duration of exercise included recovery breaks which 
would affect blood glucose concentrations. Similarly, when participating in team 
sports or playing against an opponent, the intensity and duration of exercise can be 
affected by others, in addition to their own performance which could vary from day-
to-day. These issues make it difficult to ensure that the same intensity and duration 
of exercise is maintained and may influence results and data within a scientific 
experiment.  Probably in order to minimize these variables as much as possible, 
previous studies were performed in a controlled laboratory environment. 
 
A further complication in data analysis, despite the use of controlled environments, 
was that glycaemic variability within participants was a phenomenon which offered 
researchers complex and intricate dilemmas when designing studies and analysing 
data in exercise and Type 1 studies (Jimenez 2007, Kilbride et al 2011a, Kilbride et 
al 2011b, Riddell and Perkins 2006, West et al 2010). From a self-management 
perspective, the accuracy and compliance of participants for insulin dose adjusting 
and CHO counting was considered paramount, as even the slightest change to 
insulin or CHO amounts may influence blood glucose concentrations. Other issues 
such as stress levels or hormonal effects on blood glucose concentrations, were 
never considered during patient recruitment nor recorded on experiment days, all of 
which could have a profound effect on glucose levels.  
 
As discussed previously, several studies (e.g. Peter et al 2005, Rabasa-Lhoret et al 
2001, West et al 2010), collected data following exercise, but only the minimum of 
data was presented in these publications which could not be used in the current 
study. During these studies, the participants when leaving the laboratory 
environment managed blood glucose concentrations, insulin doses and CHO without 
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any guidance from the researchers and used ad hoc management strategies for the 
post-exercise study time-period. These data were not included in the analysis and 
discussions of the publications because of the possible variability and 
inconsistencies in individuals‟ self-management. Such differences between 
participants would make extrapolating data and findings in patient management or 
related studies difficult.  
 
From the difficulties described above, the only publications found within a real-life 
environment were case studies, and described individuals rather than groups of 
patients in experiments (Butler 2006, Gravelling and Frier 2010).  
 
Butler (2006) presented the following case study which described the training and 
management programme for a person with Type 1 diabetes who planned to swim the 
English Channel. A 38 year old male with Type 1 diabetes trained for a year prior to 
the Channel swim. The training sessions could be interpreted as taking place in a 
laboratory or controlled environment (swimming pool), and lasted between 1 – 7 
hours per session. A swim of the Channel, on the other hand, would correspond to a 
real-life environment.  
 
The results gave a narrative description of insulin dose-adjusting but adjustments 
were only described in percentage terms not in actual units. The training sessions 
(controlled environment) and the swim (real-life environment) resulted in differences 
in blood glucose concentrations, but hypoglycaemia only occurred in the real-life 
situation.  A motivational strength of this study demonstrated that through trial and 
error with self-management strategies, people with type 1 diabetes can succeed in 
sport. However, a major limitation was the omission of glucose concentrations which 
were not described during training, and were only stated as satisfactory before and 
after the Channel swim. Narrative dose adjusting was described, which makes it is 
difficult to understand the precise dose-adjustment strategy despite being an 
important area of the management plan.  
 
The key messages taken from this case study were:  
1.  It was suggested that people with Type 1 diabetes discuss their exercise and self-
management plans with diabetes HCPs, and that success in self-management is 
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achieved by trial and error, which again indicated insufficient evidence to underpin 
education suggested by Gallen (2004), Kavookjian et al (2007), Lumb and Gallen 
(2009), and Perry and Gallen (2009) 
2. The study demonstrated differences in blood glucose concentrations and 
hypoglycaemia episodes between environments i.e. swimming pool (laboratory) and 
the Channel (real-life). 
 
Another case study was published by Graveling and Frier (2010) which focussed on 
the potential risk of recurring hypoglycaemia during endurance exercise. A 27 year 
old person with Type 1 diabetes was discussed, and the article was based on severe 
hypoglycaemia episodes prior to running a marathon, and resulted in one further 
severe hypoglycaemia episode during the following marathon. The publication 
presented a description of the individuals‟ pathophysiology and clinical markers 
relating to Type 1 diabetes, describing the previous 48 hours before exercise and the 
subsequent following risk of exercise induced hypoglycaemia.  
 
The publication provided a good description of pathophysiology related to 
hypoglycaemia and endurance exercise, however, specific insulin dose-adjusting 
and CHO consumption adjustments were not described. An important 
recommendation derived from this publication was an occurrence of a severe 
hypoglycaemia episode in the preceding 48 hours prior to an exercise session 
should result in the postponement of the session. This corresponded with 
recommendations from Riddell and Perkins (2006), although they did not stipulate a 
time-frame. 
 
In both of the above publications, the management strategies and outcomes were 
descriptive with limited discussion surrounding specific exercise intensity, duration or 
time.  Moreover, the interpretation of insulin dose and CHO adjustment in relation to 
glycaemic control was difficult to determine. These publications were of interest 
because they were thought-provoking and generated ideas for patient management, 
however, they cannot underpin recommendations for similar patient populations and 
situations.  
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The environment in which research is performed is an interesting concept and the 
application of laboratory findings into real-life patient self-management has not been 
analysed in any research as far as the author is aware, regarding exercise and Type 
1 diabetes. In regard to this, one must consider whether laboratory findings can be 
replicated into real-life situations and whether study interventions will have the same 
effect on individuals glycaemic control depending on the environment. This 
consideration was fundamental in the current study. 
 
2.12 Justification of study 
The literature review was structured following these three areas which identified 
gaps in the literature but also provided useful information in relation to moderate 
intensity exercise for people with Type 1 diabetes: 
 
 2.12.1 The challenges that people with Type 1 diabetes experience when 
exercising. 
A major factor that instigated this current study was that people with diabetes were 
anxious about exercising, with their main concern being hypoglycaemia. The primary 
strategy adopted to prevent hypoglycaemia was to precipitate hyperglycaemia by 
consuming CHO before and after exercise, particularly at bedtime (Brazeau et al 
2008, Kilbride et al 2011a, Wallymahmed et al 2007). It was apparent that the lack of 
understanding surrounding insulin pharmacokinetics made insulin adjusting difficult 
to use as a preventative measure for patients (Brazeau et al 2008, Kilbride et al 
2011a). The difficulties experienced by patients suggested a lack of evidence-based 
education or information to encourage and achieve current exercise 
recommendations (Diabetes UK 2012, SIGN 2010, WHO 2010). The evidence 
supports the initial presumptions regarding the importance of this current study. 
 
2.12.2   The self-management algorithm design 
There were no published self-management algorithms identified for direct use in 
patient care. All the research was performed in the laboratory environment, studying 
one aspect of self-management (Grimm et al 2004, Peter et al 2005, Rabasa-Lhoret 
al 2001, West et al 2010). This current study will attempt to pool all related evidence 
regarding self-management strategies before and after exercise together, in order to 
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provide one resource in the form of a self-management algorithm. However, in order 
to do this, gaps in the evidence, and discrepancies in experiential opinions for 
moderate intensity exercise were identified regarding: 1) Insulin adjustment after 3 
hours of insulin administration, 2) pre-exercise CHO intake, 3) target blood glucose 
concentrations, and 4) post-exercise insulin and CHO adjustment, for prevention of 
delayed hypoglycaemia risk. The algorithm design was devised after considering the 
appropriate key messages from individual studies, and the experiential opinions in 
the absence of experimental evidence, as described in section 2.8.  
 
2.12.3  The study environment 
No research was found comparing environments or research, based in a real-life 
environment. The impact of a self-management algorithm in the current study was 
analysed in both the laboratory and real-life environments, and was the first time that 
this approach was used.  
Comparisons between glycaemic responses in the two environments would provide 
information about the reproducibility of laboratory research findings into everyday life 
scenarios. However, glycaemic variability surrounding exercise in both environments 
was described by authors (Kilbride et al 2011b, West et al 2010), but further 
clarification is needed. 
 
2.13 Conclusion 
A self-management algorithm is essential to fill the gap in current research with 
regard to self-management after moderate intensity exercise in real-life. This should 
incorporate strategies to prevent hypoglycaemia to assist people with Type 1 
diabetes perform normal exercise, at a commonly preferred time of the day i.e. 
before an evening meal. It would also provide HCPs with evidence-based guidelines 
evaluated during real-life situations which is an essential part of holistic patient 
education (Perry and Gallen 2009, Rabasa-Lhoret et al 2001), and will support 
patients achieving the current recommendations for exercise (Diabetes UK 2012, 
SIGN 2010, WHO 2010.  
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Therefore, the aim and objectives of the current study are: 
 
Aim:  
To test the effectiveness of a self-management algorithm for adults with Type 1 
diabetes, during moderate intensity exercise within and outside the laboratory 
environment. 
Objectives: 
 
1. To examine the effects of a self-management algorithm on glycaemic control 
during a running session of 40 minutes exercise at 70% VO2 max and also for 
the following 12 hours in the real-life environment.   
2. Propose self-management algorithm adjustments to prevent hypoglycaemia 
and improve glycaemic control in the real-life environment. 
3. To investigate the impact of the environment (real-life versus laboratory) on 
blood glucose concentrations during and after the exercise session.  
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Chapter Three 
Methodology 
 
In this chapter the study design is described and justified. 
 
3.1 Research approach. 
A quantitative study design was selected for this study as objective measurements 
and statistical analysis were appropriate for data analysis. There were no 
requirements for the researcher to ascertain descriptions of personal self-
management, attitudes, and perceptions from participants that were related to 
performing exercise. 
A quasi-experimental design was selected, as this design type involved selecting 
groups and observing changes which occurred over time as a result of an 
intervention (Bryman 2008). In relation to the current study, the participants 
performed 40 minutes of moderate intensity exercise both in a laboratory 
environment and a real-life environment. The effects of the intervention, being the 
self-management algorithm, were analysed in both environments, and the blood 
glucose concentrations were analysed over time, between baseline and up to 12 
hours post-exercise for changes and differences between environments. 
Quasi-experiments are often used in natural settings, where the use of an artificial 
environment is inappropriate to use in order to answer the research question 
(Gerrish and Lacey 2009).  This was a key issue with the current study where the 
laboratory exercise sessions were controlled by the researcher and possibly such 
sessions could be considered as an artificial environment. However, the real life 
environment sessions were performed outside where the participant chose to jog or 
run and therefore provided strong ecological validity in the study (Bryman 2008). 
This inferred that the findings from the real-life sessions could be applied directly into 
everyday lives of people with Type 1 diabetes when they perform exercise at a 
similar intensity.  
 
Although it is acknowledged that a randomised controlled trial (RCT) is the gold 
standard for experimental studies (Bryman 2008), it was considered inappropriate to 
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randomise participants into comparison groups for the current study. One participant 
group would have to be a control group which meant they would have to self-
manage their diabetes (adjust insulin and CHO amounts). However, the participants 
within a control group may use different methods to adjust their insulin and CHO 
intakes with some having more success than others. In order to overcome this 
problem, the control group would be given guidelines regarding self-management, 
though some may class this advice as an intervention (Bryman 2008). Such a 
procedure has the danger of making the standardisation of the control groups‟ self-
management and subsequent analysis difficult. However, in a quasi-experiment 
design there is no control group, and participants act as their own control, hence 
individual differences would have less of an effect. For these reasons a quasi-
experiment was chosen for the present study. 
 
3.2 Population and sample 
The study used a purposive sampling technique to ensure suitable participants were 
approached, which resulted in the recruitment of nine participants. This particular 
technique was appropriate because of the rigorous inclusion and exclusion criteria 
and the necessity not to involve non-exercising participants, as the intensity and 
duration of the exercise may have been too difficult to achieve for non-exercisers.  A 
power calculation was not performed for this pilot study due to the lack of related 
research and evidence. 
 
The inclusion and exclusion criteria for the participants are listed below. These 
criteria were selected to ensure that the study aim and objectives were achievable 
and that patient safety was assured.   
 
Inclusion 
 People with Type 1 diabetes for over 2 years duration: This time period was 
decided because within 2 years of diagnosis, pancreatic function is often 
fluctuating. For example, if a person was producing their own insulin on a study 
day, then the resulting hypoglycaemia would bias data, since the injected dose of 
insulin or the exercise performed, would not have contributed directly to the 
hypoglycaemic episode. 
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 Between 18 – 60 years old: People under 18 years old often have erratic 
glycaemic control caused by fluctuating hormone levels, which again could bias 
results. There were also concerns that the use of the exercise protocol at 70% 
VO2 max may prove difficult for some older people, in view of the cardiovascular 
risk. 
 HbA1c under 10.0%: An HbA1c over 10% is regarded as poor glycaemic control 
(SIGN 2010). These patients rarely have blood glucose levels under 12.0mmol/l 
and may have difficulty achieving the starting pre-exercise blood glucose level of 
8.0mmol/l. There is also the risk of diabetic ketoacidosis caused by reductions of 
insulin doses within the algorithm.  
 Using basal bolus insulin regimen with fast-acting analogue insulin: This is the 
most common insulin regimen for active people with Type 1 diabetes, and allows 
greater flexibility to manage lifestyle activities. 
 Hypoglycaemic awareness: A complication of suffering Type 1 diabetes for a 
long-time is the potential to lose the ability to detect hypoglycaemia, which can 
result in moderate and severe episodes. For participant safety, it was essential 
that they were able to detect falling blood glucose concentrations during the 
exercise sessions. Patients were also at possible risk of delayed hypoglycaemia 
especially at night, and so study participation may put people at risk if 
hypoglycaemic awareness was impaired. 
 Participates in exercise twice a week or more: 70% VO2 max exercise is of 
moderate intensity and the study required participants to jog for 40 minutes whilst 
maintaining the level of intensity. A person not familiar with regular exercise may 
find this intensity uncomfortable. 
 English speaking: It was considered unsafe to have a person included within the 
study if the guidelines describing insulin doses, for example, were not clearly 
understood. If the participant did not understand how to perform the real-life 
exercise sessions, or to follow the algorithm, then these problems may put them 
at risk and also bias results. 
 
Exclusion 
 Pre-Proliferative/Proliferative retinopathy: This condition may be exacerbated 
during the strenuous exercise sessions causing retinal bleeding. 
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 Neuropathy/Foot ulceration: Running may cause increased pressure within a 
training shoe, and could cause friction and potential skin abrasion that could 
progress to ulceration. 
 Blood Pressure >150/90: Hypertension is an indicator of cardiovascular disease. 
This study requires exercise at 70% VO2 max which may increase the risk of 
cardiovascular problems. 
 Cardiovascular disease / history of angina: Increased exercise levels causing 
hypertension could exacerbate angina, myocardial infarction or stroke. 
 Orthopaedic problems: This may inhibit the participant from running, or cause 
deterioration of an orthopaedic condition. 
 
Suitable participants who attended two large NHS hospitals within one Health Board 
were identified via the local diabetes database. At the time of recruitment, the data 
base had 261 (Hospital A) and 99 (Hospital B) eligible participants who fell within the 
inclusion and exclusion criteria. However, it was unknown if these patients were 
regular exercisers as this data was not collected on the database. The invitation 
stipulated that to participate in the pilot study they must exercise at least twice a 
week. The Invitations from the Diabetes Specialist Nurse and Consultant Physician 
containing the relevant study information were posted to these eligible participants 
over a four-month period (see appendix 2). The other students named on this patient 
information sheet performed separate exercise studies, and the potential participants 
could choose which study to take part in. 
 
 
3.3  Methods and data collection instruments 
To answer the research questions and to examine the effects of exercise and the 
self-management algorithm strategies on blood glucose, the instruments used to 
collect data included blood glucose monitors and participant diaries (see appendix 
3). The data collection was carried out over two, four-day periods on days 1 - 4 and 8 
– 11 as shown below in Table 3.1.  
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Table 3.1 
Three-week study period: This is an example of a study schedule. Days 1 and 8 
could be performed on any day between Monday and Wednesday, with subsequent 
days 3 and 10 on any day between Wednesday and Friday. 
Week 1 
 
Any day of the week 
Environment Pre-test Laboratory session 
Exercise Sub-maximal incremental walking test performed 
on treadmill 
Data collection and tasks performed 
 
 
1. Study rationale and design explained 
2. Study checklists completed 
3. Consent performed 
4. TrueResult blood glucose meter 
demonstrated 
5. Study schedule and visit dates decided. 
6. GP information letter sent 
 
Week 2  
 
Day 1  Day 2  Day 3  Day 4  Day 
5 
Day 
6 
Day 
7 
Week 3 Day 8 Day 9 Day 10 Day 11 Day 
12 
Day 
13 
Day 
14 
Environment Laboratory 
session: 
No 
exercise 
Real-life 
session: 
    
Exercise Treadmill 
running which 
was 
programmed 
using their 
personal 70% 
VO2 max 
Measurements. 
 Running 
using Polar 
wrist watch 
and Training 
Heart Rate 
    
Data 
collection 
Data collection 
methods start: 
1.Self Blood 
Glucose 
Monitoring 
2.Continuous 
Blood Glucose 
Monitoring 
Continue: 
1, 2, 3, 4. 
Continue: 1, 2, 
3, 4. 
Data 
collection 
methods 
stop 
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3.Monitoring 
diary 
4.Hypolycaemia 
diary 
 
 
3.3.1 Self-management algorithm 
The self-management algorithm as shown in Table 3.2 was followed by participants 
on days 1, 3, 8 and 10. The algorithm incorporates evidence and experiential 
opinions that were found in the literature review and discussed in the previous 
chapter. The participant copy did not contain references to support each section. 
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Table 3.2 
 
Algorithm for Insulin and Carbohydrate adjusting for exercising at 70%  VO2 max 
 
Before exercise 
 
 
Lunchtime insulin 
 
 If exercising within 2 hours of eating a meal, reduce the bolus/meal dose by 75%. (Rabasa-
Lhoret et al 2001, West et al 2010). 
 
Blood glucose 
 
 Aim for blood glucose of 8mmol/l immediately before exercise. 
 If blood glucose over 12mmol, check for ketones and take a correction dose. 
 If blood glucose over 17mmol do not exercise (American Diabetes Association 2002, 
Ertl and Davis 2004, Gallen 2004, Riddell and Perkins 2006). 
 
Food 
 
 If blood glucose under 8 mmol/l have the following carbohydrate (DAFNE 2002, Grimm et al 
2004): 
Blood glucose prior to exercise Amount of CHO (g) 
 
Under 4 30 
4 - 6 20 
6 - 8 10 
8 or over 0 
 
After exercise 
 
 
Bolus/meal insulin 
 
 Eat within 2 hours of exercise and reduce the bolus/meal dose by 30% (Ertl and Davis 2004, 
Gallen 2004, Rabasa-Lhoret et al 2001, Riddell and Perkins 2006). 
 After 2 hours return to usual dose 
 
Long acting insulin  
 
 Take usual Lantus or Levemir dose (Peter et al 2005). 
 
Blood glucose 
 
 If blood glucose at 8 mmol/l or under before bedtime have 10-20 grams of CHO. 
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3.3.2 Blood glucose monitoring  
For the purpose of the study, frequent blood glucose monitoring was essential to 
determine the effects of the algorithm described in Table 3.2, and the environment 
effects on glycaemic control. To ascertain the blood glucose concentration of an 
individual, the only current methods are invasive: Self Blood Glucose Monitoring 
(SBGM), Venepuncture then sending samples to a laboratory, or a Continuous 
Glucose Monitor System (CGMS). Venepuncture is painful, time-consuming and 
resource intensive, with delayed time for obtaining the result, and so SBGM and 
CGMS were the chosen methods.  
 
A. Self Blood Glucose Monitoring 
Participants were required to perform SBGM prior to each bolus insulin dose and 
meal which was equivalent to four times a day. The tests taken by participants were 
also used for CGMS calibration. For the exercise sessions, SBGM was performed at 
baseline, 20 minutes during and 40 minutes after exercise. This was to detect that 
the glucose concentration was safe for participants. Another SBGM test was also 
carried out before the following meal and insulin dose. These tests used whole blood 
and gave point of time results. During the data collection period, to confirm 
hypoglycaemic episodes, participants were also asked to test and record results 
whenever they suspected having a low blood glucose concentration. SBGM was 
used for analysis from baseline to before evening meal time-points (table 3.3), as 
immediate results were required during the exercise session and the CGMS would 
not be recording results within the first 2 hours. 
 
There are a multitude of self-blood glucose meters on the market. The TrueResult 
blood glucose system was chosen because of ease of use, size ( ideal for carrying in 
the real-life sessions), precision and the wide glycaemic test range which is 
beneficial for accurate measurements down to 1.1mmol/l (Home diagnostics 2009).  
 
B. Continuous Blood Glucose Monitoring System  
CGMS was described by Maia and Araujo (2007) as an effective management tool to 
identify postprandial hyperglycaemia and to detect hypoglycaemia. The Minimed iPro 
was the monitor used in this study which showed an accurate overall assessment of 
the past, present and immediate future of glycaemic status (Klonoff 2005). The 
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CGMS does not directly measure glycaemia, but the glucose concentration in the 
subcutaneous interstitial fluid which mimics the fluctuations in glycaemia (Melki et al 
2006). Previous studies comparing CGMS and SBGM tests reported a time lag 
between results and real-time (Melki et al 2006) and this has been a cause for 
concern amongst HCPs regarding the accuracy of CGMS data. However, a recent 
comparison during sessions of 50% VO2 max exercise showed a good correlation 
between the two methods of testing (Kilbride et al 2011b).   
 
The participants were connected to the CGMS prior to the exercise sessions on days 
1 and 8 and then removed 3 days later. To ensure accuracy, a minimum of one 
SBGM result during every 24 hour period was added into individual participants‟ 
CGMS database, to allow for correlation of results after the system was removed 
and downloaded. To increase precision, the four pre-meal tests were also included, 
with any additional hypoglycaemic test results. The SBGM results were extrapolated 
from the monitoring diary. In the current study, data were recorded every 10 minutes 
for the two, four-day data collection periods. The whole data-set is important as 
hypoglycaemic episodes may have been missed especially during the night and it 
was considered inappropriate to instruct participants to perform frequent SBGM tests 
(Melki et al 2006).  Patients often experience undetected hypoglycaemic or 
hyperglycaemic experiences (Deiss et al 2006), which would go unnoticed without a 
CGMS method of recording, and therefore the usage was essential for the 
recognition of these conditions. CGMS results were used for analysis for the 2 to 12 
hour time-points shown in Table 3.3. 
 
3.3.3 Monitoring diaries  
On day 1, the participants were advised how and when to record data using 
monitoring diaries, which were in a paper format (appendix 3). However, it was 
acknowledged that accuracy was dependent on the participants being conscientious 
and fastidious. The diaries were used to record:  
 
1). Blood glucose concentrations. 
These measurements were recorded before each meal at breakfast, lunch, evening 
and bedtime. Extra tests were advised if participants felt any hypoglycaemic or 
hyperglycaemic symptoms to enable prompt treatment.  
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2). Insulin dose. 
The insulin dose data collection was essential to ensure participants had followed 
the algorithm. The usual insulin dose plus the adjusted dose were recorded to clarify 
that a 30% fast-acting analogue reduction had been given. This strategy within the 
algorithm would affect the overall data and therefore documentation to verify that this 
procedure was performed was considered vital. 
 
3). CHO intake. 
This part of the data collection and its accuracy could be subjective to the participant. 
Some participants may have been CHO counting for a long-period of time which may 
have instilled complacency in some, as was often seen in clinical practice. The 
importance of the accuracy in CHO counting was highlighted on day 1. The intake 
was checked when participants experienced hypoglycaemia to ensure the cause 
was not due to decreased CHO consumption. Participants were asked to consume 
the evening meal within 2 hours of finishing the exercise session. 
 
3.3.4    Hypoglycaemia diaries  
The hypoglycaemia diary is shown in Appendix 3. For the current study, 
hypoglycaemia was defined as: participants experiencing symptoms of 
hypoglycaemia confirmed with a SBGM of <4.0 mmol/l, or a SBGM <4.0 mmol/l 
without symptoms. These parameters followed the SIGN (2010) guidelines, although 
it has been acknowledged that some studies described in the literature review used 
lower concentrations (Grimm et al 2004, Rabasa-Lhoret et al 2001, West et al 2010).  
The term “severe” hypoglycaemia was used if help was required from a third party to 
instigate treatment. If hypoglycaemic unawareness occurred and participants 
experienced hypoglycaemic symptoms, but had a SBGM > 4.0 mmol/l, they were 
also asked to complete the diary. The CGMS also recorded hypoglycaemia and the 
data sheets highlighted blood glucose < 2.2mmol/l. This would ensure that if 
participants were unaware of the development of nocturnal hypoglycaemia or even 
failed to awaken, the CGMS monitor would confirm overnight glucose 
concentrations. In the diary, the time of hypoglycaemia in relation to exercise was 
reported, because it was essential to differentiate between possible causative factors 
within the algorithm, and to ascertain whether exercise was the cause of the 
episode.  
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3.4 Exercise intensity and study equipment 
The equipment used to perform the study included heart rate monitoring and 
exercise equipment. The type of exercise chosen to perform at 70% VO2 max 
exercise, was running.  In the laboratory sessions, which were situated in the 
University, the treadmill was the piece of equipment that was considered best to 
replicate running in a real-life environment. The 70% VO2 max and 40 minute 
duration of the laboratory exercise session, was precisely controlled, and measured 
safely and effectively by participants running on a motor-driven treadmill (Potteiger 
2010). The intensity was controlled by manipulating the speed and grade to ensure 
that 70% VO2 max was achieved, as pre-determined by the pre-test described in 
section 3.4.2.  
 
3.4.1 Exercise Intensity 
Exercise intensity can be monitored by three different methods (Wilmore and Costill 
2004): 1). the training heart rate (THR), 2). metabolic equivalent (ME) or 3). ratings 
of perceived exertion (RPE).  
 
1). Training Heart Rate  
Measuring the heart rate is the recommended method for clarifying exercise intensity 
as it is closely correlated with the energy and heart expenditure (Wilmore and Costill 
2004). The THR is a measurement of heart rate that is equivalent to a percentage of 
an individuals‟ VO2 max. The THR range is an accurate method because if the 
exercise period utilised more energy and oxygen consumption, the individual would 
run to the same heart rate. This fact is important, as external variables i.e. weather 
conditions or ground conditions may affect the toughness of exercise and could be 
different on both real-life exercise session days. 
 
2). Metabolic Equivalent 
The ME relates to the oxygen requirements needed for energy expenditure required 
for certain activities, but is an approximation and does not account for individual 
variables i.e. metabolic efficiency, physical conditioning and environmental factors. 
The metabolic efficiency and physical conditioning can vary between participants. 
For real-life sessions environmental factors such as the weather, inclines and hills, 
and road or grass surfaces can affect performance and exercise intensity. 
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Consequently, the ME was not incorporated into the data collection methods of this 
current study.  
 
3). Ratings of Perceived Exertion 
The RPE is a method of subjectively measuring the intensity of exercise, and is a 
simple and convenient tool to use (Karavatas and Tavakol 2005). Individuals rate the 
intensity of exercise by matching their physical state and perceived exertion with a 
comparable numbered scale (Wilmore and Costill 2004). However, one commonly 
used scale called the BORG scale (1998) has been criticised for reliability and 
consistency (Chen et al 2002, Karavatas and Tavakol 2005). Also a meta-analysis of 
RPE scales showed inconsistencies regarding the ratings and physiological 
measures i.e. heart rate (Chen et al 2002). The ratings can also be influenced by 
current mood, motivation and other emotional factors at the time of the test (Pandolf 
1982). An individual‟s RPE is subjective and for these reasons, this method was also 
not chosen for use in the current study. 
 
When evaluating a specific type of physical activity and its possible effects, it was 
important to ensure that the equipment, techniques and protocols were designed for 
the item being measured (Potteiger 2010). With regard to this, the THR was used. 
During the laboratory exercise sessions, the intensity of 70% VO2 max was 
established by following the individual treadmill speed which was determined from 
the sub-maximal incremental walking tests described in section 3.4.2. However, 
during the real-life sessions, it was more difficult to achieve this scenario. From the 
THR, each participant was given an individual heart rate measurement to achieve 
during the real-life sessions, which gave a low and high range of heart rate specific 
to their 70% VO2 max. The use of a Polar wristwatch and by exercising within the 
THR parameters, was the easiest way for the participants to ensure they were 
performing exercise at 70% VO2 max when in real-life sessions.  This ensured that in 
both environments, the same exercise was performed. 
 
3.4.2  Pre-test: Sub-maximal incremental walking test 
A sub-maximal incremental walking test (appendix 4) was designed by a member of 
the research team (Kilbride et al 2011b) and was performed to determine 70% VO2 
max, which is acknowledged as moderate intensity exercise. The test consisted of 3 
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minute workloads with progressive increments in treadmill speed and gradient.  For 
this test, the participants were given the opportunity to familiarise themselves with 
walking on the treadmill and were fitted with a heart rate (HR) monitor (Polar) and a 
face mask for a breath gas analysis to measure VO2.  During the test, the HR and 
VO2 were recorded at the last 30 seconds of each stage.  The blood glucose 
concentration was also recorded using SBGM at the beginning, at 10 minutes into 
the test and at the end.   The end-point of the test was at, or just before 85% of the 
participant‟s age-predicted maximum HR. For safety reasons, however, in the event 
of a monitoring system failure or if a participant experienced chest discomfort, light-
headiness, confusion, dyspnoea, nausea, blood glucose under 4mmol/l, or overall 
feelings of discomfort, the test was terminated. The pre-test was essential to 
standardize the exercise intensity. 
 
3.5 Study procedure 
The study ran over a three week period (Table 3.1) for each participant. The three- 
week time-period was necessary to accommodate laboratory room bookings, 
opening times and equipment use, whilst also avoiding weekends for CGMS 
downloading. Within the study period, participants visited the laboratory for three 
exercise session visits, and performed two exercise sessions in a real-life 
environment, which took place in an area outside and chosen by the participant. The 
visit checklists and procedures used throughout the study can be found in Appendix 
4. 
 
3.5.1 Week 1: Pre-test laboratory session  
The study checklists and consent (Appendix 4) were performed at the pre-test 
laboratory session prior to performing the pre-test. The study design was described 
to the participant and questions were discussed. The pre-test was performed, then 
the study schedule described below and shown in Table 3.1 was discussed, and the 
following exercise session dates were decided with the participant before they 
completed the visit. The participants‟ GP was informed by letter as shown in 
Appendix 5. 
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3.5.2 Weeks 2 and 3: Laboratory treadmill sessions 
The following weeks on Day 1 and 8, the participants attended the laboratory. Data 
collection methods were explained and commenced prior to the exercise session. On 
arrival the CGMS was connected to the participant, SBGM was demonstrated and 
the participant performed a test under observation to ensure they were able to use 
the meter correctly.  Monitoring and hypoglycaemia diaries were discussed again 
and participant usage and accuracy was highlighted. Information sheets to explain 
usage were given to emphasise verbal information. 
 
Exercise was performed 3 hours after administering the previous fast-acting 
analogue dose of insulin and the lunchtime meal. It was considered important to 
determine the time of the previous dose and meal because exercising within 3 hours 
may result in fast-acting analogue insulin still circulating and thus increase the risk of 
hypoglycaemia. Participants administered their normal lunch insulin dose and had 
the usual amount of CHO for that insulin amount. Participants had previously been 
asked not to consume afternoon snacks to ensure no food was eaten within 3 hours 
of the exercise session. The self-management algorithm (table 3.2) was used when 
the participants had tested their pre-exercise blood glucose using the SBGM. 
 
Participants then undertook a 40 minute period of treadmill running in the laboratory 
environment whilst following the self-management algorithm. Blood glucose 
concentrations using the SBGM were taken at baseline before exercise commenced, 
20 minutes into the exercise session and also 40 minutes at the end of exercise. If 
participants felt that their blood glucose was changing, it was checked for 
reassurance and safety. CGMS was not used for the exercise sessions because the 
system can take up to two hours to calibrate and to start recording blood glucose 
concentrations. 
 
3.5.3    Weeks 2 and 3:  day 2 and 9 with no exercise 
An explanation was given to participants that no exercise should be taken on days 2 
and 9 in between the laboratory and real-life exercise sessions.  This was because 
of the risk of exercise causing hypoglycaemia, and thereby influencing the following 
days‟ glycaemic control and glycogen stores on days 3 and 10. Participants should 
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not have experienced any hypoglycaemia episode 24 hours prior to undertaking a 
study exercise session, because there is an increased risk of a further occurrence 
(Graveling and Frier 2010). It was important to stress during the discussions on days 
1 and 8, delayed hypoglycaemia experienced after the effects of exercise could 
prevent participants from performing in the real-life sessions.  
 
3.5.4 Weeks 2 and 3: Real-life exercise sessions 
On Day 3 and 10, participants undertook their own running session at 70% VO2 max 
outside the laboratory environment either outside or in a chosen sports hall, whilst 
following the self-management algorithm. This part of the experiment was discussed 
on days 1 and 8 when the data collection methods were explained. Again, exercise 
was performed 3 hours after administering the previous fast-acting analogue dose of 
insulin and meal and the importance of this was highlighted for the reason described 
in the laboratory session section. Only running was performed, and participants were 
asked not to use a different type of exercise, in order to replicate the laboratory 
session. 
 
The controlled exercise session within the laboratory was replicated in real-life 
exercise by participants using the Polar wristwatch and the THR, thus ensuring, 
when possible, the maintenance of 70% VO2 max. This was a difficult situation to 
replicate and was dependent on the participant following guidelines. The participant 
had to observe their heart rate and duration of exercise during the session.  Again 
participants tested their blood glucose via SBGM at the start of exercise for baseline 
measurements, 20 minutes later and 40 minutes at the end of the session. If 
participants felt hypoglycaemic or thought that their blood glucose was changing, 
they were advised to perform extra tests. At this time, however, although the CGMS 
was recording blood glucose, to reduce possible variability between blood glucose 
testing systems, the SBGM was used only for data collection. There should have 
been no differences in the replication of the laboratory session into real-life, and to 
achieve this, the participant had to conduct it themselves without the researcher to 
prompt, check the timings, and observe that the THR was within the correct range. 
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3.6 Validity and Reliability 
From the participant inclusion criterion and study design, some issues may affect the 
data collected. A confounding internal variable described a component that may 
have an effect on the findings of the effectiveness of an intervention (Bryman 2008). 
For the current study the confounding variables suspected were: glycaemic control, 
participant data collection, equipment and selection bias. 
  
With regard to glycaemic control, one variable to consider could be the participants‟ 
different levels of glycaemic control. There are several issues involved here, the first 
being that participants with higher HbA1cs or erratic glycaemic control, may find it 
difficult to achieve the target starting blood glucose of 8.0mmol/l. This may result in 
participants having lower starting glucose concentrations (which would result in CHO 
consumption) or higher than the target level, which could cause prolonged 
hyperglycaemia at 20 minutes and 40 minutes at the end of the session. Also, 
depending on the level of hyperglycaemia, a postponement of the exercise session 
may be necessary. 
 
If participants experienced different hypoglycaemic awareness they may classify 
hypoglycaemia as different glucose concentrations i.e. under 3.0, 3.5 or 4.0mmol/l, 
which could be another confounding variable. In this study the frequency of 
hypoglycaemia is a measure to determine the effectiveness of the algorithm, and it 
was crucial to collect accurate data. In an attempt to alleviate these issues, the 
participants were informed at all sessions that a hypoglycaemic episode is a blood 
glucose episode of 4.0mmol/l or less, and any episodes measured at this level 
should be recorded. 
 
Another variable could be the equipment being used and the data collection 
methods. Measurement validity is concerned with the measurement tool reflecting 
the concept it was supposed to denote (Bryman 2008). As described earlier, all 
participants used the same equipment and were instructed on the usage, with written 
information to support understanding.  All these factors assured the validity of the 
study. Education and the reinforcement of this information were given at all study 
visits, especially on the importance of accuracy of recording-keeping in diaries. 
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Selection bias may occur as this quasi-experiment used participants who were 
available and willing to participate (Parahoo 1997). The inclusion and exclusion 
criteria used in the current study was narrowly defined, however most people with 
Type 1 diabetes use basal bolus regimens, and by keeping the HbA1c level under 
10% excluded individuals with very poor glycaemic control, who may have had 
difficulty achieving the target starting blood glucose. It was also deemed to be 
important that to test the algorithm on participants, they should be experienced 
exercisers who could perform the exercise intensity and duration required. Also 
participants performed exercise in both environments and acted as their own control 
which lessened variability. 
 
External variables described by Parahoo (1997) are in relation to applying findings to 
similar populations in different settings. The individuals recruited in this study were 
motivated and had a positive approach with regard to their general and diabetes 
health.  After the study, if the algorithm is used outwith the study environment and in 
patients‟ everyday lives, it would be envisaged that individuals wanting to use the 
algorithm would be motivated to want to exercise and maintain acceptable glycaemic 
control.  
 
3.7 Ethical considerations. 
Prior to performing this research, issues regarding patient protection were reviewed. 
Bryman (2008) described the following four main issues that support ethical 
principles: patient safety, informed consent, confidentiality, and deception. These 
issues are concerned with patient protection but can also be applied to the 
researcher to ensure safe and competent care (Nursing and Midwifery Council 2007, 
Royal College of Nursing 2009). The current study was approved by a local and 
national ethics committee who considered patient safety and the method used for 
patient consent, which ensured these issues were safeguarded. 
 
3.8 Data analysis  
To establish the effectiveness of the algorithm a comparison was made between the 
controlled laboratory exercise and the participants‟ real-life exercise. Participant data 
were analysed on all four exercise days, plus days 2 and 4 and up to the 12 hour 
post-exercise period of days 4 and 11.  
72 
 
Days 1 and 8 were compared to examine laboratory exercise and glycaemic 
response, and also days 3 and 10 to determine real-life exercise and the glycaemic 
response whilst following the algorithm. Analytical comparison was made between 
days 1 and 8, and 3 and 10, to establish differences in controlled exercise compared 
to real-life, and to answer the question whether the algorithm can be applied to the 
real-life situation. Data analysis from the real-life exercise sessions underpinned 
algorithm amendments. 
 
Ten time-points detailed in Table 3.3 were selected for measurement and analysis, 
as these were specific time-points that would allow the examination of treatment 
adjustment strategies. For the data between base-line until before evening meal, the 
SBGM recordings were used, and between 2 – 12 hour time-points the CGMS 
recordings were used. A description is given below for the time-points that 
correspond to each algorithm section: 
 
a). During exercise. The time-points of baseline, 20 minutes mid-way and 40 minutes 
at the end of the exercise session are incorporated into this algorithm section. These 
data will correspond to pre-lunch insulin dose adjusting, the starting blood glucose 
and CHO consumed prior to exercise.  
b). Before evening meal within 2 hours of end of exercise. This time point will provide 
information regarding the need for CHO consumption at the finish of exercise, which 
was not incorporated into the algorithm. 
c). 2 - 6 hours post-exercise. The time-points of 2, 4, 6 hours after the evening meal 
will be used in this algorithm section. These data will analyse the effect of reducing 
the evening meal fast-acting analogue dose by 30%. 
d). 8 – 12 hours post-exercise. The time-points of 8, 10, 12 hours after evening meal 
will be used in this algorithm section. These data will relate to basal insulin dose 
adjustments or CHO consumption at bedtime.  
 
Statistical analysis was performed using IBM Statistic Package for Social Sciences 
software (version 18, SPSS inc. Chicago, IL), for data storage and basic analysis. 
The units of analysis were based on blood glucose concentrations. All data were 
checked for suitability for parametric analysis then analysed using repeated 
measures of variance (ANOVA) on 3 factors (two environments x 10 separate time 
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points x two separate exercise sessions in week 1 or 2) with Bonferroni adjustments 
to demonstrate differences.   Time-points are shown in Table 3.3. 
 
Table 3.3 
The algorithm strategies and sections with the time-points for analysis to 
influence algorithm adjustment. X= the time-point to be used for analysis. 
 
Time-points Baseline 20 
minutes 
40 
minutes 
Before 
evening 
meal 
2  h 4  h 6  h 8 h 10 h 12 h 
Pre-exercise fast-
acting analogue 
dose reduction 
× × × ×       
Pre-exercise  
blood glucose 
target 
× × × ×       
Pre-exercise 
CHO amounts 
× × × ×       
CHO 
consumption at 
finish of exercise 
   × ×      
Post-exercise 
fast-acting 
analogue dose 
reduction 
   × × × ×    
Long-acting 
analogue 
reduction 
       × × × 
Pre-bed blood 
glucose target 
     × × × × × 
CHO 
consumption at 
bedtime 
     × × × × × 
 
To evaluate the effectiveness of the algorithm descriptive analysis was also 
performed to evaluate the number of participant episodes for glucose ranges of: 
hypoglycaemia (≤4.0mmol/l), 4-9mmol/l and hyperglycaemia (≥9.0mmol/l) at each 
time-point. This was performed as extreme outliers may not be highlighted on 
statistical analysis. 
 
The data analysis would confirm whether the algorithm maintained acceptable 
glycaemic control. The findings would either instigate refinements within the 
algorithm, or allow the prediction of glycaemic control whilst exercising at moderate 
intensity when following the algorithm to prevent hypoglycaemia or hyperglycaemia.  
The comparison of environments would also show whether laboratory research can 
be applied to clinical practice and real-life scenarios.
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Chapter Four    
Results 
 
 
4.1 Introduction 
The following chapter will describe the findings of the study. 
 
4.2 Participant demographics 
Nine participants that matched the inclusion/exclusion criteria (five males, four 
females) were included in the study. All participants completed the study and 
performed all exercise sessions. No participant failed to perform an exercise session 
due to hypoglycaemia in the preceding 24 hours. The demographic data are 
presented as means ± standard deviation: age 39.3 years ± 10.5 (range 24 – 56), 
BMI 24.8 ± 1.7kg/m², weight 75.6 kg ± 6.2 kg, HbA1c 7.9 ± 0.7 %, duration of 
diabetes 16.8 years ± 14.2 (range 4 – 46 years). All performed CHO counting and 
insulin dose adjustments using an analogue basal bolus regimen. The insulin types 
were: fast-acting analogue: Humalog (n=3), Novorapid (N=6), and basal analogue: 
Lantus once daily (n=7), Levemir (n=1), Isophane taken three times a day (n=1). All 
participants engaged in exercise for more than two sessions a week. All had 
hypoglycaemic awareness, with no long-term complications or orthopaedic problems.  
 
4.3  Statistical analysis  
This was performed using the mean blood glucose concentrations and standard 
deviations, and a 3-way repeated measures test (ANOVA).  
4.3.1 Mean glucose concentrations 
The pooled data of mean glucose concentrations taken at the specific time-point with 
standard deviations in the laboratory and real-life sessions are shown in Table 4.1. 
Figure 4.1 displays the comparison between environments. The mean glucose 
concentrations revealed similar results in both environments. However, the glucose 
concentrations appeared to be more variable at the real-life time-points which were 
recognised by the larger standard deviations, compared with the laboratory time-
points (Table 4.2).  
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Table 4.1 
The mean glucose concentrations (and standard deviations) at each time-point 
in the laboratory and real-life environments.  
 
 Baseline 20 
minutes 
during 
exercise 
40 
minutes 
at end 
Before 
evening 
meal 
2  h 4  h 6 h 8 h 10 h 12 h 
Laboratory 
Blood glucose 
(mmol/l) 
 
10.3 
(2.2) 
8.3 
(2.6) 
6.9 
(2.8) 
8.0 
(1.9) 
9.9 
(4.0) 
9.4 
(3.2) 
8.9 
(3.7) 
8.2 
(2.9) 
8.0 
(2.3) 
8.3 
(2.6) 
Real-life    
blood glucose 
(mmol/l) 
 
10.9 
(3.4) 
8.8 
(3.7) 
7.6 
(3.4) 
9.9 
(4.1) 
10.3 
(3.3) 
10.5 
(4.8) 
9.2 
(3.3) 
7.7 
(3.2) 
7.4 
(3.2) 
7.9 
(3.7) 
 
 
Figure 4.1 
A comparison of mean glucose concentrations in laboratory and real-life 
sessions. The error bars represent standard deviations. 
 
 
 
4.3.2 Environmental differences between exercise sessions 
Data were tested for normal distribution and suitability for parametric analysis using 
the mean glucose concentrations at all time-points together with tests of normality 
using the Kolmogorov-Smirnov test. The significant levels ranged between 0.131-
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0.200. A quantile-quantile (Q-Q) scatterplot revealed a straight line at all time-points, 
the linearity of the points suggested that the data were normally distributed. Hence, 
parametric statistical tests were used as a normal distribution was demonstrated.  
The 3-way ANOVA was conducted to explore any differences in glycaemic control 
between: environment, exercise sessions and time-points. Bonferroni adjustments 
were used to control the probability of finding Type 1 errors. Statistical significance 
was set at p<0.05. Data are presented as means ± standard deviation.  
 
The four exercise sessions were analysed using a 3-way ANOVA to investigate 
differences in blood glucose measured in mmol/l across the 10 time-points, in the 
two environments, and in the two sessions (i.e. week one and week two). The 3 
factors were: environment (laboratory (L) or real-life (RL)), the time-point (before 
exercise, 20 minutes during, 40 minutes (end of session), before evening meal, 2 
hours after, 4 hours after, 6 hours after, 8 hours after, 10 hours after and 12 hours 
after), and exercise session (first or second).  
 
Differences between time-points 
There was a highly significant main effect on time-point [F(9, 72) = 4.088, p  < 0.005, 
partial eta-squared = 0.338, which represents a large effect size]. Post-hoc 
Bonferroni pairwise comparison indicated that the blood glucose at 20 minutes 
(mean 8.4mmol/l) was significantly lower (p=0.011) than before exercise at baseline 
(mean 10.6mmol/l), with a mean blood glucose difference of 2.20 (se±0.354). A 
similar significant decrease was also shown between baseline and 40 minutes at the 
end of exercise (mean 7.2mmol/l) (p=0.007) with a mean blood glucose difference of 
3.41mmol/l (se±0.511). This demonstrated that a significantly lower blood glucose 
concentration occurred as a consequence of exercise. There were no significant 
differences between other time-points, all p-values >0.05. 
 
Differences between environments 
One of the principal research questions asked in this study was to establish whether 
any differences occurred in glycaemic control when using the algorithm in two 
different environments. With the overall mean glucose concentrations, the 3-way 
ANOVA verified that the environment did not have a significant main effect on the 
glycaemic control of participants [F(1, 8) = 1.489, p = 0.257]. This referred to the 
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comparison of all mean glucose concentrations for both environments, without 
examining change in blood glucose over time.  
 
Differences between exercise sessions 
The participants performed two exercise sessions in each of the two environments. 
As described in section 3.5.4, the exercise intensity and duration, and self-
management strategies were the same for both environments. It was thought that 
participants may have become familiar with their exercise sessions and become 
lenient and diligent in their self-management following the algorithm, thus avoiding 
an adverse effect on glycaemic control. However, this concern transpired  not to be 
an issue, as there was no significant main effect identified on glycaemic control 
between the separate exercise sessions [F(1, 8) = 0.384, p = 0.553]. 
 
Interactions between environment, time-points and exercise sessions 
When investigating 2-way interactions regarding glucose control between the 
variables, there were no significant effects on environments and times [F(9, 72) = 
0.499, p = 0.871],  or  environments and exercise sessions [F(1, 8) = 0.778, p = 
0.404], or exercise sessions and times [F(9, 72) = 1.616, p = 0.127]. 
There was also no significant 3-way interaction effect on environments, times and 
exercise sessions [F(9, 72) = 1.280, p = 0.263]. 
 
4.4 Descriptive analysis 
A descriptive analysis was also performed as the characteristics of these statistical 
tests along with the small participant numbers used would not reveal the extreme 
glucose episode outliers. It would also describe the blood and subcutaneous glucose 
results within ranges and the environment differences between time-points, to 
identify the effects of each specific self-management strategy.  
Across the four exercise sessions all data were analysed for the occurrence of 
glycaemic episodes in different ranges. There were 18 individual participant 
episodes (9 participants X 2 sessions) for each time-point. The number of participant 
episodes for glucose ranges of hypoglycaemia (≤4.0mmol/l), 4-9mmol/l and 
hyperglycaemia (≥9.0mmol/l), were analysed for each algorithm section. The 
frequency of individual participant episodes for each of these ranges, were stated as 
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numbers. Table 3.2 in the methodology chapter shows the algorithm section and 
self-management strategy with the relevant affected time-points. The data obtained 
from the time-points were reviewed to establish whether algorithm adjustments were 
required. These adjustments were based on patterns and trends of glucose results. 
 
Table 4.2 shows the percentage of episodes for each blood glucose range (SBGM 
for baseline to before teatime) and subcutaneous glucose measured by the CGMS 
(2 to 12 hours), in the time-points within the algorithm sections. The percentages 
were not based on the whole time-period but only the specific algorithm section and 
the number of individual measurements during the time-point range.  
 
 
Table 4.2  
A summary of episode percentages and numbers in the algorithm sections for 
each glucose range. 
Algorithm 
section 
Baseline-40 
minutes 
Before evening 
meal 
2 – 6 hours after 8 – 12 hours 
after 
Environment Lab Real-
life 
Lab Real-
life 
Lab Real-
life 
Lab Real-
life 
Blood 
glucose 
range 
        
Under 
4mmol/l  
13.9% 
(5) 
2.8% 
(1) 
5.6% 
(1) 
0 
(0) 
5.6% 
(3) 
1.9% 
(1) 
5.6% 
(3) 
14.8% 
(8) 
4 – 9mmol/l 52.8% 
(24) 
77.8% 
(34) 
55.6% 
(10) 
50% 
(9) 
46.3% 
(25) 
46.3% 
(25) 
53.7% 
(29) 
61.1% 
(33) 
Over 9mmol/l 33.3% 
(25) 
19.4% 
(19) 
38.9% 
(7) 
50% 
(9) 
48.1% 
(26) 
51.9% 
(28) 
40.7% 
(22) 
25.9% 
(14) 
 
 
4.4.1 ≤ 4.0mmol/l or hypoglycaemia range 
With reference to a concentration < 4.0mmol/l the terminology “hypoglycaemia” was 
used. Because hypoglycaemia is a major problem for people with Type 1 diabetes in 
their ability to perform exercise, its prevention was therefore an important challenge 
in this study. It was essential to analyse the data and the frequency of 
hypoglycaemia in the participants in order to determine the effectiveness of the 
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algorithm, and the changes that were necessary to increase the probability of 
hypoglycaemia prevention. The statistical analysis used mean blood glucose 
concentrations which meant that hypoglycaemic concentrations would have been 
undetected. The chart shown in Figure 4.2 demonstrates the hypoglycaemic 
episodes in the laboratory and real-life environments at each of the ten time-points.  
 
Figure 4.2 
Number of individual episodes of glucose concentrations of ≤ 4.0mmol/l at 
each time-point at two sessions, and in both environments. Participant  
number = 9. 
 
 
 
 
As demonstrated in Figure 4.2, prior to the start of exercise no participants in either 
the laboratory or real-life groups were hypoglycaemic. During exercise, 36% (5 
episodes) of all hypoglycaemic episodes for the whole laboratory study time-period 
occurred at this time-point. However, at this time-point in the real-life environment, 
the frequency of hypoglycaemia was lower (1 episode). Before the evening meal, 
hypoglycaemia was reduced to only one episode after the laboratory session.  At the 
2 – 6 hour algorithm section, increased hypoglycaemia occurred after the laboratory 
sessions compared to the real-life sessions.  
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In order to identify any hypoglycaemic episodes, it was decided to view all CGMS 
data after exercise for low subcutaneous glucose concentrations out-with the 2 
hourly time-point intervals. Additional hypoglycaemia episodes were noted at 3 hours 
for both laboratory and real-life sessions (1 episode each) and 5 hours, for laboratory 
(1 episode) and zero for real-life environments. For the following 8 – 12 hour 
algorithm section, there was a change in the occurrence of hypoglycaemia between 
environments, with increased episodes in the real-life sessions. Furthermore, during 
the real-life sessions and for the whole 12 hour period, the highest number of 
hypoglycaemic episodes were recorded at this time-point (8 episodes), which 
accounted for 73% of all hypoglycaemic episodes over the whole time-period.  
 
For the whole experimental period from baseline to 12 hours post exercise, in the 
laboratory sessions 7.0% (14 episodes) and the real-life sessions 5.5% (11 
episodes), of  episodes were hypoglycaemic glucose concentrations. Of the 
participants in this study, 8 out of 9 experienced at least one episode of symptomatic 
hypoglycaemia or a glucose concentration ≤ 4.0mmol/l within the study period 
(minimum number = 1 , maximum number = 3). 
 
These observations were based on episodes of glucose concentrations and not 
determined through statistical analysis. 
 
Hypoglycaemic unawareness 
From the data, hypoglycaemic episodes were extrapolated from the hypoglycaemia 
diaries and CGMS. When an episode was noted in the CGMS data sheets, but not 
recorded in the monitoring or hypoglycaemia diaries, and the SBGM result was not 
used for CGMS calibration, it was presumed that the participant was unaware of their 
low glucose value. Hypoglycaemic unawareness was noted in 32% (8 episodes 
(laboratory=5, real-life=3)) of the 22 episodes, plus 3 episodes at 3 and 5 hours. 
These episodes occurred in different participants at time-points between 4 – 12 
hours, when participants were probably asleep. 
 
Hypoglycaemia on non-exercising days 
To identify whether the hypoglycaemia episodes were an effect of exercise or just a 
normal consequence of Type 1 diabetes, the hypoglycaemic episodes were 
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analysed from SBGM, CGMS and hypoglycaemia diaries on non-exercise days (day 
2 and 9). Three hypoglycaemic episodes occured at 3, 6 and 12 hours after evening 
insulin injections and CHO intake. For two of the individuals, a hypoglycaemic 
episode occurred at the same time on exercise days, which suggested that this was 
a normal feature for the individual and not the result of increased physical activity.  
The frequency of hypoglycaemia was much less on non-exercising days which 
clarified the assumption that exercise caused hypoglycaemia. It also suggested that 
the algorithm needed further modification in order to achieve similar results as 
demonstrated on non-exercising days.  
 
4.4.2 4 – 9 mmol/l or acceptable glucose range 
The blood glucose range decided as an acceptable target level in this study was set 
between 4-9mmol/l. It was necessary to ascertain the frequency of episodes within 
this target range to determine the effectiveness of the algorithm, and also when 
comparing both environments to establish whether differences had occurred.  Figure 
4.3 demonstrates the episodes within the 4-9mmol/l range in both environments at 
each time-point. There were 18 individual participant episodes for each time-point in 
both environments. 
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Figure 4.3 
Number of individual episodes of glucose concentrations in the target range of 
4-9mmol/l at each time-point in two sessions, within both environments. 
Participant number = 9. 
 
 
 
In the algorithm, the target starting blood glucose concentration was 8.0mmol. 
Because it was extremely difficult to achieve a specific blood glucose value, the 
range of 7.5-8.5mmol was chosen to represent an in-target value. From 18 
participant episodes (9 participants X 2 sessions), this was achieved in 22% (4 
episodes) of laboratory participants and 5.6% (1 episode) of real-life participants. 
However, the use of the 4-9mmol/l target, gave similar starting results in both 
environments as shown in figure 4.3. 
 
With a higher starting blood glucose concentration of ≥9mmol/l (see Figure 4.4) the 
commencement of exercise caused the blood glucose concentration to drop. After 
the first 20 minutes of exercise, a drop in blood glucose was demonstrated in both 
environments (Figure 4.3). The blood glucose concentration continued to drop during 
the next time-point which resulted in increased hypoglycaemia (Figure 4.2), and 
subsequently a slight decline was recorded by 40 minutes in the 4-9mmol/l range. 
However, when combining the whole period of time during exercise, 52.8% (19 
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episodes) of episodes in the laboratory sessions and 77.8% (28 episodes) of those 
in the real-life sessions were within the target range (4-9mmol/l).  
 
After the initial effects of exercise and the lowering of blood glucose concentrations, 
approximately half of the participants before the evening meal, achieved 4-9mmol/l 
values in both environments, which also continued during the 2 – 6 hour algorithm 
section, and did demonstrate a decline in hypoglycaemic episodes which coincided 
with CHO consumption. During the following algorithm section of 8 - 12 hours after 
the evening meal, the participants achieved slightly better glycaemic control 
(laboratory 53.7% (29 episodes), real-life 61.1% (33 episodes)), but a decline in 
episodes occurred at the 12 hour time-period. This corresponded with changes at 
the same time-period in glucose concentrations  ≥9.0mmol/l (Figure 4.4). 
 
Overall, the patterns suggested that the real-life sessions achieved greater 4-
9mmol/l episodes compared with the laboratory sessions, except before the evening 
meal and 2 hours after the exercise time-points. For the whole of the experimental 
period from baseline to 12 hours post-exercise, in the laboratory sessions 51.2% (83 
episodes) and the real-life sessions 57% (95 episodes),  episodes were in the 
acceptable range. However, these observations were based on episodes of glucose 
concentrations and not determined through statistical analysis. 
 
4.4.3 ≥ 9.0mmol/l or hyperglycaemic glucose range  
 
In this study, hyperglycaemia was classified as a glucose concentration of 9.0mmol/l 
or above. It is appreciated that often people with Type 1 diabetes purposely aim for 
higher blood glucose concentrations before, during and after exercise, in an attempt 
to prevent hypoglycaemia. The rationale supporting the algorithm design was an 
attempt to maintain acceptable glycaemic control and the prevention of 
hypoglycaemia and hyperglycaemia and corresponding symptoms.   
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Figure 4.4 
Number of individual episodes of  glucose concentrations ≥ 9mmol/l at each 
time-point for two sessions within both environments. Participant number = 9. 
 
 
 
 
A high number of participants started with an elevated blood glucose concentration, 
which did not delay the start of exercise, and no participant administered extra fast-
acting insulin at this point. In both environments during exercise, the pattern of 
hyperglycaemic episodes dropped from baseline to the 20 minute time-point and 
remained at a similar episode frequency until 40 minutes at the end of the exercise 
session. The number of participants who experienced blood glucose concentrations 
over 9.0mmol for the whole exercise time period was: laboratory sessions 33.3% (12 
episodes) and real-life sessions 19.4% (7 episodes). 
 
From the end of exercise to 4 hours after the evening meal, the pattern of 
hyperglycaemic episodes increased, and measurements taken before the evening 
meal probably coincided with a decline in physical activity and glucose-lowering 
effect of the lunchtime insulin dose.  Four hours after the evening meal, 
hyperglycaemia was anticipated because of a blood glucose increase after CHO 
consumption. Between 4 and 12 hours after the evening meal and fast-acting 
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analogue injections, there was a decline in the incidence of ≥ 9.0mmol/l episodes, 
which corresponded with an increase in nocturnal hypoglycaemia (Figure 4.2).  
For the whole experimental period from baseline to 12 hours post-exercise, in the 
laboratory sessions 41.3% (67 episodes) of participants and in the real-life sessions 
35.8% (58 episodes) of participant episodes had glucose concentrations over 
9mmol/l. From the monitoring diaries there appeared to be no difference in CHO 
consumption between environments and exercise sessions, which could cause 
hyperglycaemia. 
 
4.5 Time point glucose trends 
Although the sample size in the current study was small, there was consistency 
between the two environments with each time-point glucose trend or change in 
direction from the previous time-point, apart from 4 hours after exercise (Table 4.5). 
The 4 hour time-point also showed the greatest standard deviation in the real-life 
sessions (sd ± 4.79) (Table 4.2). The trends appeared to be consistent with the 
predicted changes in glycaemia relating to physiology: a blood glucose decline 
during exercise, a rise in glucose concentrations after exercise and CHO 
consumption, a decline 4 to 12 hours after the evening meal and fast-acting 
analogue insulin injection, when delayed hypoglycaemia was a risk. Despite these 
trends being detected, their statistical significance has not been demonstrated, 
however they will be useful for patient education.  
 
Table 4.3  
 Blood glucose trend at time-points 
 Laboratory glucose trend  Real-life glucose trend 
20 minutes Lower Lower 
40 minutes Lower Lower 
Before Tea Higher Higher 
2 hours after Higher Higher 
4 hours after Lower Higher 
6 hours after Lower Lower 
8 hours after Lower Lower 
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10 hours after Lower Lower 
12 hours after Higher Higher 
 
 
4.6 Conclusion 
The 3-way ANOVA test showed no differences in glycaemic control when following 
the algorithm in the laboratory and real-life environments, but significant differences 
were demonstrated between time-points during exercise, confirmed also by the 
mean blood glucose values in Figure 4.1. However, when a descriptive analysis was 
performed using episodes of glycaemic ranges i.e. hypoglycaemia, 4-9mmol/l and 
hyperglycaemia, two important differences in glucose concentrations were apparent. 
The first difference between environments involved the hypoglycaemia episodes 
during and at 40 minutes at the end of exercise with higher episode numbers in the 
laboratory environment. While the second difference was apparent during the 8 to 12 
hour period after the evening meal and fast-acting analogue insulin injection with an 
increase in hypoglycaemic episodes in the real-life environment. However, it is 
acknowledged that these differences were observed patterns and thus were not 
statistically analysed. The increased hypoglycaemic episodes were acknowledged 
for patient safety, which highlighed the potential risk and possible deterrent for 
people with Type 1 diabetes involved in physical activity.  
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Chapter Five  
Discussion 
 
 
5.1 Introduction  
In this chapter the results of the study will be discussed in conjunction with other 
related literature to emphasise the importance of this research, and its contribution to 
the evidence base. Each algorithm section will be discussed separately. In view of 
the first two study objectives, the real-life environmental data and corresponding self-
management strategy will be analysed. The similarities and differences with regard 
to the glycaemic response in different environments will also be discussed in each 
section to determine if a particular environment has differences regarding patterns 
and frequency of episodes of glucose concentrations.  
 
Before exercise  
When evaluating the algorithm sections before performing exercise, the blood 
glucose response and in particular, any hypoglycaemic episodes during exercise are 
important factors to consider. This will determine the effect of the administered 
insulin dose and CHO consumption prior to exercise.  
 
5.2 Pre-exercise algorithm section and effect on glycaemic control during a 
40 minute exercise session.  
The 3-way ANOVA showed a significant blood glucose decrease at time-points 
during the 40 minute exercise session (see table 4.2). This anticipated glucose 
decrease as described by several authors (Peter et al 2005, Rabasa-Lhoret al 2001, 
West et al 2010), resulted in five episodes of hypoglycaemia in the laboratory 
environment during exercise, compared to only one in real-life. One possible 
explanation for the difference in hypoglycaemia episodes may be related to the fact 
that participants during real-life exercise were not exercising as intensely. If they 
were performing at a lower VO2 max, this would cause less hypoglycaemia, caused 
by a lower glucose value being required for energy production (Nagi 2005). When 
participants controlled their exercise intensity during real-life sessions without 
supervision by a member of the research team, compared with supervised sessions 
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in the laboratory they were able to decrease their intensity as they wished. However 
if this was the case one would not expect the finding from this study which showed a 
greater increase in nocturnal hypoglycaemia after the real-life sessions, as described 
in section 5.6. 
Another possible explanation for the increased hypoglycaemic episodes observed 
during exercise in the laboratory environment agreed with the findings of Brazeau et 
al (2008). When analysing barriers to exercise, hypoglycaemia was a major 
deterrent, however if participants exercised with another person this significantly 
resulted in fewer anxiety episodes caused by the hypoglycaemia risk (p<0.001). This 
was an interesting observation, because in the laboratory environment, the 
researchers constantly observed the participants, and regularly checked their 
physical state, hence, they may have felt safe, compared with the real-life 
environment, when they were without a researcher which may have instigated 
participants to take preventative strategies. However, the participant‟s monitoring 
diaries did not show increased CHO consumption during real-life sessions, a finding 
one might have expected if participants had used preventative strategies. 
 
The real-life sessions demonstrated better glycaemic control with more episodes in 
this target range (4-9mmol/l). In both environments, at 20 minutes into exercise, 
there was an increase in 4-9mmol/l episodes, which declined by 40 minutes which 
was a result of increased hypoglycaemia. This however, was expected due to 
glucose usage for energy and falling blood glucose concentrations as described by 
Nagi (2005).  
 
Finally, when considering blood glucose episodes over 9.0mmol/l, in both 
environments the mean blood glucose value was similar although higher than the 
target at baseline. This observation agrees with Wallymahmed et al (2007), who 
noted that patients‟ aim for hyperglycaemia prior to commencing exercise. These 
reasons were not explored for study participants starting with a higher blood glucose 
concentration in our study, however Rabasa-Lhoret et al (2001) and West et al 
(2010) both described hyperglycaemic baseline concentrations. One can only 
speculate that participants had possibly self-managed to achieve a higher blood 
glucose concentration, or had difficulty in achieving such a specific glucose value of 
89 
 
8.0mmol/l. During the pre-assessment visit at week one, participants were not given 
guidance regarding insulin doses or CHO consumption at lunchtime on exercise 
days, although they were informed of the target blood glucose concentration of 
8.0mmol/l at the start of the exercise session. However, by starting with higher blood 
glucose concentrations, glucose was utilised for energy and caused an increase of 
episodes into the acceptable range of glucose during exercise (Riddell and Perkins 
2006). During the exercise sessions in both environments, the number of 
hyperglycaemic episodes decreased from baseline to 40 minutes and was the 
anticipated effect caused by glucose transfer into skeletal muscle for energy usage 
(Riddell and Perkins 2006). Another factor to consider was that the mean starting 
blood glucose values were higher in both environments. If 8.0mmol/l had been 
achieved, there may have been more hypoglycaemic episodes during exercise. 
 
Due to these results, the pre-exercise self-management strategies in the algorithm 
worked well in the real-life environment, as only one hypoglycaemic episode out of a 
possible 36 episodes occurred, and 77% of glucose episodes were within the 
acceptable range. Unfortunately, these results cannot be compared because similar 
research was unavailable in the literature. The causative self-management strategies 
will now be discussed along with algorithm adjustments. 
 
5.2.1 Pre-exercise fast-acting analogue dose reduction 
When considering physiological response to exercise, insulin dose reduction is a 
logical self-management strategy to prevent hypoglycaemia prior to exercise (Riddell 
and Perkins 2006, Ertl and Davis 2004). The current study design involved the use of 
the full normal dose of fast-acting analogue insulin at lunchtime before the exercise, 
and no studies were found where exercise started 3 hours after the insulin dose. 
However, since performing the original literature review and this current study, Iscoe 
and Riddell (2011) published a similar study which investigated the effects of 
exercise 5 hours after insulin administration. Their aim was to compare the delayed 
risk of hypoglycaemia and hyperglycaemia in athletes with Type 1 diabetes while 
performing 45 minutes of continuous moderate intensity exercise (Group 1) and 
moderate intensity exercise with intermittent high intensity exercise (Group 2); both 
sessions were performed in the afternoon. Eleven participants were recruited: ages 
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35.1 ±3.5 years, duration of diabetes 15.6 ±5.6 years, HbA1c 7.8 ±0.4%, six used 
insulin pump therapy and five used a basal bolus regimen. Participants had 
interstitial glucose measured by CGMS and analysed for the following 12 hours, 
although the reported results were not described in time-points but just grouped into 
one 12 hour period. The glucose was monitored for one sedentary day and one 
exercise day (randomized to Groups 1 or 2), then repeated 1-4 weeks later for one 
sedentary day while performing the other exercise type (Groups 1 or 2). On exercise 
days, it was stated that the lunchtime fast-acting analogue insulin was given 5 hours 
prior to exercise performed at 1700 hours, designed to mimic the normal exercise 
time for many people (a factor used in this study design). The time-period is later 
than exercise performed in this current study, however, due to insulin actions both 
are similar as out-with the peak action, and within the duration of 6 hours. Post-
exercise insulin doses were not reduced. A low GI snack was given to participants at 
bedtime to prevent nocturnal hypoglycaemia. For the purpose of the comparison with 
the current study, the data for the moderate intensity exercise group were explored. 
 
Iscoe and Riddell (2011) did not reduce insulin doses prior to exercise, although 
participants were not given pre-exercise guidelines and were permitted to self-
manage how they preferred. The blood glucose decrease during exercise was 
5.1mmol/l (±0.7), with 64% of the participants becoming hypoglycaemic during 
exercise. This high incidence of hypoglycaemia was in contrast to the results 
observed in the current study. These results reported by Iscoe and Riddell (2011) 
are confusing because the hypoglycaemia risk should be minimal due to the time 
when circulating fast-acting insulin would be decreasing after 5 hours. It has to be 
assumed that this observation was caused by patient self-management prior to 
starting exercise, despite not being described in the publication. 
 
All other previous studies in the literature review described a fast-acting insulin dose 
reduction 30 – 120 minutes before exercise (Lumb and Gallen 2009, Rabasa-Lhoret 
et al 2001, West et al 2010). In the current study, consideration was initially given to 
reduce the pre-exercise lunch dose by 10 or 20 % but the author decided against 
this because of the concern regarding hyperglycaemia at the start of the exercise 
session, since West et al (2010) demonstrated the peak action was 60 minutes after 
administration, which was before 3 hours used for the start of exercise in the current 
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study.  If participants had reduced their lunch doses during the current study, it would 
have resulted in even higher glucose concentrations at baseline. To support this 
factor, pre-exercise insulin reduction resulting in hyperglycaemia at the start of 
exercise, was demonstrated in both the Rabasa-Lhoret et al (2001) and West et al 
(2010) studies.  
 
In the current study, the administration of the full lunchtime insulin dose was effective 
when considering the episodes of glucose concentrations previously described.  With 
regard to the algorithm changes, a reduction for the pre-meal insulin dose was not 
implemented because of the potential threat of hyperglycaemia, and  cancellation of 
an exercise session from blood glucose concentrations over 17mmol/l as 
recommended by Lumb and Gallen (2009), American Diabetes Association (2002) 
and Fery et al (1987). 
 
5.2.2 Pre-exercise CHO amounts 
A common strategy used by patients prior to exercise, to prevent hypoglycaemia, is 
the consumption of extra CHO. From the algorithm, amounts of fast-absorbed 
glucose in the form of Lucozade and Dextrosol tablets were given to participants 
depending on the blood glucose concentrations, to achieve the blood glucose 
concentration of 8.0mmol/l. This was based on DAFNE principles (DAFNE Group 
2002), which state that 10g of CHO would raise the blood glucose by 2.5mmol/l, and 
from the real-life results this appeared to work. For the participants with starting 
concentrations around 8.0mol/l (n=6), they had glucose concentrations ranging 
between 4.5-8.0mmol/l at 40 minutes, and the CHO amount taken before exercise 
appeared to prevent hypoglycaemia. However, one participant with the lowest blood 
glucose of 6.9mmol/l consumed the recommended amount of glucose but still 
developed hypoglycaemia (3.8mmol/l). Although this is based on only one participant, 
the avoidance of hypoglycaemia is of paramount importance and it was 
recommended therefore that the glucose/CHO amount be increased if the starting 
blood glucose value was less than 7.0mmol/l as shown in the amended algorithm 
(table 5.1).  
Since performing the current study, an updated literature search revealed one 
publication by West et al (2011) examining CHO before exercise. The study 
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compared the consumption of two different types of CHO (Isomaltulose (ISO; low GI) 
and Dextrose (DEX; high GI)), taken 2 hours prior to a 45 minute running session at 
80% VO2 max, during which the glucose response was measured.  Eight participants 
with Type 1 diabetes performed the study. The pre-exercise starting blood glucose 
level was 12.2 ± 0.5mmol/l with ISO compared to 15.0mmol/l (no sd presented) with 
DEX. During exercise there was a similar drop in blood glucose in both groups: ISO 
4.4mmol/l ±0.4 vs DEX 5.8mmol/l ±0.3 (p=0.11). Immediately at the end of exercise 
the blood glucose in ISO group were significantly lower than DEX group (p=0.05). In 
the 3 hour period after exercise, the blood glucose concentrations were lower in the 
ISO Group compared with the DEX Group at all time-points (p=0.05). There were no 
hypoglycaemic episodes in the 2 hours pre-exercise or during exercise. The study 
concluded that the consumption of ISO prior to exercise maintained more acceptable 
blood glucose concentrations before, during and after exercise, compared with the 
consumption of DEX. One limitation of the study was that the ISO and DEX amounts 
were not stated. Another potential problem present from a participant point of view, 
were the potential hyperglycaemic symptoms which may have occurred at the start 
of exercise from high glucose concentrations.  
 
Although this study by West et al (2011) was performed 2 hours prior to exercise, the 
results were considered sufficiently useful to incorporate them into the amended 
algorithm (table 5.2), which suggested a low GI lunch could prevent high starting 
glucose values and ensure a steady CHO absorption rate. Current practice is to 
consume dextrose prior to exercise, however West et al (2011) demonstrated that a 
low GI CHO snack or meal before exercise, may be more effective for glucose 
control.  
 
5.2.3 Pre-exercise blood glucose target 
The target starting blood glucose concept was not highlighted in any other similar 
research (Rabasa-Lhoret et al 2001, West et al 2010). For the current study, this was 
decided at 8.0mmol/l based on the presumption that hypoglycaemia precipitated by 
the exercise session was a minimal risk due to the time of the previous insulin 
injection (West et al 2010). Previous research suggested a starting level of 10 – 
15mmol/l (Lumb and Gallen 2009, West et al 2010), which the author considered too 
high in an ideal scenario in view of patient comfort regarding possible 
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hyperglycaemic symptoms. However, when designing the algorithm, it was 
acknowledged that the possible need to increase the target to 10.0mmol/l if 
hypoglycaemia was detected during the real-life sessions, and to comply with patient 
preference of hyperglycaemia, to give reassurance and as a preventative approach 
for hypoglycaemia (Wallymahmed et al (2007).  
 
In the current study, the mean starting blood glucose was 10.9mmol/l (sd±3.4). In the 
West et al (2010) study, the mean starting blood glucose for the full insulin dose 
Group, 2 hours prior to exercise was 9.4mmol/l (sx 0.5), and from all those seven 
participants there were no hypoglycaemic episodes reported. Iscoe and Riddell 
(2011) did not state the mean starting blood glucose although from the blood glucose 
graph it appeared to be around 10.5mmol/l. Both of these studies do not specify a 
target starting blood glucose, although the level may be decided by the participant. 
Brazeau et al (2008) and Wallymahmed et al (2007) reported that people with Type 1 
diabetes aim for higher starting glucose concentrations and the above findings are 
consistent with this. 
 
The further danger of hyperglycaemia during exercise is the risk of developing 
ketoacidosis. Since the initial literature review, an additional short report has been 
published by Bracken et al (2011), which presented analysis from the West et al 
(2010) study. This sub-section of the study investigated the impact of pre-exercise 
insulin reductions on ketogenesis after running. They found that large reductions (25, 
50 or 75% insulin reduction) in the pre-exercise fast-acting analogue insulin doses 
did not affect beta-hydroxybutyrate (ketone) formation, to the extent that ketoacidosis 
occurred. Participants performed a 45 minute run at 75% VO2 max, beta-
hydroxybutyrate concentrations were then tested at the end of the run and up to 3 
hours after. Ketoacidosis was defined as beta-hydroxybutyrate concentrations 
≥3.0mmol/l (normal range 0.0 – 0.6mmol/l). Results showed normal beta-
hydroxybutyrate concentrations during exercise. Immediate post-exercise beta-
hydroxybutyrate concentrations demonstrated a significant increase which ranged 
between 0.03mmol/l to 0.06mmol/l (p > 0.05). However, all of these values are in the 
normal range, and are not therefore a cause for concern. Unfortunately the 
corresponding blood glucose concentrations were not stated. These values would 
have been useful in interpreting data into clinical practice. 
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These new data provide reassurance that hyperglycaemia caused by insulin 
reduction or aiming for a higher starting glucose can be safe strategies for people 
with Type 1 diabetes, although the findings are in contrast to recommendations and 
guidelines previously stated by the American Diabetes Association 2002, Fery et al 
1987, and Lumb and Gallen 2009. These studies all advise avoidance of exercise if 
blood glucose is over 17mmol/l. However, they do not take into account the recent 
findings from Bracken et al (2011), which suggested that by considering the recent 
glycaemic pattern and if a solitary pre-exercise high concentration is caused by 
exercise-insulin reduction, it is safe to exercise. This knowledge will be highlighted in 
the amended algorithm.   
 
It is acknowledged this current study had a small sample size, but in view of all the 
above, along with the low hypoglycaemia risk, the target blood glucose concentration 
before exercise could safely remain at 8.0mmol/l. It will be highlighted that glucose 
concentrations less than this may increase the risk of hypoglycaemia. However, if 
patient preference is a higher starting concentration, this is safe to do so but 
consideration must be given to the recent glycaemic pattern and to ensure fast-
acting analogue insulin is in circulation (Bracken et al 2011), plus overall glycaemic 
control (HbA1c). 
 
After exercise 
Next to consider are the glucose concentrations and self-management strategies for 
the 12 hours following exercise which will be analysed and incorporated into the 
post-exercise section of the algorithm.  
 
5.3 End of exercise prior to the evening meal   
In both environments before the evening meal a similar glucose pattern was 
demonstrated, which showed an increase in mean blood glucose concentrations and 
hyperglycaemic episodes from the end of the exercise session to the evening meal. 
This corresponds with the physiological description by Riddell and Perkins (2006) 
whereby gluconeogenesis and glycogenolysis was increased in response to 
increased energy demands during exercise. As described by West et al (2010), the 
last fast-acting analogue insulin dose was administered at lunchtime in the current 
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study, and it would be expected to peak therefore around 60 minutes, with a duration 
of 5 hours, so the hypoglycaemic action would thus end by the evening meal. This 
would account for the increasing blood glucose concentrations in both environments 
at this time-point. 
 
The blood glucose concentration taken before the evening meal provided information 
regarding any self-management interventions between the end of exercise and the 
evening meal. Carbohydrate consumption at the end of the exercise sessions were 
not included in the algorithm, as no evidence was found in the literature to support 
this, apart from an experiential opinion by Gallen (2004) who recommended 
consumption of CHO to prevent hypoglycaemia. This was an area of uncertainty in 
the algorithm design when relating the exercise sessions to physiology that there 
might be two outcomes. The first being hypoglycaemia as glycogen stores would be 
replaced at the end of exercise (Montague et al 2005), or hyperglycaemia due to 
glycogenolysis and the depletion of lunch insulin (Nagi 2005).  
 
The results used to clarify this notion was the use of the 3-way ANOVA pairwise 
comparison between 40 minutes and before the evening meal which showed a non-
significant difference in the change in blood glucose between time-points (p=0.803), 
and so hypoglycaemia was not a potential risk, and during the real-life sessions 
hypoglycaemic episodes did not occur. Also examining the trend of blood glucose in 
Table 4.4, revealed blood glucose to be on the increase, although this is not 
statistically proven. This would suggest that if CHO was consumed at the end of 
exercise, increased hyperglycaemia would result.  Since the initial literature search, 
there have been no new publications in relation to this topic. Due to these factors, 
CHO at the end of exercise will not be introduced into the amended algorithm. 
 
5.4 The effect on glycaemic control during 2-6 hours after insulin and 
evening meal. 
The following algorithm section was 2-6 hours after the evening meal. Again there 
was little difference between environments for the mean glucose concentrations 
during this time-period, although one of the main issues in this algorithm section was 
glucose variability which was the highest in both environments within the full 12 hour 
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study-period with standard deviations at time-points ranging between; 3.2 – 
4.0mmol/l in the laboratory, and 3.3 – 4.8mmol/l in real-life. Factors that could cause 
this increased variability is the GI of the CHO type consumed at the evening meal, 
and also activity levels, where many people will be inactive during this period before 
bed. This finding cannot be compared with Iscoe and Riddell (2012) as they did not 
report the time of the glucose concentrations. Glucose variability in individual 
participants is an important factor to consider regarding reproducibility of findings, 
and is discussed further in section 5.7.  
 
Similar glucose patterns occurred in both environments, participants achieved 
exactly the same number of episodes within the range of 4-9mmol/l, and there were 
also similar frequencies of increased hyperglycaemia. This response of increased 
blood glucose concentrations from before evening meal were expected because of 
the absorption of CHO food and 30% dose reduction of pre-meal fast-acting 
analogue insulin and there were no changes in prevailing insulin to CHO ratios. 
These two self-management strategies relating to this algorithm section are 
discussed below.  
 
5.4.1 Post- exercise fast-acting analogue dose reduction. 
Post-exercise insulin reduction after exercise is not a commonly used strategy in 
clinical practice despite hypoglycaemia risk due to physiological actions (Riddell and 
Perkins 2006, Ertl and Davis 2004). In the current study, in order to evaluate the 
strategy of 30% fast-acting insulin reduction, the time-points at 2, 4 and 6 hours after 
the evening meal were examined which coincided with the insulin peak action and 
duration.  
 
The frequency of hypoglycaemia and hyperglycaemia were considered important 
physiological factors in this study. In the real-life experiments the statistical analysis 
showed no differences in blood glucose between environments at the time-points, 
however, the variability was considerable as shown by high standard deviations. The 
frequency of glucose episodes in the 4-9mmol/l range (46.3%), and over 9.0mmol/l 
(51.9%)  (shown in Table 4.4), must therefore be considered as well as in the overall 
mean result.  This appears to suggest stable, though slightly higher glucose 
concentrations, albeit minimal hypoglycaemia. These data were to be expected, as 
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post-prandial hyperglycaemia is a common phenomenon in Type 1 diabetes and can 
occur because subcutaneous insulin acts more slowly than absorbed glucose from 
CHO food. In contrast, Rabasa-Lhoret et al (2001) recommended a post-exercise 
dose reduction of 50-75%. It is thought that this would cause increased 
hyperglycaemia as even with the 30% reduction, 52% of results were above 9 mmol/l 
in the current study.  
 
Again, since the initial literature review there are no new publications on this topic. 
The similar study published by Iscoe and Riddell (2011) did not adjust the post-
exercise dose and only used CHO at bedtime as an intervention to prevent nocturnal 
hypoglycaemia. From the above data, no amendments were made to the algorithm 
and that by reducing the dose by 30%, the hypoglycaemia risk was minimised. This 
approach was also recommended by Lumb and Gallen (2009). 
 
5.5 The effect on glycaemic control during 8-12 hours after insulin and 
evening meal. 
In the next algorithm section which covered the period 8-12 hours after the evening 
meal, the standard deviations were the lowest in both environments demonstrating 
less variability. This observation occurred because the participants were asleep, and 
not performing daily living activities nor consuming CHO, all of which influence blood 
glucose concentrations. In view of the frequency of 4-9mmmol/l glucose episodes, a 
slight increase was shown in the real-life environmental studies, but more 
importantly, differences in the hypoglycaemia and hyperglycaemia patterns were 
found.  
 
Hypoglycaemia was an important area to investigate in this section, as participants 
will generally be asleep. The real-life sessions showed an increase in hypoglycaemia 
episode frequency with eight episodes occurring out of a possible fifty-four 
participant episodes (15%), compared with three out of fifty-four (5.5%) in the 
laboratory environment. These data were found in participants CGMS and 
hypoglycaemia diaries. This observation has not been demonstrated in any 
previously related research as far as this author is aware, because the reported time-
periods were limited to 3 hours post-exercise (Peter et al 2005, Rabasa-Lhoret et al 
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2001, West et al 2010). However, several authors have commented on the risk of 
delayed hypoglycaemia, but no research studies appear to be available to 
demonstrate this (Guelfi et al 2005, Lumb and Gallen 2009, Perry and Gallen 2009, 
Riddell and Perkins 2006).  
 
Since the initial literature review, described in section 5.2.1, the publication by Iscoe 
and Riddell (2011) included nocturnal hypoglycaemia analysis, and demonstrated 
that five out of eleven participants (45%) in the moderate intensity exercise group, 
experienced glucose concentrations ≤4.0mmol/l during 0300 to 0600 hours, in 
comparison with non-exercising days where only two out of eleven episodes 
occurred. This factor was also apparent in the current study during non-exercising 
days where one episode from a possible 18 occurred during the 8-12 hour time-point. 
These findings are very similar to the current study despite different self-
management strategies being used post-exercise, and Iscoe and Riddell (2011) 
stated that insulin sensitivity was increased post-exercise and thus accounted for the 
hypoglycaemic effect. Hypoglycaemia would also be caused by the probable 
physiological response to exercise and the replenishment of glycogen stores in the 
liver and muscles (Riddell and Perkins 2006), however, this would not account for 
the differences between the laboratory and real-life environments.  
 
Due to the delayed glucose lowering effect after exercise (Ertl and Davis 2004), the 
hyperglycaemic episode frequency decreased in both environments. However, the 
laboratory hyperglycaemic episodes were greater compared with those in the real-
life environment, resulting in 22 episodes compared with 14 episodes respectively. 
The cause of the hyperglycaemia difference is difficult to interpret, as is the 
increased hypoglycaemia in the real-life environment. Insulin reductions cause 
hyperglycaemia, but exercise can also instigate hypoglycaemia. As the exercise 
sessions were the same in both environments, it is difficult to understand why the 
physiological response is different between environments, and highlights the need 
for further investigation.  
 
The self-management strategies applicable to this algorithm section which 
contributed to these results will now be discussed. 
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5.5.1 Long-acting analogue dose adjustment 
Long-acting insulin or basal dose reduction is a commonly used strategy to prevent 
hypoglycaemia in clinical practice despite the lack of evidence to support the 
recommendation. The time-points at 8, 10 and 12 hours after the evening meal were 
examined in relation to this section of the algorithm.  As discussed previously, it was 
important to avoid hypoglycaemia at these time-points and was highlighted in the 
real-life environment of the current study when eight hypoglycaemic episodes out of 
a possible 54 episodes occurred. These data, along with the glucose patterns for the 
following day, related to the effects of the basal insulin dose.  
 
The study conducted by Peter et al (2005), suggested that Lantus would not be a 
contributing factor to hypoglycaemia occurring during, or in the 3 hour period, 
following a 30 minute exercise session at 65% VO2 max. However, the nocturnal 
glucose response post-exercise and specifically at the 8 – 12 hour time-period was 
not studied. In the current study, hypoglycaemia episodes increased during the night, 
however, the hypoglycaemia frequency decreased during the following day. 
Considering this observation, it does not appear necessary to reduce the Lantus 
dose which may cause possible risk of hyperglycaemia the following day. This topic 
has not been studied by any other researchers and so comparisons cannot be made 
at this stage. However, it has been recognised that previous authors have suggested 
the basal dose may need to be reduced (Lumb and Gallen 2009). Since the initial 
literature review there have been no new publications relating this topic, and in the 
similar study by Iscoe and Riddell (2011) they did not reduce the basal insulin dose. 
 
5.5.2 Before bed blood glucose concentration and CHO amounts 
For people with Type 1 diabetes, the consumption of CHO at bedtime is a customary 
strategy for the prevention of nocturnal hypoglycaemia, even when exercise has not 
been performed. The strategy of consuming a bedtime snack was described by 
Brazeau et al (2008) which showed participants who did this were less anxious about 
nocturnal hypoglycaemia (p=0.007), but unfortunately failed to state if the 
intervention actually prevented nocturnal hypoglycaemia.   In the current study, 10-
20g of CHO before bed was advised if the blood glucose was below 8mmol/l at 
bedtime to prevent nocturnal hypoglycaemia, however, this was not evidence based, 
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although the DAFNE collaborative (2010) do recommend CHO consumption if the 
blood glucose is below 9.0mmol/l at bedtime. When reviewing the participants 
CGMS data, the period between 8 – 12 hours post-exercise corresponded with the 
early hours of the morning. If increased CHO in the region of 20-40g were given at 
bedtime this may cause hyperglycaemia within the post-exercise 4 – 6 hour time-
period which would be around midnight. Although used at a different time-period, 
West et al (2011) showed the delay in absorption of low GI CHO, and the 
subsequent stable effect on glycamic control. Hence, if low GI foods i.e. certain fruits, 
porridge and cereals containing bran (as stated by Diabetes UK 2012), were 
consumed at bedtime this would be absorbed slowly and cause a delayed rise in 
blood glucose.  A potential advantage of this over adjusting basal insulin is that it 
would not have a knock on effect on the full 24 hour time-period as would be the 
case if the basal insulin dose was reduced.  
The recent publication by Iscoe and Riddell (2011) used a bedtime snack strategy. 
The participants who performed moderate-intensity exercise before the evening meal 
did not reduce the post-exercise evening meal insulin dose, but consumed a 30g low 
GI CHO snack at bedtime, without taking fast-acting analogue insulin. The idea 
behind this snack was to prevent nocturnal hypoglycaemia. However, 45% of 
participants still experienced nocturnal hypoglycaemia. Unfortunately the individual 
blood glucose concentrations before bedtime were not stated, although a graph 
appeared to demonstrate a value of approximately 9.5mmol/l.  It was therefore 
difficult to decipher the change in blood glucose levels during the night. However, the 
authors stated that the CHO snack at bedtime was insufficient, and reducing the 
basal insulin dose might be more beneficial.   
 
This CHO strategy may not be accepted by some people with Type 1 diabetes if the 
main reason for performing exercise is for weight loss or weight maintenance, as 
extra CHO will contain an increased calorific content. In this instance, the basal 
insulin dose may need to be reduced. Both basal insulin reduction and the 
consumption of extra low GI CHO snack are options to prevent hypoglycaemia and 
should be dependent on patient choice. These options were included in the 
amended algorithm and patients are permitted to choose their preferred approach. 
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The consumption of CHO at bedtime may also help alleviate patient anxieties 
regarding nocturnal hypoglycaemia (Brazeau et al (2008).  
 
In relation to bedtime, a target blood glucose concentration was not stipulated in the 
self-management algorithm, however, after reviewing the findings, a blood glucose of 
10.0mmol/l at bedtime was advised with regard to prevent hypoglycaemia. This will 
also help patients determine the amount of CHO they consume to achieve this target 
at bedtime using the DAFNE recommendations (DAFNE collaborative 2010). 
 
5.6 Nocturnal hypoglycaemia risk 
When considering hypoglycaemia, issues arose after data analysis, which were not 
contemplated during the study design. Firstly it was important to ascertain whether 
exercise caused the overnight hypoglycaemia episodes in participants or whether 
this was a normal feature of participants diabetes control.  Analysis of the overnight 
glucose results on non-exercising days was therefore performed.  This showed that 
on non-exercising days, one participant had a glucose concentration under 
4.0mmol/l at 12 hours compared with eight hypoglycaemic episodes in the real-life 
exercise session days. This confirms that exercise is likely to be a significant factor 
in causing overnight hypoglycaemia. 
 
A new and important finding in this study was revealed from the descriptive analysis. 
This showed that it was apparent from the monitoring and hypoglycaemia diaries and 
CGMS calibration, that a number of participants were not aware of low glucose 
episodes during the night whilst asleep. This was a big concern for patient well-being 
and safety. During the 3 – 12 hour time-points, 18 hypoglycaemic episodes occurred 
within both environments. From these episodes two participants had an episode that 
lasted for two consecutive time-points (both after real-life sessions at 8-10 and 10-12 
hour time-points) which indicated one extended hypoglycaemia episode. From the 
18 episodes, eight were not documented in the participant diaries or CGMS 
calibrations, and thus it was assumed that the participants had hypoglycaemia 
unawareness at that time. Iscoe and Riddell (2011) used CGMS in their study, 
although they failed to stipulate if any nocturnal hypoglycaemic episodes occurred 
and unawareness was never discussed in previous publications.  
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The CGMS was an essential data collection tool in this worrying finding, although it 
had been acknowledged that discrepancies may occur with the time-lag difference 
(Melki et al 2006) compared with plasma glucose, and that results may be debated 
with regard to being an accurate low glucose episode, as the results were based on 
interstitial fluid. These concerns were recognised but considering no other method 
was available to monitor glucose overnight, other than invasive blood extracting 
methods, these data were used for the algorithm evaluation.  
 
As delayed hypoglycaemia was shown in this study to be a genuine problem, it is 
vital to educate patients about the risk, and how it might be prevented. This will be 
incorporated into the algorithm by recommending occasional SBGM monitoring in 
the time-period of 8-12 hours post-exercise. This clinical finding needs to be 
highlighted to HCPs involved in diabetes care, and incorporated into patient 
education for those who wish to exercise.  
 
5.7 Glucose variability 
Another issue not considered in the initial objectives of the current study was the 
concept of individual variability. Patient individuality is occasionally discussed by 
expert authors in review articles when recommending exercise management 
strategies, and they advocate that insulin and CHO adjustments must be tailored to 
the individual (ADA 2002, Kavookjian et al 2007, Lumb and Gallen 2009, Perry and 
Gallen 2009). This variability of glucose was also found and described by previous 
researchers.  In the West et al (2010) study which investigated a similar intensity of 
75% VO2 max, authors discussed the problem with the intra-individual variability. 
They acknowledged that this could contribute to the lack of statistical significance. 
Also, in the qualitative study described by Kilbride et al (2011a), participants 
highlighted that any form of exercise provoked inconsistency, unpredictability and 
variability in glycaemic control. This may be caused by a multitude of external and 
internal factors i.e. diet, physical activity, stress, lifestyle as discussed by Perry and 
Gallen (2009) and Riddell and Perkins (2006). In the current study, participants were 
not asked at exercise sessions if they were experiencing factors such as stress, 
which may have contributed to any irregularities in glycaemic control. When 
considering stress, performing in the laboratory environment could be considered as 
a stressful situation by some participants.  
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The mean glucose concentrations at each time-point in both environments were 
similar with a 0.3-0.7mmol/l difference. The exception occurred, however, before the 
evening meal (1.9mmol/l difference) and 4 hours after (1.1mmol/l difference) with 
higher levels identified in the real-life sessions (see Table 4.1 and Figure 4.1). The 
standard deviations of the individual mean glucose results were an important factor 
to consider. The highest figure was seen at the 4 hour time-point in the real-life 
sessions, with a blood glucose level of 10.5mmol/l (sd ± 4.8mmol/l). The mean 
values or the ANOVA used in this current study did not highlight the extreme levels 
of individual participants episodes of hypoglycaemia nor even those of 
hyperglycaemia. For this reason a descriptive analysis was also undertaken.  
 
Iscoe and Riddell (2011) presented far lower standard deviations of glucose 
concentrations after performing 45 minutes of moderate intensity exercise during the 
evening. Standard deviations were highest in Groups 1 (2.6 ±0.51mmol/l) and group 
2 (2.8 ±0.44mmol/l) compared with those from the sedentary days (2.0 ±0.31mmol/l) 
(p=<0.05). Unfortunately there was no information differentiating between types of 
insulin therapy and demonstrated the erratic effect that exercise can have on 
glycaemia. When considering glucose variability after exercise, the nighttime 
minimum and maximum glucose concentrations were between 5.0mmol/l (±0.7) to 
12.4mmol/l (±1.3). The night glucose range for the laboratory sessions in the current 
study were 8.0mmol/l (±2.3) to 9.4mmol/l (±3.2), and in the real-life sessions 7.4 
mmol/l (±3.2) to 10.5mmol/l (±4.8). This demonstrated that the actual mean glucose 
range was wide with small standard deviations (Iscoe and Riddell 2011), compared 
with the current study which revealed a smaller mean glucose range but large 
standard deviations.  The two study designs were similar, but the main differences in 
the two studies which may account for the variations observed, were Iscoe and 
Riddell (2011) controlled the meal-times and CHO amounts consumed throughout 
the whole study period, whereas the participants in this study consumed their normal 
amounts at their own decided times. The aim was to try and mimic normal life 
behaviour and not to dictate times that may indispose participants. Furthermore, in 
the current study, the post-exercise insulin dose was reduced and participants only 
consumed CHO at bedtime if their blood glucose levels were under 9.0mmol/l. In the 
Iscoe and Riddell (2011) study, participants did not reduce post-exercise insulin and 
consumed a fixed amount of CHO at bedtime. The variability in meal and insulin 
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injection times may have caused the wider glucose variability in the current study, 
however, Iscoe and Riddell (2011) demonstrated an increased variability on 
exercising days compared with sedentary days, which was a similar finding in the 
current study. 
 
The above issues do question whether a larger study using statistical analysis would 
show any significant differences in glucose variability as shown by the large standard 
deviations, and therefore may be beyond the control of the participant or researcher 
in a real-life study design. Small participant numbers have not helped the situation 
both in the current study and those of Iscoe and Riddell (2011) and West et al 
(2010). For a further study, specific timings for meal-times and insulin dosing may be 
required as a way of reducing glucose variability. However, some variability would be 
expected because of multiple factors than can affect glycaemic control.  
 
5.8 Effectiveness of the self-management algorithm 
 
Despite variability, when comparing the impact of environments on the glucose 
response for individual participants, for the whole period from baseline to 12 hours 
post-exercise, a similar frequency for  hypoglycaemic episodes occurred where the 
laboratory environment had 14 hypoglycaemic episodes, and the real-life 
environment had 11.  However, some differences did occur in the times of the 
hypoglycaemic episodes as was previously described. Hypoglycaemia prevention 
was a primary aim of the study, but another was also to achieve glucose values less 
than 9mmol/l.  The results showed that over one-third of episodes, during the whole 
time-period, were above 9mmol/l, (laboratory environment 40.5% and real-life 
environment 33.9%). This may be viewed negatively by HCPs, with the implication 
that the algorithm was ineffective. However, one might consider that 9mmol/l was too 
tight a target, and some HCPs may aim for a target <11.0mmol/l especially with 
regard to post-prandial hyperglycaemia in the 2-4 hour time-point range. In both 
environments, around half of all episodes were in the acceptable 4-9mmol/l range, 
48.3% in the laboratory and 53.3% in real-life. This figure could depict that the 
algorithm was unsuccessful, however, the chosen range of 4–9 mmol/l may be 
considered by HCPs as too stringent considering the difficulties encountered around 
exercise.  Across the whole time-period of 13 – 15 hours, when considering patient 
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preference of running blood glucose concentrations higher with exercise 
(Wallymahmed et al 2007), this figure may be acceptable. Difficulties do arise, 
however, when making such statements on small sample sizes, together with the 
challenges of analysing data using descriptive methods rather than statistical tests.    
5.9 Summary of self-management strategies and amendments after data 
analysis 
The analysis of each algorithm section with regard to self-management strategies 
and the effect on glycaemic control have been described. From these factors, a 
summary of key changes can be seen in Table 5.1, which states the current self-
management strategies with new amendments after analysing the data and 
considering the new evidence since the initial literature review.  
 
Table 5.1 
Summary of amendments 
Current algorithm 
 
New algorithm 
Pre-exercise fast-acting analogue dose 
reduction: no change to meal bolus insulin 
dose if taken at least 3 hours prior to 
exercise 
 
No change 
 
Pre-exercise blood glucose target: To aim for 
a blood glucose of 8.0mmol/l. 
No change 
Pre-exercise CHO amounts: CHO amounts 
as per algorithm (see table 3.2) 
For the meal prior to exercise, consume low 
GI CHO.  
Immediately prior to exercise if the blood 
glucose is <7.0mmol/l, increase the 
recommended amount by 10g extra CHO.  
Post-exercise fast-acting analogue dose 
reduction: Reduce dose by 30% 
No change to the 30% reduction 
Long-acting analogue: Take usual dose. Basal insulin to be reduced if patient 
exercise goal was to lose weight 
Pre-bedtime blood glucose concentration 
and CHO amounts: If blood glucose below 
8.0mmol/l take 10-20 g of CHO. No specific 
target level stipulated. 
Consume 20-40g of low glycaemic index 
food. At bedtime, aim for a blood glucose 
concentration of 10mmol/l. 
 
 Nocturnal hypoglycaemia risk: It is essential 
that patients when exercising in the evening 
occasionally perform a blood glucose test 8-
12 hours after administering the evening 
meal fast-acting analogue insulin dose. 
 
These amendments for the self-management strategies will be incorporated into the 
self-management algorithm as shown below in table 5.2. 
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Table 5.2: Amended self-management algorithm 
Amended algorithm for Insulin and Carbohydrate adjusting for exercising at  
70%  VO2 max  
 
Before exercise 
Lunchtime insulin 
 
 Have slowly absorbed carbohydrate and if you are exercising within 2 hours of eating a 
meal, reduce the bolus/meal dose by 75%.  
Blood glucose 
 
 Aim for blood glucose of 8mmol/l immediately before exercise. 
 If blood glucose over 15mmol, check for blood ketones and consider taking a 
correction dose. 
 If blood glucose over 17mmol do not exercise unless this is: 1). A “one-off” high 
blood glucose level and previous blood glucose levels have been acceptable, 2). You 
have given a bolus/meal insulin dose within 5 hours. 
 If you have blood ketones over 0.6 do not exercise. 
Food 
 
 If blood glucose under 8 mmol/l have the following quickly absorbed carbohydrate i.e. 
sugary drink or dextrosol.  
Blood glucose prior to exercise Amount of CHO (gm) 
 
Under 4 40 
4 - 6 30 
6 - 8 20 
8 or over 0 
 
After exercise 
Bolus/meal insulin 
 
 Eat within 2 hours of exercise and reduce the bolus/meal dose by 30%.  
Long-acting insulin  
 
 Take usual Lantus or Levemir dose. 
Blood glucose 
 
 Before bedtime have 30-40 grammes of slowly absorbed CHO i.e. cereal, banana. 
 Aim for a blood glucose of 10mmol/l. 
 It is important to test blood glucose occasionally 8-12 hours after evening meal to check 
for night-time hypoglycaemia. 
If you would prefer not to eat CHO at bedtime you can reduce your long-acting insulin, 
however this can affect your blood glucose for the following 24 hours. You should 
discuss this with your diabetes team. 
107 
 
 5.10 Summary of the impact of the environment  
 
Objective three was to evaluate differences in glucose concentrations between 
environments. The exercise session environments were designed to mimic each 
another, and the self-management algorithm used was exactly the same for both 
environments. Participants were questioned how they would perform the real-life 
sessions to ensure consistency. One might predict therefore, that there would be no 
difference between the glucose response in each environment. As described, 
statistically, no difference was found, but these pilot study findings were based on 
only 9 participants. The findings cannot be compared with other results in the 
literature since no studies, as far as this author is aware, have been published 
comparing environments in this manner. This remains an important issue for 
patients, because differences regarding hypoglycaemia were shown in the 
descriptive analysis, but will require further investigation using a larger study, with a 
full power analysis. From this analysis the following key messages were obtained: 
 
1. Using statistical analysis, the two environments did not have a different effect on 
the glycaemic control when following the self-management algorithm. This 
observation must provide reassurance that previous laboratory based research and 
subsequent findings can be used in patient education to advise on self-management 
strategies during exercising and subsequently clarify the reproducibility of clinical 
research in everyday life. However, it must be taken into consideration that the 
sample size was a limitation of this study. The sample size appears to be a common 
problem with this type of research and was highlighted by several authors (Iscoe and 
Riddell 2011, Kilbride et al 2011b, Rabasa-Lhoret et al 2001, West et al 2010).  
2. Glucose variability was apparent from the large standard deviations that were 
demonstrated in both environments, thus supporting previous findings (Jimenez et al 
2004, Kilbride et al 2011b, Riddell and Perkins 2006, and West et al 2010). This 
variability provoked difficulty in extrapolating data, particularly from the statistical 
analysis with extreme outliers between environments e.g.  hypoglycaemia and 
hyperglycaemia were not highlighted.  
3. The descriptive analysis emphasized these outliers, and differences in time-points 
were found when analysing the mean and individual participant hypoglycaemic 
episodes. This factor suggested that in the laboratory environment, there was an 
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increased risk of hypoglycaemia during exercise, and in the real-life environment an 
increased risk during the night between 8 – 12 hours after insulin doses and the 
evening meals (also demonstrated by Iscoe and Riddell 2011). In contrast, during 
the night the laboratory environment demonstrated increased hyperglycaemic 
episodes. A comparison between other studies with regard to overnight glycaemia 
cannot be made as data was not presented (Rabasa-Lhoret et al 2001, West et al 
2010).  With regard to this, it would appear that there was a difference between 
environments.  
 
The statistical analysis does suggest that laboratory based findings can be applied 
into a patient‟s everyday lifestyle when performing a comparable exercise, however, 
they should be aware of the glucose-lowering effect during exercise and the delayed 
risk of hypoglycaemia especially 8-12 hours after the post-exercise insulin dose. This 
is an important finding for patient safety and education regarding prevention of 
hypoglycaemia, although it has been acknowledged this was not demonstrated 
statistically. 
 
 
5.11 Strengths and limitations 
It is important that the strengths and limitations of the study are considered. These 
will be combined with potential amendments and adaptations for a follow-on study 
which will be discussed in the recommendations chapter. 
 
This study has certain characteristics that make it different to previously-related 
studies regarding moderate intensity exercise in Type 1 diabetes. No other research 
was performed where the principal focus was to examine post-exercise self-
management strategies, rather than pre-exercise strategies. A key difference 
supporting a post-exercise focus, was the recording and analysis of the glucose 
response for 12 hours post-exercise. This included the data collection of the glucose 
response overnight; a very important time for patients who greatly fear overnight 
hypoglycaemia.  Previous research has only concentrated on the glucose response 
in the immediate post-exercise time-period. Other research has been performed after 
breakfast (Peter et al 2005, Rabasa-Lhoret et al 2001, West et al 2010), despite 
many people exercising or wishing to exercise in the early evening following work. 
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The timing of the exercise in this study was influenced by patients who described 
their normal exercise routines, which often was before the evening meal.  
 
As discussed by Bryman (2008), in order to have ecological validity, the study design 
must incorporate or mimic the real-life situation that is under investigation. This was 
an important concept in the planning stages of this study and one of the objectives 
and strengths of the study. This is the only study to incorporate a real-life 
environment into the study design as all other research, other than case studies by 
Butler (2006) and Gravelling and Frier (2010) have been performed in a controlled 
laboratory environment. But despite this, laboratory findings regarding self-
management strategies were used by HCPs to advise patients on exercise 
management in daily life, but they were not evaluated in that environment (Grimm et 
al 2004, Peter et al 2005, Rabasa-Lhoret et al 2001, West et al 2010). In the current 
study, the participants managed to perform the required exercise sessions in  the 
real-life environment on day 3 and 10, and this allowed the comparison of controlled 
laboratory exercise and every-day exercise. This has demonstrated that participants 
were able to effectively follow instructions which included an ecological component in 
the exercise study. The combination of these attributes made this study unique, 
while addressing an important gap in the evidence base. 
 
Another strength of the study is the everyday practicality for ordinary people with 
Type 1 diabetes to use a commonly-used insulin regimen and exercise.  This is 
important as some of the previous research including expert opinions, has focused 
on elite athletes and it is therefore not applicable to the more general population. 
One of the major concerns prior to commencing the study was that of patient 
compliance with self-management and adherence to the study protocol, and also 
performing data collection. However, the participants were compliant and adhered to 
guidelines regarding SBGM, insulin dose, monitoring diaries and also not exercising 
on days 2 and 9. This was confirmed by a review of the participants‟ diaries and 
questioning them during exercise sessions. 
Another strength related to the participants‟ role, was that despite potential 
difficulties, the participants performed the study without experiencing any significant 
problems. The patient involvement and interaction were intensive, as were the 
researcher expectations, and also demands on patient compliance were 
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considerable when performing such research in a laboratory environment, and even 
more so when including a real-life component. When conducting a research 
programme which involves humans, it is important to consider their feelings, both 
physical and mental, during participation. Despite the intensive demands on the 
participants, their overall comment of enjoyment was apparent and they felt they 
developed a greater understanding of the effects of exercise on their body, 
especially when provided with their CGMS data after the study. Several participants 
also mentioned the appreciation of support received in the laboratory, and the time 
and communication with an exercise expert and diabetes nurse. This feedback was 
reassuring for the research team. 
 
Another strength was the use of CGMS, which was invaluable for overnight glucose 
monitoring. This method of data collection for glycaemic control had not been used in 
other similar research (West et al 2010, Peter et al 2005, Rabasa-Lhoret et al 2001). 
The CGMS enabled frequent glucose monitoring without disturbing the participant 
whilst sleeping. It also provided data regarding hypo-unawareness. Calibration was 
not a problem with participants in this study, although occasional blood glucose 
concentrations were not recorded on the CGMS data sheet. However, this was for 
short and limited times, and as results were provided every 10 minutes it was not an 
issue. Concerns regarding measurement validity as described in section 3.6 were 
not encountered, although the accuracy of these data may be questioned by some 
HCPs. In the authors opinion the data was valid and applicable for use in clinical 
care. 
 
There were, nevertheless, several limitations to this study, the main one being the 
sample size, although in spite of this one significant result was found. Recruitment to 
the study was more difficult than initially thought, although similar difficulties were 
noted by other research teams (West et al 2010, Kavookjian et al 2007, Peter et al 
2005, Rabasa-Lhoret et al 2001) regarding recruitment for the correct sample size, in 
order to achieve the statistical power. 
One deterrent could have been the commitment in time and effort that was required 
by the participants to adhere to the demanding study protocol. They performed five 
exercise sessions over a 3 week period, at a particular time of day, three of which 
would involve travel to the laboratory. The target population was of working age, had 
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busy lives and work schedules which may have influenced their decision not to 
participate in the study. In order to increase participant numbers, further recruitment 
from other diabetic clinics was an option, however, there was insufficient time to do 
this.  
 
Another deterrent may have been the strict inclusion criteria which was required for 
the purpose of patient safety. Participants were required to have acceptable 
glycaemic control and use a basal bolus regimen, and participate in regular exercise 
which did reduce the number of eligible participants.  
 
Apart from the sample size, there were also limitations with the data collection 
methods. During the real-life environment sessions, the participants were relied upon 
to accurately collect data for this study and some may criticise the impact this 
method of data collection had on the reliability of the data.  Similar studies have used 
research staff to collect all study data (West et al 2010, Peter et al 2005, Rabasa-
Lhoret et al 2001). This was not possible during the real-life sessions of this study 
and so the benefits of making the study clinically relevant to people lives had to be 
weighed up against potential issues. Despite the onus of data collection being placed 
on the participant, outside the laboratory the participant monitoring and 
hypoglycaemia diaries provided essential data regarding hypoglycaemia and 
hypoglycaemic unawareness, the confirmation of reducing evening meal dose by 
30% and the CHO consumption at bedtime. These parameters were all verified from 
the diaries and they provided valuable information, despite possible concerns stated 
in section 3.6 regarding the accuracy of record-keeping.   
 
Occasionally there was missing data, such as blood glucose times which were not 
recorded in the participants‟ diaries, and had to be determined by the CGMS data 
sheets, and time of basal insulin administration in the evening after exercise was not 
recorded. However, this did not impact on the overall results but it was time-
consuming for data analysis. In a further study, the recommendation would be for 
more stringent guidelines, stressing the importance of participant record-keeping 
when explaining the monitoring diaries.  
 
112 
 
The Polar wristwatch was worn by participants during the real-life sessions and they 
were instructed with usage and given a minimum and maximum heart-rate to 
achieve during the 40 minute exercise sessions. These watches cannot be 
downloaded to verify whether the participant exercised at the expected intensity, and 
the researcher had to trust that the participant did this. In a further study, the author 
would include in the diaries to record the heart-rate at ten minute intervals in an 
attempt to encourage the correct exercise intensity.  
 
With regard to the environment, an order effect could be a possible limitation as all 
participants performed in the laboratory environment first, followed by the real-life 
environment. However this order was decided to ensure participants had experience 
of running at 70% VO2 max prior to undertaking the real-life session. In a further 
study, randomised exercise sessions should be considered.  
 
Despite having limitations especially regarding the sample size, this study has 
generated useful information and data in which to perform a power calculation to 
perform a subsequent study with full power analysis. 
 
5.12  Summary 
 
In this chapter, the results of the study have been discussed whilst linking with 
related research and current guidelines. Important issues have been discovered that 
could be applied into clinical practice and patient education which will be described 
in the following recommendations chapter.  
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Chapter Six 
Recommendations 
 
6.1 Introduction 
This study has several implications for clinical practice regarding evidence-based 
guidelines and patient education which will be discussed in this chapter. The 
reliability and efficacy of the algorithm and the feasibility of a further study will also 
be determined. 
 
6.2 Implications for clinical practice 
 
Healthcare research generates information for clinical practice which are; firstly to 
provide evidence-based recommendations for national guidelines and policies, and 
secondly to provide HCPs with evidence to underpin information for patients.   
 
6.2.1 Implementation of findings into clinical care 
The descriptive results may not be considered robust or sufficiently influential to 
incorporate into evidence-based guidelines in diabetes management such as SIGN 
or NICE documents. This is disappointing as several authors have commented on 
the gap in the current research with regard to moderate intensity exercise and post-
exercise insulin adjustment in real-life situations (Brazeau et al 2008, Gallen 2005, 
Guelfi et al 2005, SIGN 2009, Walleymahmed et al 2007).  
 
Despite this, the findings will be conveyed to diabetes HCPs in the local NHS for 
their own use. The issues stated below in section 6.2.2, could be discussed with 
patients with Type 1 diabetes who perform or are considering exercise. These issues 
could be incorporated into individual patient management plans, with the advice that 
they are based on findings from a small study but may help to improve glycaemic 
control and prevent hypoglycaemia, when performing moderate exercise. The major 
factor for HCPs to be aware of, and to consider and include in education sessions 
with patients, is the risk of delayed hypoglycaemia and the possibility of 
hypoglycaemic unawareness during the night after evening exercise. The findings 
from this study do suggest that previous laboratory-based findings regarding self-
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management strategies may be applied into the real-life environment but one must 
be careful not to over-interpret the results; this algorithm had the same effect in the 
laboratory and real-life environments. This may be due to the small sample size and 
differences with hypoglycaemic episodes. 
 
6.2.2 Self-management issues to implement into patient education 
From clinical experience, it is unusual for patients to reduce insulin after exercise, 
which may increase the risk of post-exercise hypoglycaemia in some patients. Post-
exercise hypoglycaemia was a crucial finding, but to implement this finding it may be 
difficult to encourage patients to include SBGM into their usual nighttime monitoring 
after exercise, although many who are motivated to exercise will be keen to be 
informed of this finding. However, the focus group analysis described by Kilbride et 
al (2011a), did highlight that motivated patients use different strategies in an attempt 
to improve their glycaemic control and their knowledge related to exercise.  
Communicating the hypoglycaemia risk to the diabetes HCP community and patient 
population is essential for patient safety, and prevention of developing 
hypoglycaemic unawareness or exacerbating the severity of hypoglycaemia 
unawareness. If HCPs have access to CGMS, this would be a useful tool to use with 
people with Type 1 diabetes who are evening exercisers. From the current study, the 
participants were given their own CGMS recordings and were very interested in 
examining data, and subsequently making changes to their own exercise 
management strategies.   
 
After analysing the data and applying the findings into the real life situation and 
patient self-management, the following issues could be discussed with patients to 
consider and evaluate in their own personal self-management plans. It would have to 
be stressed to patients, however, that these strategies would have to be monitored 
and maybe modified depending on the effects on the individual: 
 
 There is a risk of delayed nocturnal hypoglycaemia after performing moderate 
intensity exercise in the evening.  
 After this type and time of exercise, reduce the evening meal fast-acting 
analogue insulin dose by 30%. 
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 At bedtime, have a banana or low GI snack to eat. 
 Monitor blood glucose before and after exercise, then before evening meal 
and bedtime, then again the following morning to evaluate the insulin dose 
reduction and bed snack. 
 Occasionally set an alarm and check blood glucose between 8-12 hours after 
the evening meal and fast-acting analogue insulin dose. 
 
6.3 Future research 
 
Determining the reliability of the glucose response of patients repeatedly using the 
algorithm is essential if it is to be used as evidence to support patient education in 
clinical practice. Unfortunately, it is difficult to determine the reliability of the algorithm 
within this pilot study, on a small sample size. This limited the interpretation of the 
current results.  An additional problem was the high standard deviations when using 
the mean glucose concentrations, which meant a high variability in individual 
participants‟ glucose values. A further study, using results from this study to perform 
a full power analysis with a larger sample size, would be required to achieve 
statistical power to evaluate the amended algorithm and ensure findings were the 
result of the effects of the algorithm and not by chance. However, a descriptive 
analysis would still need to be performed to ensure any extreme outliers are 
detected as these are important clinically.  
 
As this is the first time a complete self-management algorithm has been investigated, 
it would not be deemed as unusual that the algorithm requires amendments. Also, 
findings from recent publications by Iscoe and Riddell (2011) and West et al (2011) 
recommended similar adjustments which could be incorporated into the algorithm. 
The study highlighted areas in the algorithm sections where adjustments may 
increase the effectiveness and improve glycaemic control (Table 5.1 and 5.2). 
Although based on a small sample size, there was consistency in the data regarding 
glucose concentrations and patterns that emphasised specific glycaemic problems at 
certain time-points. In each algorithm section, the participant episodes within the 
acceptable range varied between 50-77.8%, and by making the suggested 
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amendments to the algorithm, and re-evaluating the effectiveness, the author would 
hope to improve this outcome, whilst reducing hypoglycaemic episodes. 
The major challenges in designing and performing a larger study would be regarding 
recruitment and cost. A multi-centre study would have to be considered. This is not 
without its challenges e.g. finding suitable research sites with appropriate personnel, 
the organisational issues, and cost implications. If these obstacles were overcome, 
the benefits of running a larger multi-centre study with the outcomes for evidence-
based guidelines to inform HCPs and patients would be immense, and add to the 
evidence-base.  
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Chapter Seven 
Conclusion 
 
7.1 Introduction 
The initial idea and motivation behind the pilot study aims and objectives were to 
develop guidelines to help people with Type 1 diabetes perform exercise without the 
risk of hypoglycaemia. This was instigated after patients had discussed their 
anxieties and problems encountered with exercise in their usual daily routines. 
These quotes from the Kilbride et al (2011a) focus group study support this: 
 
 “You can‟t just take anything for granted…you‟ve always got to be ten steps 
ahead of it and trying to work out what‟s going to happen”, and 
 
 “Once you understand your own body a bit then you‟re not as frightened. I 
used to be really frightened about having hypos when I was exercising”, and finally, 
 
 “I think diabetes is really quite hard work” (Kilbride et al 2011a, pp.75-75). 
 
When deciding specific details about the current study design, there was the desire 
to generate convincing evidence that would be applicable to the normal population 
when dealing with these challenges, hence the reason for the type of exercise, 
intensity and time used in this study. 
 
7.2  Related evidence 
The literature review highlighted a major gap in evidence regarding self-management 
strategies for people exercising before the evening meal. It also clarified the vast 
amount of variables (type of exercise, intensity, glycaemic control, time in relation to 
insulin), issues, problems and questions within the exercise and diabetes realm. All 
the previous research had been performed in the laboratory environment and not 
applied into similar real-life situations. It was unclear if laboratory-based research 
would be relevant outside the laboratory. None of the research analysed a complete 
self-management tool for patients before, during and after exercise, and all had only 
evaluated one management strategy. Evidence regarding delayed hypoglycaemia 
was also poor, with only experiential opinions available to acknowledge the problem. 
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7.3 Self-management algorithm 
This pilot study has been useful and informative as a starting point to evaluate a new 
idea for a self-management algorithm to be used by HCPs and patients to decrease 
the problems exposed to patients. The management strategies incorporated into the 
algorithm were based on the author‟s clinical experience plus expert opinions, 
though not always evidence-based because of lack of appropriate research. This 
study has been crucial to ascertain the success of combining these strategies into 
one self-management tool, and the current data analysis together with the recent 
findings from Iscoe and Riddell (2011) will underpin changes required for certain 
sections of the algorithm (Table 5.2).  
 
7.4 Hypoglycaemia 
This is the first pilot study to provide data demonstrating the risk of delayed and 
nocturnal hypoglycaemia after evening exercise. The data also highlight the worrying 
finding of nocturnal hypoglycaemic unawareness. Although not significantly proven,   
suggestions derived from this study can be disseminated to diabetes HCPs and 
patients regarding the importance of performing SBGM between 8-12 hours following 
an evening meal insulin dose with evening exercise to prevent hypoglycaemia. The 
data also confirm the advantages for HCPs to use CGMS in appropriate patients in 
order to investigate their individual hypoglycaemic risk, and to support education and 
identify accurate self-management adjustments.  
 
7.5 Differences between environments 
It appears that the two exercise environments in the laboratory and real-life have a 
similar effect on glycaemic control, and therefore previous research findings can be 
utilized in patient education. However in the current study, statistical analysis was 
performed with a small sample size, and results may have been different if 
performed with larger numbers. Extreme outliers were not highlighted, but the 
descriptive analysis demonstrated a difference with the patterns of hypoglycaemia in 
each environment.  
 
7.6 Future research 
A further study using a full power analysis, to evaluate the amended algorithm is 
necessary, and to also investigate differences between environments, as the 
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aetiology of the difference in hypoglycaemia episodes and nocturnal hyperglycaemia 
is not clear. It is inspiring that since the initial literature review, another research 
team had aims similar to those of the current study (Iscoe and Riddell 2011), and 
contact with them to discuss future research would be beneficial for the possibility of 
a collaborative study combining both post-exercise interventions.  
 
Since performing the literature review and having increased awareness of related 
research, the author has been in contact with the West et al (2010) team to discuss 
research results, and consequently, a UK interest group in physical activity and Type 
1 diabetes has been established. This offers a greater opportunity to increase 
research awareness, and to develop potential collaborations in exercise/diabetes 
research in the UK, with the aim to help people with Type 1 diabetes perform a 
normal activity safely.  
 
7.7 Summary 
This pilot study has added to the small evidence-base in self-management strategies 
for people with Type 1 diabetes when performing moderate intensity exercise, to 
achieve recommendations for health (American College of Sports Medicine 2007, 
Department of Health 2009, SIGN 2010, WHO 2010). The key findings regarding 
hypoglycaemia are essential for patient well-being, and should be incorporated into 
patient education to support patients to perform exercise safely.  
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Appendix 1a 
Search strategy 
 
 
Print Sea rch History  
 
Wednesday, August 04, 2010 8:50:54 AM  
#  Query  Limiters/Expanders  Last Run Via  Results  
S22  S10 and insulin management  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full 
Text;British Nursing 
Index;MEDLINE;SPORTDiscus  6  
S21  S10 and S11  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full 
Text;British Nursing 
Index;MEDLINE;SPORTDiscus  25  
S20  
type 1 diabetes* and 
exercise*  
Limiters - English 
Language; English Language  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full 
Text;British Nursing 
Index;MEDLINE;SPORTDiscus  542  
S19  
(("sport") and (S5 or S6 or 
S7)) and (S4 and S8)  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full 
Text;British Nursing 
Index;MEDLINE;SPORTDiscus  13  
S18  
(("sport") and (S5 or S6 or 
S7)) and (S4 and S8)  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full 
Text;British Nursing 
Index;MEDLINE;SPORTDiscus  13  
S17  S14 and insulin management  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - British Nursing 
Index;CINAHL with Full 
Text;MEDLINE;SPORTDiscus  Display  
S16  S14 and S15  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - British Nursing 
Index;CINAHL with Full 
Text;MEDLINE;SPORTDiscus  Display  
S15  
type 1 diabetes* and 
glycaemic control*  
Limiters - English 
Language; ; English 
Language; Human; ; 
Language: English  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - British Nursing 
Index;CINAHL with Full 
Text;MEDLINE;SPORTDiscus  Display  
S14  
type 1 diabetes* and 
exercise*  
Limiters - English 
Language; ; English 
Language; Human; ; 
Language: English  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - British Nursing 
Index;CINAHL with Full 
Text;MEDLINE;SPORTDiscus  Display  
S13  S10 and insulin management  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  1  
S12  S10 and S11  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  4  
S11  type 1 diabetes* and Limiters - English Interface - EBSCOhost  Display  
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glycaemic control*  Language; ; English 
Language; Human; ; 
Language: English  
Search modes - 
Boolean/Phrase  
Search Screen - Advanced Search  
Database - British Nursing 
Index;CINAHL with Full 
Text;MEDLINE;SPORTDiscus  
S10  
type 1 diabetes* and 
exercise*  
Limiters - English Language  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  143  
S9  
(("sport") and (S5 or S6 or 
S7)) and (S4 and S8)  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full 
Text;British Nursing 
Index;MEDLINE;SPORTDiscus  13  
S8  ("sport") and (S5 or S6 or S7)  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  4320  
S7  "sport"  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  Display  
S6  
(MM "Physical Activity") or 
(MM "Physical Activity 
(Omaha)")  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  Display  
S5  
(MM "Exercise+") or (MM 
"Aerobic Exercises+") or (MH 
"Anaerobic Exercises")  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  Display  
S4  
(("insulin dependant 
diabetes") or (MM "Diabetes 
Mellitus, Insulin-Dependent")) 
and (S1 or S2 or S3)  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  5215  
S3  
("insulin dependant 
diabetes") or (MM "Diabetes 
Mellitus, Insulin-Dependent")  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  Display  
S2  
("type 1") or (MM "Diabetes 
Mellitus, Insulin-Dependent")  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  Display  
S1  type 1  
Search modes - 
Boolean/Phrase  
Interface - EBSCOhost  
Search Screen - Advanced Search  
Database - CINAHL with Full Text  Display  
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Appendix 1b 
 
Key publications 
 
 
   Original studies 
 
Brazeau et al (2008) Type: A qualitative research design 
Aims: To determine barriers for people with Type 1 diabetes against participating in physical activity 
Method: 103 people with Type 1 diabetes (mean age 43.5 ± 11.6 years) attending routine clinic 
appointments completed a diabetes-specific barriers measure (BAPAD1 scale).  
Results: The highest barrier scores were fear of hypoglycaemia, work schedule, loss of glycaemic 
control and low fitness levels respectively, however P values not stated. Exercising with another person 
significantly resulted in fewer barriers (P<0.001). Participants having an evening CHO snack after 
exercise significantly reduced hypoglycaemia fear (P<0.007). Although not significant, participants with 
time actions and pharmacokinetics of insulin reduced the fear (P=0.021). 
Strengths: A random sample of participants with Type 1 diabetes to extrapolate data to inform the 
current study of participant and real life barriers to performing physical activity. 
Limitations: Numbers of people actively performing physical activity were not stated thus possibly 
skewing the data, depending on the number of non-exercisers. 
Key message: Hypoglycaemia risk is a feared and major barrier. Thus supporting the need for this 
particular study in delayed hypoglycaemia prevention. The need for patients to understand insulin 
actions will be demonstrated in the self-management algorithm, giving people with diabetes education 
regarding insulin and dietary strategies. Highlighting bed snacks depending on the bg level in the 
algorithm will attempt to allay nocturnal hypoglycaemia.  
 
 
Grimm et al (2004) Type: Comparison study 
Aims: To compare different therapeutic options related to dose adjusting and CHO ingestion on people 
with Type 1 diabetes exercising at different intensities and durations. 
Method: 67 participants with well controlled diabetes (HbA1c <7.5%) and placed into 4 different 
treatment groups. Each participant was then placed into different intensity and duration groups. It was 
not stated how these decisions were made. 
Results: Data very poorly presented and vague despite the complex study design. In relation to this 
study for 20-60 minutes exercise at 60-70 VO2 max, 20-60 grammes of CHO would need to be 
ingested to prevent hypoglycaemia. Recommendations in general for intense and moderate duration 
require 20-30% reduction of total daily dose (not stating analogue or NPH).  
Strengths: Considering a multiple array of exercise and treatment options. 
Limitations: Very difficult to decipher data. Hypoglycaemia was stated as BG levels <2.8mmol which is 
very low. Insulin used were fast acting analogues or NPH which is an old intermediate acting insulin 
with peak between 4-8 hours after injection which could bias data. Unable to extrapolate any 
information or evidence to incorporate into this study. 
Key message: None with regard to research questions. But when writing up data be specific and don‟t 
have too many treatment groups/variables within the study as interpretation is impossible. 
 
Peter et al (2005) Type: Randomised cross-over design 
Aims: to study the effects in Type 1 diabetes on the absorption of Lantus after exercise. 
Method: 13 participants with Type 1 diabetes using basal bolus regimen given usual Lantus dose on  
the evening before visit 1 and the same on visit 2. Then randomly assigned to perform 30 minute bout 
of exercise at 65% VO2 max on one visit. Blood samples collected to assess bg and insulin levels. 
Results: fasting bg levels similar on both days (8.4 and 8.2 respectivly). During 210 min post exercise 
period showed no difference in glucose (P=0.345), however during exercise glucose levels were 
significantly lower (P=0.001). No statistical differences in insulin levels during (0.506) or after (P=0.116) 
exercise on both days. 
Strengths: Insulin levels remained stable during and 210 minutes post exercise.   
Limitations: Unusual time of data collection (3 hours and 30 minutes post exercise). No description of 
adjustments to fast acting analogue pre-exercise which could have resulted in the glucose drop during 
exercise. No data collection for bg levels for following 24 hours when hypoglycaemia is a potential risk. 
This study is disappointing as post exercise data up to 24 hours would have been interesting for the 
algorithm design to support Lantus adjustment.  
Key message: Lantus would not be a contributing factor to hypoglycaemia during or in the initial period 
after exercise.  
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West et al (2010) Type: Randomised quasi – experiment into 3 groups with no control 
Aims: to examine pre-exercise insulin reductions before running and the consequent 24 hour effect on 
glycaemic control. 
Method: 7 participants were given a reduction of 25, 50 or 75% of their usual fast acting analogue 
dose 2 hours prior to exercise. 
Results: Pre-exercise bg levels ranged 11-15mmol in all groups, however the intra-individual variability 
across participants could have contributed to a lack of statistical significance. 
Each group experienced 1 hypoglycaemia episode at 180 mins (not significant). All groups experienced 
decreases in bg levels (P<0.01). During and 21 hours post exercise all groups experienced 
hypoglycaemia, although the 75% experienced less (P<0.05). The 75 % reduction experienced more 
acceptable 24 hour post bg levels.  
Strengths: Similar participant characteristics performing moderate intensity 70% V02 max running for 
45 minutes. 
Limitations: Hypoglycaemia stated as bg <3.5mmol. For the 75% reduction bg levels at finish were 
11.0mmol and participants took correction doses which would have contributed to post exercise 
hypoglycaemia. No data regarding post exercise dose adjusting or data collection of bg levels via 
CGMS. Post exercise participants performed their own individualised self-management strategies 
which were not correlated or described with bg levels. Lack of statistical power – required sample size 
of 33 but recruited 7. BG levels before, during and after not described in detail. Only performed in 
laboratory environment not real life. 
Key message: Peak insulin concentrations occurred 60 minutes after injection. Higher starting bg 
levels maybe required as this study aims for 8.0mmol. Reported variability of bg levels in controlled 
environments and a factor to consider in future research. For the algorithm, if exercising within 2 hours 
reduce pre-exercise dose by 75%. A discussion with the researcher would be beneficial to get detailed 
results. This could be combined with this study as this looks at pre dose adjusting. 
 
 
 
 
Review articles 
 
 
American Diabetes 
Association (2002) 
Aim: Recommendations given for diabetes and exercise 
Method: Only 6 publications reviewed to give clinical recommendations for health care professionals 
when advising patients on exercise management. 
Results: A narrative description of physiological issues and management strategies for Type 1 and 
Type 2 diabetes. 
Key messages: Avoid exercise if BG > 13.9mmol with ketosis, or BG > 17mmol without ketosis. This 
information is included in the algorithm. Eat CHO if BG <5.5mmol before exercise. This information was 
not included as hypoglycaemia risk would be increased. 
Gallen (2004) Aim: A narrative description of the physiological challenges in exercise and Type 1 diabetes, and 
management strategies to normalise BG and prevent hypoglycaemia. 
Method: No description of search strategy. 40 references cited. 
Results: A narrative description of key findings from original studies, although individual studies not 
critically analysed. Experiential descriptions and recommendations given by the author which are not 
supported with evidence. 
Key messages: After exercise 60-120 grammes of CHO should be taken with insulin to replenish 
glycogen stores. However not evidence based or relating to any particular intensity or duration of 
exercise. Very vague information. 
Jimenez et al on 
behalf of the 
National Athletic 
Trainers 
Association (2007) 
Aim: To give recommendations to certified trainers regarding Type 1 diabetes management 
Method: No search strategy shown. 91 references cited. 
Results: A practical narrative description of type 1 diabetes and exercise management, aimed at 
trainers with no diabetes knowledge. 
Key messages: None. However it did highlight the complex intricacies of management that being a 
HCP working in diabetes can assume people understand. 
Kavookjian et al 
(2007) 
Aims: A systematic review to assess and summarise evidence and gaps in the literature regarding 
interventions for exercise among people with diabetes. 
Method: 12 databases were searched for exercise in all types of diabetes for learning, behavioural, 
clinical and humanistic outcomes. 
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Real life studies 
 
 
Butler (2006) Type: Case study 
Aims: To describe the training and management plan for a person with Type 1 diabetes swimming the 
channel. 
Method: A review of the literature regarding pathophysiology, diet and insulin modification, hypo and 
hyperglycaemia risks for relating to Type 1 and exercise. A description of the individualised training and 
insulin/diet adjustment strategies. During the swim fast acting analogue doses were stopped and long 
acting analogue reduced by 30% for 2 days prior and after the swim.  
Results: The person finished the swim but experienced a hypoglycaemic episode during, and vomited 
on several occasions. May be due to the high energy supplements differing during the swim compared 
to training sessions. Training sessions of 7 hours duration maintained acceptable bg levels. 
Strengths: One of the few articles found that is undertaken in real life. Highlights the importance of 
regular SBGM and individualised dose adjusting. Training sessions could be classified as laboratory or 
controlled environments, and the swim being real life. 
Limitations: Only had 1 participant. Bg levels not described during training, although satisfactory 
before and after the channel swim, which could have been correlated to laboratory and real life. The 
Results: The results focused mainly on Type 2 diabetes with limited Type review.  
Key messages: Self-management and glycaemic control intervention studies are conducted in artificial 
environments i.e. laboratory, with no translation into the patients daily life. No analysis of diet/dose 
adjusting intervention studies due to the nature of the review, which was acknowledged by the author. 
 
Lumb & Gallen 
(2009) 
Aim: A narrative description of management strategies for exercise and Type 1 diabetes, based 
around patient scenarios.  
Method: No description of search strategy. 28 references cited. 
Results: Experiential descriptions and recommendations for different intensities and types of exercise 
are given by the authors, which are not supported with evidence. Studies acknowledged were not 
critically analysed. 
Key messages: If severe hypoglycaemia occurs in the previous 24 hours, exercise should be 
performed with caution if at all. Peak hypoglycaemia risk time after moderate intensity exercise is 60-90 
minutes post and during the night. A post exercise dose reduction of 30% advised although not 
evidence based. Management strategies should be tailored to individuals. 
Nagi & Gallen; on 
behalf of the British 
Clinical 
Diabetologists 
Committee (2010) 
Aim: A position statement to assist diabetes HCPs to familiarise themselves with issues regarding 
exercise management. 
Method: No description of search strategy. 41 references cited. 
Results: A narrative description of key findings from original studies, although individual studies not 
critically analysed. Experiential descriptions and recommendations given by the authors which are not 
supported with evidence. The information recommended was disappointing from this well-recognised 
expert group as the information was not analysed or limitations from studies discussed. 
Key messages: No evidence that moderate intensity exercise has a detrimental effect on non-
proliferative retinopathy. Physical activity (apart from high intensity, strenuous exercise) should not be 
restricted in people with nephropathy. Jogging or treadmill use should be undertaken by people with 
significant neuropathy. Advantages and disadvantages for specific dose adjusting was described, 
however post bolus reduction was not mentioned, although post basal reduction was which highlighted 
a reduction in nocturnal hypoglycaemia but may cause morning hyperglycaemia – for this reason in the 
algorithm bolus was reduced to alleviate nocturnal hypos but maintain morning usual BG levels. 
Perry & Gallen 
(2008 
Aim: Physiology description of Type 1 and exercise and literature review regarding evidence based 
management strategies. 
Method: No description of search strategy. 42 references cited. 
Results: A narrative description of key findings from original studies, although individual studies not 
critically analysed. Experiential descriptions and recommendations given by the authors which are not 
supported with evidence. 
Key messages: Multiple variables control glucose homeostasis. Advice for individuals will differ. 
Reducing post exercise meal dose will prevent nocturnal hypoglycaemia (amount not given). Starting 
BG between 7-12mmol. Lack of research performed in real life environments. 
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swim took 14 hours, this study looks at moderate intensity exercise for 40 minutes. 
Key message: Insulin and dietary modification is essential. Training sessions (controlled environment) 
and the swim (real life) resulted in differences in bg levels and hypoglycaemia occurred in real life. 
 
Graveling & Frier 
(2010) 
Type: Case study 
Aims: A description of metabolic events in Type 1 diabetes, in the preceding 48 hours before exercise 
and the risk of exercise induced hypoglycaemia. 
Method: A case history describing a 27 year old person with Type 1 diabetes suffering severe 
hypoglycaemia then running a marathon resulting in further severe hypoglycaemia. 
Results: Description of the individuals pathophysiology and clinical markers. 
Strengths: Highlights the risk of rebound and delayed hypoglycaemia and the necessity for dietary and 
insulin dose adjustment. 
Limitations: Only 1 person performing a marathon not 40 minutes moderate intensity exercise. No 
description of post exercise dose adjustment to prevent hypoglycaemia. 
Key message: People with insulin-treated diabetes should not attempt prolonged strenuous exercise 
within 48 hours of experiencing a severe hypoglycaemic episode. 
Wallymahmed 
(2007) 
Type: Comparison study 
Aims: To assess the relationship between glycaemic control, self-reported vigorous activity, aerobic 
capacity and hypoglycaemia avoidance in people with Type 1 diabetes. 
Method: 50 patients attending a routine diabetes clinic appointment participated. Aerobic fitness 
assessed by a sub-maximal step test, physical activity, hypoglycaemia and hypo avoidance measured 
by a non-validated questionnaire. 
Results: 60% reported participating in regular vigorous exercise (RVE) with significantly worse HbA1c 
compared to those not regularly participating (NVA) (9.5% vs 8.5% p<0.02). The RVA group reported 
aiming for higher starting blood glucose before exercise levels compared to the NVA group (8 vs 0 
p<0.03). In the RVA group 83% reported taking precautions to avoid hypoglycaemia. From these 77% 
ate more, 7.7% reduced insulin, 12.8% ate and reduced insulin.  
Strengths: A good description of exercise/diabetes behaviour in a normal population of people with 
Type 1 diabetes.  
Limitations: No description of insulin type and dose adjusting in the 83% who did. Used a non-
validated questionnaire that was not shown in the paper. Difficult to extrapolate data to use in other 
studies as specific areas i.e. dose adjusting, food amounts, BG levels around exercise, hypos related 
to exercise, all not described in detail. 
Key message: Patients tend to eat more CHO around exercise to aim for higher BG levels, despite 
advice being given previously on insulin dose reduction.  
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Appendix 2 
Patient study information 
 
 
 
EDINBURGH NAPIER UNIVERSITY 
Faculty of Health, Life and Social Sciences Research Ethics and Governance 
Committee  
 
Information Sheet/Letter for Potential Participants 
 
 
Our names are Jacqui Charlton, John Chisholm and Lorraine Steel and we are currently 
research students from the Faculty of Health, Life and Social Sciences at Edinburgh Napier 
University.  As part of our degree courses we are involved with NHS Lothian in a programme 
of research looking at the effects of Type 1 diabetes and exercise, and ways to manage 
blood glucose levels.  Dr. X has given us names of patients who attend the X diabetic clinic, 
and you have been identified as a possible participant for this research because you have 
type 1 diabetes.  
 
We have 3 separate studies starting in the next few months. The information about each 
study is enclosed. The studies will investigate the effects on blood glucose levels for people 
with type 1 diabetes when performing different types of exercise. All studies are suitable for 
adults over the age of 18 years old.  
 
The findings from the projects will be valuable because many people with type 1 diabetes 
are anxious about exercising due to the fear of hypoglycaemia and the possibility of having 
erratic blood glucose levels. There is limited information available regarding the effects and 
so gathering this information could help many people with type 1 diabetes to enjoy 
participating in sport and exercise. 
 
We are looking for volunteers to participate in the projects.  As have type 1 diabetes and use 
a basal bolus insulin regimen we would like to invite you to take part in a study. However it is 
important that you already participate in regular exercise. 
 
If you decide to take part in a study you will be asked to attend the exercise laboratory at 
Merchiston Campus of Edinburgh Napier University in Colinton Road. Each study runs for a 
2-3 week period, and the following information sheets tell you what the each study entails. 
As all of the study sessions involve exercise, please attend wearing flat shoes (preferably 
trainers) and comfortable clothing. 
 
You will be free to withdraw from the study at any stage, you would not have to give a 
reason, and it will not affect your treatment. This project will also mean that we will have to 
look at your diabetic hospital records. 
 
Since your participation will involve you travelling to Edinburgh Napier University you will be 
reimbursed for out-of-pocket expenses. 
 
All data will be anonymised as much as possible. Your name will be replaced with a 
participant number and it will not be possible for you to be identified in any reporting of the 
data gathered. Any data collected will be kept in a secure place to which only the study team 
has access. These will be kept till the end of the examination process.  
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The results may be published in a diabetes or sport journal, or presented at a diabetes or 
sport conference.  It will also be possible for you to obtain written or verbal feedback on your 
results of the study in order to help you better understand your diabetes management 
relating to the specific form of exercise.  We will also send you information regarding the 
results of the study when it has finished. 
 
If you would like to contact an independent person, who knows about this project but is not 
involved in it, you are welcome to contact Barbara Neades, who is a lecturer and 
chairperson of the research committee at Edinburgh Napier University.  Her contact details 
are given below. 
 
Before you decide if you would like to participate in a study it is important for you to 
understand why we are undertaking this research and what it will involve.  Please take time 
to read the information sheets carefully and discuss it with others if you wish. If there is 
anything that you do not understand, or if you would like more information, please contact 
us.  
 
If you decide to take part, please let us know which study you would like to take part in and 
send the completed form back to us. 
 
Thank you very much for your time. 
 
 
Kind regards, 
 
 
 
Dr. X, Consultant Physician 
Jacqui Charlton, Diabetes Specialist Nurse 
Lorraine Steel & John Chisholm, Research students 
 
 
 
Contact details of the independent adviser: 
 
Name of adviser: Barbara Neades 
Address:  Edinburgh Napier University 
   Canaan Lane Campus 
Edinburgh 
EH9 2TB 
   
Email / Telephone: b.neades@napier.ac.uk / 0131 455 5659  
 
 
 
 
 
 
 
 
 
Please return in the pre-paid envelope. 
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Name: 
 
Address: 
 
 
 
Email: 
 
Phone number: 
 
 
 
I am interested in taking part in the following study/s (please tick): 
 
1. Self management algorithm for moderate intensity  
 
2. The effect of intermittent exercise on blood glucose levels 
 
3. The effects of weight training on blood glucose levels 
 
 
 
Thanks very much. 
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Information sheet - self management algorithm for adults exercising with type 
1 diabetes 
 
Assessment 
visit 
In the exercise laboratory at Edinburgh Napier University. 
Informed consent will be obtained. 
Questionnaire to establish general fitness to undertake 
study will be completed. 
Blood pressure and blood glucose will be measured to 
make sure these are at safe levels for the exercise to take 
place. 
Heart rate monitor and face mask to measure exhaled air 
will be fitted. 
Participants will be asked to follow an exercise plan, 
lasting approximately 40 minutes, this will be a brisk 
walk/slow jogging pace on a treadmill. 
 
Day 1 
Monday 
You will be connected to a watch to monitor your heart 
rate.  
You will be connected to the 24 hour blood glucose 
monitor and connect you up to it by means of a sensor 
placed under your skin. We will explain how it works. 
You will be asked about your usual management of insulin 
doses and food intakes when you exercise. 
We will discuss guidelines for the management of insulin 
doses and food intake while exercising. You will then be 
asked to follow these guidelines for the exercise session 
undertaken at this and your next 3 exercise sessions. 
You will be given diaries to record blood glucose levels, 
food intake, insulin doses and any incidences of low blood 
glucose to be filled in for the next two 4 day periods. 
You will then be asked to start the exercise session, which 
will be jogging lasting 40 minutes on the treadmill. 
At the end of the session you will be asked to continue 
wearing the heart rate and blood glucose monitors and 
carry out your normal routine the following day. 
Day 3 
Wednesday 
You will be asked to undertake your own usual exercise. 
Day 4 
Thursday 
You will be asked to return to have the monitors removed. 
Day 8 
Monday 
In the exercise laboratory at Edinburgh Napier University. 
Same as day 1 
Day 10 
Wednesday 
Same as day 3. 
Day 11 
Thursday 
You will be asked to return for removal of the monitors. 
End of study. 
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Appendix 3 
Participant folder 
 
To compare the effectiveness of a self management algorithm 
during and after controlled laboratory and real life moderate 
intensity exercise in Type 1 diabetes 
 
Name:  
 
Subject ID: 
 
 
 
Contact numbers 
 
 
Jacqui Charlton 0131 455 5676 (Mon,Tue,Wed) 0131 5371747 (Thu, Fri) 
 
Exercise lab at Merchiston campus 0131 455 2599 
 
Diabetes Doctor on call: 0131 537 1000 and ask to bleep diabetes doctor on call 
 
Medtronic (Minimed) helpline  01923 205142 (office hours) 
                                       01223 577379 (24 hour helpline, USA number 
charged at local rate)          
This folder has been designed to allow you to record the information that we 
require for this study. On the page before each form there is information 
relating to the way we would like you to complete the forms.  
 
As part of this study we would like you to complete a diary recording your food and 
insulin intake, exercise and hypos for each day of the study. This is each day of the 
two weeks that you are attached to the monitors. 
 
Arrangements will be made with you for the collection of completed forms. 
 
The information you record will be used to produce guidelines for future treatment of 
people with diabetes, so please take time to be as accurate as you can when filling 
out the forms. 
 
There are also examples of completed sheets at the end of each section for your 
information. 
 
*Please bring this folder with you to all 
appointments* 
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Guidance notes for completing hypoglycaemic (low blood glucose) 
episodes 
 
 
 
Please indicate on the following sheet every episode of low blood 
glucose (hypoglycaemia) during this study. This is the day before and 
when you are attached to the monitors. 
 
 
We would like you to note: 
 
 the date and time of these  
 
 the severity (mild or severe) with mild being that you can treat it yourself 
and severe being if you need help from someone else 
 
 the symptoms you had 
 
 any treatment you needed 
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Hypoglycaemic Episodes 
Please record all hypo‟s related to exercise. 
Please rate as mild or severe i.e. mild = you can treat it yourself and severe = you 
need help from someone else. 
 
Date/ 
Time 
Mild or 
severe 
During 
exercise? 
Within 2 hours of 
exercise? 
Over 2 hours 
after exercise? 
During 
the night? 
Blood glucose 
(using meter) 
Symptoms 
you had 
Treatment (please circle) 
If other please specify 
  
Mild / 
Severe 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
 
mmol/l 
 
 
 
 
 
Dextrosol/ Lucozade/ Chocolate 
Hypostop / Glucostop 
Glucagon 
Other: 
  
Mild / 
Severe 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
 
 
 
 
Dextrosol/ Lucozade/ Chocolate 
Hypostop / Glucostop 
Glucagon 
Other: 
  
Mild / 
Severe 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
 
 
 
 
Dextrosol/ Lucozade/ Chocolate 
Hypostop / Glucostop 
Glucagon 
Other: 
  
Mild / 
Severe 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
Yes / No 
 
 
 
 
 
Dextrosol/ Lucozade/ Chocolate 
Hypostop / Glucostop 
Glucagon 
Other: 
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Guidance notes for completing the daily monitoring diary 
 
 
 
Carbohydrate (CHO) intake 
 
This section helps us to find out how much carbohydrate you consume before, 
during and after exercise. When recording food intake if you know how to calculate 
carbohydrate portions please use these. If not give as much information about your 
food intake as you can. For example ham sandwich does not give enough 
information whereas 2 slices of wholemeal bread spread thinly with butter with 
ham, tomato and lettuce is much more useful. 
 
Remember to also record what you have had to drink, including any alcohol. 
 
It is important to record all snacks and food taken between meals. 
 
Please be accurate about the amount of food you eat. We are not making 
judgements on what you eat but about how what you eat affects your blood 
glucose level, especially when you are exercising. 
 
You may use sugary food or drink when exercising or at other times please try and 
give accurate quantities, we are interested in what works for you. We are not looking 
at the healthiness of your diet. There is an example of a completed form at the end 
of this section. 
 
 
Blood glucose monitoring 
 
Please record your blood glucose levels before, during and after exercise. 
 
You will be given a TrueOne meter to use for the duration of the study. Please be 
sure to bring this meter to all sessions so all blood glucose measures are made from 
the same meter. 
 
Take the before reading approximately 10 minutes before exercising. 
 
If you normally test your blood glucose during exercise take a reading at a 
convenient time to yourself but record this on the sheet. 
 
Take the after reading within 10 minutes after completing the exercise. 
 
 
Insulin dose 
 
Please record any additional insulin dose taken as well as your usual dose. 
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Exercise 
 
 
Describe the session of exercise you have taken, including how long you were active 
for, and what you did.  
 For example  
 Gentle walk for 30 mins or 
20 minutes of brisk walking or 
 One hour of heavy gardening. 
 
Remember not to take any structured exercise on the in-between days that you are 
connected to the monitors.  
 
 
If you have any questions about this please contact one of the study team. The 
contact details are on the front of this pack. 
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DAILY MONITORING DIARY    Name:   Day number after visit (1-4 or 8- 11) 
                 Date:  
**Please fill in 
the time** 
Breakfast 
 
Morning Lunch Afternoon Evening 
Meal 
E Bed During night 
Total CHO eaten 
(g) 
 
 
        
Extra CHO before 
Exercise 
 
Extra CHO during 
Exercise 
 
Extra CHO after 
exercise 
        
Blood glucose 
B=before 
D=during 
A=after 
*if not exercising 
record reading in 
before (B) section 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
B 
 
D 
 
A 
 
Insulin taken         
Usual insulin dose         
Exercise: 
 
How long for? 
 
What did you do? 
 
 
 
 
 
 
       
Hypo’s 
Tick appropriate 
box if experience 
and fill details in 
hypo diary 
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Guidance notes for following the moderate intensity exercise guideline 
 
This guideline has been developed to help you to exercise safely and attempt to 
prevent large fluctuations in your blood glucose levels when exercising. 
For the purpose of the study we would prefer you to exercise after 2 hours of 
injecting insulin and eating food. 
 
Before exercise 
 
If the exercise is more than 2 hours after your last meal then you just need to take 
your usual amount of carbohydrate and insulin at that time. 
 
 For example if you are having lunch at 1 o’clock and know you are going for a 
run straight from work at 4 o’clock  then do not alter your insulin or carbohydrate at 
lunch time. 
 
Aim to have your blood glucose around 8 before you start your exercise. 
 
If your blood glucose is less than 8 you need to take the amount of fast acting 
carbohydrate suggested in the guideline. 
 
 For example if your blood glucose is 6 mmol/l before you start exercising you 
will need to take an additional 10g CHO e.g. 3 dextrosol or 60 mls. Lucozade before 
exercising. 
 
 
After exercise 
 
Test your blood glucose as soon after exercise as you can. 
 
If you normally eat straight after exercise then take your normal amount of 
carbohydrate and reduce your normal dose of humalog/ novorapid by one third.  
 
         For example if you normally take 9 units reduce this to 6 units. 
 
If you exercised in the early morning, before breakfast, you need to reduce you 
breakfast insulin by one third.  
If you exercised in the morning, after breakfast, then you need to reduce your lunch 
time insulin by one third. 
If you exercised in the afternoon then you need to reduce the insulin taken at your 
evening meal by one third. 
If you exercised in the evening then your supper time dose of humalog/ novorapid 
will need to be reduced by one third, if you usually inject and eat food at this time. 
 
It is very important to remember to test your blood glucose before bedtime and take 
your normal dose of Lantus/ Levemir. 
 
If you have exercised any time after lunch time you will need an extra 10-30g CHO at 
supper time to prevent night time hypos. 
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Appendix 4 
Pre-assessment test and study visit checklist 
 
To compare the effectiveness of a self management algorithm during and after 
controlled laboratory and real life moderate intensity exercise in Type 1 
diabetes 
 
Participant folder and checklist 
 
DO NOT REMOVE THIS SHEET FROM FOLDER  
TICK AND INITIAL IF CARRY OUT INTERVENTION 
 
 
Name: 
 
 
Subject ID:  
Minimed Serial number: 
 
 
Date of Birth: 
(age 18-60) 
 
Consent obtained: Yes / No 
Copy of consent to patient: Yes / No 
Consent obtained by: 
 
 
 
 
Exclusion criteria  
 
Initials 
Diagnosed peripheral vascular disease  
Orthopaedic problems to prevent brisk walking  
Diagnosed heart disease  
Proliferative retinopathy  
Peripheral neuropathy  
Hypoglycaemic unawareness  
 
Measure Result Initials 
HbA1c plus date obtained                %  
Date: 
 
Exercises 3x30 mins per week Yes / No  
Basal bolus regimen Yes / No  
Analogue insulin (name and 
dose) 
  
Basal insulin (name and dose)   
Insulin:CHO ratio   
CHO counting Yes / No  
Able to adjust insulin/ CHO Yes / No  
Correction dose   
Weight kg              kg  
Height (M)              m  
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BMI   
Average BP   
 
 
 
 Initials 
TrueOne meter education 
- 100 strips given 
- 1 box lancets given 
 
 
Diary education 
(insulin, food, exercise, hypo and BG monitoring) 
 
 
Exercise questionnaire 
 
 
GP information letter sent 
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Moderate intensity exercise in Type 1 diabetes 
Visit checklists 
 
Pre-assessment test 
Participant will be asked to attend wearing trainers and comfortable clothes or may 
require 
changing 
facilities. 
 
 
WORKLOAD TIME(mins) SPEED(km/h) GRADIENT 
(%) 
PREDICTED 
VO2 (ml kg
-1 
min-1) 
1 0 - 3 4 0 10.17 
Task Initial 
Obtain informed consent   
Administer questionnaire to establish general fitness 
(attached) 
 
All participants will be provided with TrueOne meters to test 
blood glucose levels. Training will be provided at this 
session. 
 
Ask participant to measure blood glucose. If less than 
4mmol-1 or more than 17 mmol-1 test will not go ahead. 
Reading………..mmol־¹ 
 
After at least 5 minute rest take 2 measures of resting BP 
if average is over 165/90 can not take part in study refer to 
Dr McKnight at WGH (letter attached) 
 
a. Measurement 1: / mmHg  
b. Measurement 2:  / mmHg  
c. Average:  / mmHg  
Allow participants to familiarise themselves with walking on 
treadmill 
 
Fit Polar heart rate monitor  
Fit face mask for Breath x Breath analyser  
Follow test protocol as below  
Participant should have access to blood glucose meter as 
will be asked to test blood glucose levels half way through 
the test (i.e. at 20 minutes) 
 
Measurement at 20 mins:  mmol־¹  
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2 3 - 6 4.8 2.5 15.9 
3 6 - 9 5.3 5 20.25 
4 9 - 12 6 6.5 25.2 
5 12 - 15 6 9.5 30.6 
6 15 - 18 6 12 35.1 
7 18 - 21 6 15 40.5 
 
During the test HR and VO2 will be monitored continuously with Rate of Perceived 
Exertion (RPE) being assessed at the end of each stage. 
 
The end point for all tests is at or just before 85% of the participant‟s age predicted 
maximum heart rate or for safety reasons when;  
 
 1. The monitoring system failed. 
 2. A participant experienced progressive angina. 
3. A participant experienced light headedness, confusion, ataxia, pallor, cyanosis or 
nausea. 
 4. A participant experienced discomfort and asked to stop. 
5. A participants blood glucose falls beneath 4 mmol l־¹. or they experience 
symptoms of hypoglycaemia. 
 
If any of the above occur please complete an adverse event form 
 
 
After exercise session is completed: 
 
Blood glucose level:   mmol/l  
Initials:  
 
Carbohydrate will be available if required. 
Ensure participant leaves with monitoring diaries and clear instructions to complete 
this on the evening before, and morning of, the next visit i.e. day 8.  
Monitoring diaries will be completed from days 8 to 18 inclusive.  
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Visit 1 (Day 1) 
 
1. On arrival at the laboratory the participant will be connected to their minimed 
monitor, and given instruction on its use.  
2. They will then be taken through the procedures for recording food intake, insulin 
dosage, hypoglycaemia and physical activity that they will be required to complete 
for the duration of the study. 
3. Finally the participants will be attached to the Actiheart physical activity monitor. 
 
Ask participants about usual management of food and insulin when exercising with 
the attached questionnaire. If anomalies are apparent offer education. 
 
After a period of at least 1 hour has elapsed and stable readings are obtained from 
the minimed meter the participant should be asked to measure their blood glucose 
levels using their TrueOne meter; if blood glucose levels are not above 17 mmol l־¹ 
or below 4 mmol־¹, the participant will be put on a Polar heart rate monitor in 
preparation for their treadmill walking exercise. 
 
Current blood glucose level:    mmol/l  
Initials:          
 
 
Previous blood glucose time:            Level:  
Previous dose of insulin taken:                   mmol/l 
Usual Insulin dose                                        mmol/l 
Time of meal: 
CHO taken:                                   g. 
 
The participant will commence their 40 minute walk at 3km.h-1 for 2 minutes then the 
intensity will be increased to elicit 60% VO2max determined from the Incremental 
Walking Test.  
During the 40 min exercise participants will have their HR and blood glucose levels 
continuously monitored and RPE will be assessed every 10 minutes.  
Participants should be asked to measure their blood glucose levels 20 minutes 
through the exercise period. 
This test will be terminated if: 
1. The monitoring system failed. 
2. A participant experienced progressive angina. 
3. A participant experienced light headedness, confusion, ataxia, pallor, cyanosis or 
nausea. 
4. A participant experienced discomfort and asked to stop. 
5. Blood glucose levels dropped below 4mmol l־¹ or the participant experiences 
symptoms of hypoglycaemia. 
If any of the above occurs please complete an adverse event form. 
 
 
 
 
Results of blood glucose taken during exercise:         mmol/l    Initials: 
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Ensure that participants test blood glucose levels on completing the period of 
exercise. 
 
Blood glucose level:   mmol/l  
Initials:  
 
 
 
On completion of the test the subject would adopt their normal life style. 
 
Participants would be asked not to perform any structured exercise on day 2.  
 
On day 3 they will be instructed to perform their own exercise at 60% VO2 max for 
40 minutes and check blood glucose levels before, during and after.  
 
Actiheart and minimed meters to be worn continually, and arrangements will be 
made to collect on day 4. 
 
Remind participants to keep monitoring diaries up to date until handing in equipment.  
 
 
 
Day 3 – own exercise 
 
Type: 
Time of day: 
 
Record blood glucose  
Before: 
During: 
After: 
 
Reduce following meal dose: 
 
 
Day 4 
 
Arrangements for collection of equipment and diaries: 
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Visit 2 (day 8) 
 
1. On arrival at the laboratory the participant will be connected to their minimed 
monitor, and given instruction on its use.  
2. Any problems from the previous week will be discussed regarding: diaries, 
equipment and own exercise. 
3. Finally the participants will be attached to the Actiheart physical activity monitor. 
 
After a period of at least 1 hour has elapsed and stable readings are obtained from 
the minimed meter the participant should be asked to measure their blood glucose 
levels using their TrueOne meter; if blood glucose levels are not above 17 mmol l־¹ 
or below 4 mmol־¹, the participant will be put on a Polar heart rate monitor in 
preparation for their treadmill walking exercise. 
 
The participant should be asked to measure their blood glucose levels using their 
TrueOne meter; if blood glucose levels are not above 17 mmol l־¹ or below 4 mmol־¹, 
the participant will be put on a Polar heart rate monitor in preparation for their 
treadmill exercise. 
 
Current blood glucose level:    mmol/l  
Initials:          
 
 
Previous blood glucose time:            Level:  
Previous dose of insulin taken:                   mmol/l 
Usual Insulin dose                                        mmol/l 
Time of meal: 
CHO taken:                                   g. 
 
 
The participant will commence their 40 minute walk at 3km.h-1 for 2 minutes then the 
intensity will be increased to elicit 60% VO2max determined from the Incremental 
Walking Test.  
During the 40 min exercise participants will have their HR and blood glucose levels 
continuously monitored and RPE will be assessed every 10 minutes.  
Participants should be asked to measure their blood glucose levels 20 minutes 
through the exercise period. 
This test will be terminated if: 
1. The monitoring system failed. 
2. A participant experienced progressive angina. 
3. A participant experienced light headedness, confusion, ataxia, pallor, cyanosis or 
nausea. 
4. A participant experienced discomfort and asked to stop. 
5. Blood glucose levels dropped below 4mmol l־¹ or the participant experiences 
symptoms of hypoglycaemia. 
 
If any of the above occur please complete an adverse event form. 
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Blood glucose level during test:          mmol/l 
 
 
 
Ensure that participants test blood glucose levels on completing the period of 
exercise. 
 
Blood glucose level:   mmol/l  
Initials:  
 
 
On completion of the test the subject would adopt their normal life style. 
 
Participants would be asked not to perform any structured exercise on day 9.  
 
On day 10 they will be instructed to perform their own exercise at 60% VO2 max for 
40 minutes and check blood glucose levels before, during and after.  
 
Actiheart and minimed meters to be worn continually, and arrangements will be 
made to collect on day 11. 
 
Remind participants to keep monitoring diaries up to date until handing in equipment.  
 
 
Day 10 – own exercise 
 
Type: 
Time of day: 
 
Record blood glucose  
Before: 
During: 
After: 
 
Reduce following meal dose: 
 
 
Day 11 
 
Arrangements for collection of equipment and diaries: 
  
Initials: 
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Appendix 5 
GP information letter 
 
Edinburgh Napier University 
Faculty of Health, Life and Social Sciences Research Ethics and Governance 
Committee 
 
 
 
 
Date:    
 
 
 
Dear Dr. 
 
 
Testing a self–management algorithm for people with Type 1 diabetes undertaking 
moderate intensity exercise. 
 
Name of participant: _____________________________________ 
 
Date of Birth:   _____________________________________ 
 
 
Your patient has agreed to participate in this research project (see attached patient 
information sheet). The research has been given approval by the NHS and X Ethics 
Committee. If you have any questions please contact me by email or phone. 
  
 
Kind regards 
 
 
 
Jacqui Charlton 
Lecturer/Practitioner in Diabetes 
Edinburgh Napier University 
 
 
 
 
 
Contact details: 
 
Name:  Jacqui Charlton 
Edinburgh Napier University, 74 Canaan Lane, Edinburgh EH9 2TB 
Email / Telephone: j.charlton@napier.ac.uk / 0131 455  5676 
 
